RTC2RaymondChungRaymond Taeyong Chung, M.D.42.36241700000000-71.0689370000000078843Chung, RaymondTaeyong617/724-7562Professor of Medicinecatalyst:advisorInMentoringCompletedStudentProjectcompleted student projectscatalyst:eCommonsLogineCommons LoginMentoring - Completed Student Projectprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:overviewoverviewvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofvivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 1048680529478294Chen JY, Ren Y, Yan P, Belina ME, Chung RT, Butt AAJournal of viral hepatitisTricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES. J Viral Hepat. 2018 07; 25(7):825-833.J Viral Hepat2018-03-22T00:00:002018Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES.11429030Abraczinskas DR, Chung RTTransplant infectious disease : an official journal of the Transplantation SocietyAllograft dysfunction and hyperbilirubinemia in a liver transplant recipient. Transpl Infect Dis. 2000 Dec; 2(4):186-93.Transpl Infect Dis2000-12-01T00:00:002000Allograft dysfunction and hyperbilirubinemia in a liver transplant recipient.12408781Goessling W, Chung RTCurrent treatment options in gastroenterologyAmebic Liver Abscess. Curr Treat Options Gastroenterol. 2002 Dec; 5(6):443-449.Curr Treat Options Gastroenterol2002-12-01T00:00:002002Amebic Liver Abscess.Authorship 105074612Authorship 105068836Authorship 10522572128465298Long MT, Yin X, Larson MG, Ellinor PT, Lubitz SA, McManus DD, Magnani JW, Staerk L, Ko D, Helm RH, Hoffmann U, Chung RT, Benjamin EJJournal of the American Heart AssociationRelations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study. J Am Heart Assoc. 2017 May 02; 6(5).J Am Heart Assoc2017-05-02T00:00:002017Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study.29537660Qu C, Zheng D, Li S, Liu Y, Lidofsky A, Holmes JA, Chen J, He L, Wei L, Liao Y, Yuan H, Jin Q, Lin Z, Hu Q, Jiang Y, Tu M, Chen X, Li W, Lin W, Fuchs BC, Chung RT, Hong JHepatology (Baltimore, Md.)Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology. 2018 09; 68(3):1125-1139.Hepatology2018-05-21T00:00:002018Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.29514030Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, Salvadori N, Cressey TR, Sirirungsi W, Achalapong J, Yuthavisuthi P, Kanjanavikai P, Na Ayudhaya OP, Siriwachirachai T, Prommas S, Sabsanong P, Limtrakul A, Varadisai S, Putiyanun C, Suriyachai P, Liampongsabuddhi P, Sangsawang S, Matanasarawut W, Buranabanjasatean S, Puernngooluerm P, Bowonwatanuwong C, Puthanakit T, Klinbuayaem V, Thongsawat S, Thanprasertsuk S, Siberry GK, Watts DH, Chakhtoura N, Murphy TV, Nelson NP, Chung RT, Pol S, Chotivanich NThe New England journal of medicineTenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. N Engl J Med. 2018 Mar 08; 378(10):911-923.N Engl J Med2018-03-08T00:00:002018Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.6366077Tramont EC, Chung R, Berman S, Keren D, Kapfer C, Formal SBThe Journal of infectious diseasesSafety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C). J Infect Dis. 1984 Feb; 149(2):133-6.J Infect Dis1984-02-01T00:00:001984Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).15510393Yachimski P, Chung RTThe AIDS readerEditorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain. AIDS Read. 2004 Oct; 14(10):568-9.AIDS Read2004-10-01T00:00:002004Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain.15685543Sherman KE, Shire NJ, Rouster SD, Peters MG, James Koziel M, Chung RT, Horn PSGastroenterologyViral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology. 2005 Feb; 128(2):313-27.Gastroenterology2005-02-01T00:00:002005Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.16604073Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HYNature geneticsBone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006 May; 38(5):531-9.Nat Genet2006-04-09T00:00:002006Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.Authorship 10552366Authorship 1055186929599296Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok ASDiabetes careRelationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B. Diabetes Care. 2018 06; 41(6):1251-1259.Diabetes Care2018-03-29T00:00:002018Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.29579601Simon TG, Trejo MEP, McClelland R, Bradley R, Blaha MJ, Zeb I, Corey KE, Budoff MJ, Chung RTInternational journal of cardiologyCirculating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis. Int J Cardiol. 2018 05 15; 259:198-204.Int J Cardiol2018-05-15T00:00:002018Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis.7509773Chung RTHepatology (Baltimore, Md.)Just say "NO" to viral hepatitis? Hepatology. 1994 Mar; 19(3):790-2.Hepatology1994-03-01T00:00:001994Just say "NO" to viral hepatitis?1383822Agnello V, Chung RT, Kaplan LMThe New England journal of medicineA role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992 Nov 19; 327(21):1490-5.N Engl J Med1992-11-19T00:00:001992A role for hepatitis C virus infection in type II cryoglobulinemia.10188829Chung WS, Cho C, Kim S, Wang Y, Lee S, Tarin T, Chung R, Housman L, Jamieson SWMicrosurgeryReview of significant microvascular surgical breakthroughs involving the heart and lungs in rats. Microsurgery. 1999; 19(2):71-7.Microsurgery1999-01-01T00:00:001999Review of significant microvascular surgical breakthroughs involving the heart and lungs in rats.18459156Hiasa Y, Kuzuhara H, Tokumoto Y, Konishi I, Yamashita N, Matsuura B, Michitaka K, Chung RT, Onji MHepatology (Baltimore, Md.)Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta. Hepatology. 2008 Jul; 48(1):59-69.Hepatology2008-07-01T00:00:002008Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.11866292Rosenberg PM, Farrell JJ, Abraczinskas DR, Graeme-Cook FM, Dienstag JL, Chung RTThe American journal of gastroenterologyRapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection. Am J Gastroenterol. 2002 Feb; 97(2):478-83.Am J Gastroenterol2002-02-01T00:00:002002Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.12351951Chung RT, Evans SR, Yang Y, Theodore D, Valdez H, Clark R, Shikuma C, Nevin T, Sherman KEAIDS (London, England)Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. AIDS. 2002 Sep 27; 16(14):1915-23.AIDS2002-09-27T00:00:002002Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects.12806627Somsouk M, Lauer GM, Casson D, Terella A, Day CL, Walker BD, Chung RTGastroenterologySpontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression. Gastroenterology. 2003 Jun; 124(7):1946-9.Gastroenterology2003-06-01T00:00:002003Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression.19284288Tai AW, Chung RTThe Journal of infectious diseasesRacial differences in response to interferon-based antiviral therapy for hepatitis C virus infection: a hardwiring issue? J Infect Dis. 2009 Apr 15; 199(8):1101-3.J Infect Dis2009-04-15T00:00:002009Racial differences in response to interferon-based antiviral therapy for hepatitis C virus infection: a hardwiring issue?19957377Moriguchi H, Chung RT, Sato CHepatology (Baltimore, Md.)New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells. Hepatology. 2010 Jan; 51(1):344-5; author reply 345.Hepatology2010-01-01T00:00:002010New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells.20156586Delgado-Borrego A, Jordan SH, Negre B, Healey D, Lin W, Kamegaya Y, Christofi M, Ludwig DA, Lok AS, Chung RTClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationReduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial. Clin Gastroenterol Hepatol. 2010 May; 8(5):458-62.Clin Gastroenterol Hepatol2010-02-12T00:00:002010Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial.Authorship 1057961429672882Chhatwal J, Bethea ED, Samur S, Chung RTHepatology (Baltimore, Md.)Reply. Hepatology. 2018 08; 68(2):793.Hepatology2018-08-01T00:00:002018Reply.16313977Hiasa Y, Blackard JT, Lin W, Kamegaya Y, Horiike N, Onji M, Schmidt EV, Chung RTJournal of virological methodsCell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication. J Virol Methods. 2006 Mar; 132(1-2):195-203.J Virol Methods2005-11-28T00:00:002005Cell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication.16421490Kotton CN, Marconi VC, Fishman JA, Chung RT, Elias N, Hertl MTransplantationCoccidioidal meningitis after liver transplantation in a nonendemic region: a case report. Transplantation. 2006 Jan 15; 81(1):132-4.Transplantation2006-01-15T00:00:002006Coccidioidal meningitis after liver transplantation in a nonendemic region: a case report.Authorship 10611256Authorship 1061025229694729Rutledge SM, Chung RT, Sise MEHemodialysis international. International Symposium on Home HemodialysisTreatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis. Hemodial Int. 2018 04; 22 Suppl 1:S81-S96.Hemodial Int2018-04-01T00:00:002018Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.29694722Sise ME, Chute DF, Gustafson JL, Wojciechowski D, Elias N, Chung RT, Williams WWHemodialysis international. International Symposium on Home HemodialysisTransplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients. Hemodial Int. 2018 04; 22 Suppl 1:S71-S80.Hemodial Int2018-04-01T00:00:002018Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients.20041404Sherman KE, Soriano V, Chung RTHepatology (Baltimore, Md.)Human immunodeficiency virus and liver disease: conference proceedings. Hepatology. 2010 Mar; 51(3):1046-54.Hepatology2010-03-01T00:00:002010Human immunodeficiency virus and liver disease: conference proceedings.20332044Chung RTGastroenterologyReaping the early harvest of the genomics revolution. Gastroenterology. 2010 May; 138(5):1653-4.Gastroenterology2010-03-21T00:00:002010Reaping the early harvest of the genomics revolution.19957369Moriguchi H, Chung RT, Sato CHepatology (Baltimore, Md.)An indicator for evaluating the risk of cancerous transformations of human induced pluripotent stem cells. Hepatology. 2010 Mar; 51(3):1085-6.Hepatology2010-03-01T00:00:002010An indicator for evaluating the risk of cancerous transformations of human induced pluripotent stem cells.Authorship 113578317561874Aweeka FT, Kang M, Yu JY, Lizak P, Alston B, Chung RTHIV medicinePharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team. HIV Med. 2007 Jul; 8(5):288-94.HIV Med2007-07-01T00:00:002007Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.Authorship 106435911Authorship 10643895Authorship 10657611329761102Fusco DN, Ganova-Raeva L, Khudyakov Y, Punkova L, Mohamed A, Cheon SSY, Koirala P, Andersson KL, Jourdain G, Sureau C, Chung RT, Lauer GFrontiers in medicineReactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy. Front Med (Lausanne). 2018; 5:97.Front Med (Lausanne)2018-04-30T00:00:002018Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy.29761169Kruger AJ, Fuchs BC, Masia R, Holmes JA, Salloum S, Sojoodi M, Ferreira DS, Rutledge SM, Caravan P, Alatrakchi N, Vig P, Lefebvre E, Chung RTHepatology communicationsProlonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis. Hepatol Commun. 2018 May; 2(5):529-545.Hepatol Commun2018-03-07T00:00:002018Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis.29746648MacBrayne CE, Marks KM, Fierer DS, Naggie S, Chung RT, Hughes MD, Kim AY, Peters MG, Brainard DM, Seifert SM, Castillo-Mancilla JR, Bushman LR, Anderson PL, Kiser JJThe Journal of antimicrobial chemotherapyEffects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. J Antimicrob Chemother. 2018 08 01; 73(8):2112-2119.J Antimicrob Chemother2018-08-01T00:00:002018Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate.16996806Rutherford A, Davern T, Hay JE, Murray NG, Hassanein T, Lee WM, Chung RTClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationInfluence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol. 2006 Dec; 4(12):1544-9.Clin Gastroenterol Hepatol2006-09-25T00:00:002006Influence of high body mass index on outcome in acute liver failure.17475911Schulze Zur Wiesch J, Lauer GM, Timm J, Kuntzen T, Neukamm M, Berical A, Jones AM, Nolan BE, Longworth SA, Kasprowicz V, McMahon C, Wurcel A, Lohse AW, Lewis-Ximenez LL, Chung RT, Kim AY, Allen TM, Walker BDBloodImmunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection. Blood. 2007 Sep 01; 110(5):1559-69.Blood2007-05-02T00:00:002007Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection.17699568Kuntzen T, Timm J, Berical A, Lewis-Ximenez LL, Jones A, Nolan B, Schulze zur Wiesch J, Li B, Schneidewind A, Kim AY, Chung RT, Lauer GM, Allen TMJournal of virologyViral sequence evolution in acute hepatitis C virus infection. J Virol. 2007 Nov; 81(21):11658-68.J Virol2007-08-15T00:00:002007Viral sequence evolution in acute hepatitis C virus infection.Authorship 103688218160439Kasprowicz V, Schulze Zur Wiesch J, Kuntzen T, Nolan BE, Longworth S, Berical A, Blum J, McMahon C, Reyor LL, Elias N, Kwok WW, McGovern BG, Freeman G, Chung RT, Klenerman P, Lewis-Ximenez L, Walker BD, Allen TM, Kim AY, Lauer GMJournal of virologyHigh level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol. 2008 Mar; 82(6):3154-60.J Virol2007-12-26T00:00:002007High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.19552960Zúñiga J, Romero V, Azocar J, Terreros D, Vargas-Rojas MI, Torres-GarcÃa D, Jiménez-Alvarez L, Vargas-Alarcón G, Granados-Montiel J, Husain Z, Chung RT, Alper CA, Yunis EJMolecular immunologyProtective KIR-HLA interactions for HCV infection in intravenous drug users. Mol Immunol. 2009 Aug; 46(13):2723-7.Mol Immunol2009-06-24T00:00:002009Protective KIR-HLA interactions for HCV infection in intravenous drug users.Authorship 1068718829788077Simon TG, Van Der Sloot KWJ, Chin SB, Joshi AD, Lochhead P, Ananthakrishnan AN, Xavier R, Chung RT, Khalili HInflammatory bowel diseasesIRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease. Inflamm Bowel Dis. 2018 09 15; 24(10):2247-2257.Inflamm Bowel Dis2018-09-15T00:00:002018IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease.21098019Lin W, Wu G, Li S, Weinberg EM, Kumthip K, Peng LF, Méndez-Navarro J, Chen WC, Jilg N, Zhao H, Goto K, Zhang L, Brockman MA, Schuppan D, Chung RTThe Journal of biological chemistryHIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB. J Biol Chem. 2011 Jan 28; 286(4):2665-74.J Biol Chem2010-11-22T00:00:002010HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB.21805170Patwardhan V, Paul S, Corey KE, Mazhar SM, Richter JM, Thiim M, Chung RTDigestive diseases and sciencesHepatocellular carcinoma screening rates vary by etiology of cirrhosis and involvement of gastrointestinal sub-specialists. Dig Dis Sci. 2011 Nov; 56(11):3316-22.Dig Dis Sci2011-07-30T00:00:002011Hepatocellular carcinoma screening rates vary by etiology of cirrhosis and involvement of gastrointestinal sub-specialists.22003405Dayyeh BK, Gupta N, Sherman KE, de Bakker PI, Chung RTPloS oneIL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy. PLoS One. 2011; 6(10):e25753.PLoS One2011-10-07T00:00:002011IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy.12438584Day CL, Lauer GM, Robbins GK, McGovern B, Wurcel AG, Gandhi RT, Chung RT, Walker BDJournal of virologyBroad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol. 2002 Dec; 76(24):12584-95.J Virol2002-12-01T00:00:002002Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection.14638359Hiasa Y, Kamegaya Y, Nuriya H, Onji M, Kohara M, Schmidt EV, Chung RTThe American journal of gastroenterologyProtein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol. 2003 Nov; 98(11):2528-34.Am J Gastroenterol2003-11-01T00:00:002003Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma.Authorship 107069317Authorship 1070956329868909Lidofsky A, Holmes JA, Feeney ER, Kruger AJ, Salloum S, Zheng H, Seguin IS, Altinbas A, Masia R, Corey KE, Gustafson JL, Schaefer EA, Hunt PW, Deeks S, Somsouk M, Chew KW, Chung RT, Alatrakchi NThe Journal of infectious diseasesMacrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. J Infect Dis. 2018 09 22; 218(9):1394-1403.J Infect Dis2018-09-22T00:00:002018Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.29859984Pringle PL, Soto MT, Chung RT, Hohmann EClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationPatients With Cirrhosis Require More Fecal Microbiota Capsules to Cure Refractory and Recurrent Clostridium difficile Infections. Clin Gastroenterol Hepatol. 2019 03; 17(4):791-793.Clin Gastroenterol Hepatol2018-05-31T00:00:002018Patients With Cirrhosis Require More Fecal Microbiota Capsules to Cure Refractory and Recurrent Clostridium difficile Infections.17194190Kim AY, Schulze zur Wiesch J, Kuntzen T, Timm J, Kaufmann DE, Duncan JE, Jones AM, Wurcel AG, Davis BT, Gandhi RT, Robbins GK, Allen TM, Chung RT, Lauer GM, Walker BDPLoS medicineImpaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med. 2006 Dec; 3(12):e492.PLoS Med2006-12-01T00:00:002006Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection.17393518O'Leary JG, Chan JL, McMahon CM, Chung RTHepatology (Baltimore, Md.)Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: a pilot clinical trial. Hepatology. 2007 Apr; 45(4):895-8.Hepatology2007-04-01T00:00:002007Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: a pilot clinical trial.17967565Rutherford AE, Hynan LS, Borges CB, Forcione DG, Blackard JT, Lin W, Gorman AR, Shaikh OS, Reuben A, Harrison E, Reddy KR, Le WM, Chung RTClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationSerum apoptosis markers in acute liver failure: a pilot study. Clin Gastroenterol Hepatol. 2007 Dec; 5(12):1477-83.Clin Gastroenterol Hepatol2007-10-29T00:00:002007Serum apoptosis markers in acute liver failure: a pilot study.Authorship 1074032729903515Simon TG, Corey KE, Cannon CP, Blazing M, Park JG, O'Donoghue ML, Chung RT, Giugliano RPInternational journal of cardiologyThe nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe. Int J Cardiol. 2018 Nov 01; 270:245-252.Int J Cardiol2018-05-26T00:00:002018The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.8482466Chung RT, Schapiro RH, Warshaw ALGastroenterologyIntraluminal pancreatic candidiasis presenting as recurrent pancreatitis. Gastroenterology. 1993 May; 104(5):1532-4.Gastroenterology1993-05-01T00:00:001993Intraluminal pancreatic candidiasis presenting as recurrent pancreatitis.14695693O'Leary J, Chung RTTaehan Kan Hakhoe chi = The Korean journal of hepatologyNew antiviral therapies for hepatitis C. Taehan Kan Hakhoe Chi. 2003 Dec; 9(4):265-74.Taehan Kan Hakhoe Chi2003-12-01T00:00:002003New antiviral therapies for hepatitis C.15073685Blackard JT, Yang Y, Bordoni P, Sherman KE, Chung RTThe Journal of infectious diseasesHepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. J Infect Dis. 2004 Apr 15; 189(8):1472-81.J Infect Dis2004-03-29T00:00:002004Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy.15362047Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, Robbins GK, Casson DR, Reiser M, Dusheiko G, Allen TM, Chung RT, Walker BD, Klenerman PGastroenterologyHigh resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004 Sep; 127(3):924-36.Gastroenterology2004-09-01T00:00:002004High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.15497158Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RTLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyLiver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl. 2004 Nov; 10(11):1343-54.Liver Transpl2004-11-01T00:00:002004Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.15962220Blackard JT, Smeaton L, Hiasa Y, Horiike N, Onji M, Jamieson DJ, Rodriguez I, Mayer KH, Chung RTThe Journal of infectious diseasesDetection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons. J Infect Dis. 2005 Jul 15; 192(2):258-65.J Infect Dis2005-06-07T00:00:002005Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons.16795921O'Leary JG, Chung RTThe AIDS readerManagement of hepatitis C virus coinfection in HIV-infected persons. AIDS Read. 2006 Jun; 16(6):313-6, 318-20.AIDS Read2006-06-01T00:00:002006Management of hepatitis C virus coinfection in HIV-infected persons.19026009Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, Young SK, Lee B, Heckerman D, Carlson J, Reyor LL, Kleyman M, McMahon CM, Birch C, Schulze Zur Wiesch J, Ledlie T, Koehrsen M, Kodira C, Roberts AD, Lauer GM, Rosen HR, Bihl F, Cerny A, Spengler U, Liu Z, Kim AY, Xing Y, Schneidewind A, Madey MA, Fleckenstein JF, Park VM, Galagan JE, Nusbaum C, Walker BD, Lake-Bakaar GV, Daar ES, Jacobson IM, Gomperts ED, Edlin BR, Donfield SM, Chung RT, Talal AH, Marion T, Birren BW, Henn MR, Allen TMHepatology (Baltimore, Md.)Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology. 2008 Dec; 48(6):1769-78.Hepatology2008-12-01T00:00:002008Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients.19220742Corey KE, Shah N, Misdraji J, Abu Dayyeh BK, Zheng H, Bhan AK, Chung RTLiver international : official journal of the International Association for the Study of the LiverThe effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int. 2009 May; 29(5):748-53.Liver Int2009-02-09T00:00:002009The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C.Authorship 1115049Authorship 1080753429987319Wakeman SE, Ladin K, Brennan T, Chung RTAnnals of internal medicineOpioid Use Disorder, Stigma, and Transplantation: A Call to Action. Ann Intern Med. 2018 08 07; 169(3):188-189.Ann Intern Med2018-07-10T00:00:002018Opioid Use Disorder, Stigma, and Transplantation: A Call to Action.21888876Zhao H, Lin W, Kumthip K, Cheng D, Fusco DN, Hofmann O, Jilg N, Tai AW, Goto K, Zhang L, Hide W, Jang JY, Peng LF, Chung RTJournal of hepatologyA functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus. J Hepatol. 2012 Feb; 56(2):326-33.J Hepatol2011-08-31T00:00:002011A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.17443478Behler CM, Vittinghoff E, Lin F, Chung RT, Peters MG, Robbins GK, Volberding PAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaHematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects. Clin Infect Dis. 2007 May 15; 44(10):1375-83.Clin Infect Dis2007-04-12T00:00:002007Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.23237992Shao RX, Zhang L, Hong Z, Goto K, Cheng D, Chen WC, Jilg N, Kumthip K, Fusco DN, Peng LF, Chung RTAntiviral researchSOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication. Antiviral Res. 2013 Feb; 97(2):101-7.Antiviral Res2012-12-10T00:00:002012SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication.18054581Corey KE, Chung RTGastroenterologyTreating difficult-to-treat hepatitis C virus infection: we may still need to push the ribavirin envelope. Gastroenterology. 2007 Dec; 133(6):2062-3.Gastroenterology2007-12-01T00:00:002007Treating difficult-to-treat hepatitis C virus infection: we may still need to push the ribavirin envelope.19286138Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, Xavier RJ, Chung RTCell host & microbeA functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe. 2009 Mar 19; 5(3):298-307.Cell Host Microbe2009-03-19T00:00:002009A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.Authorship 1088107730119616Martins PN, Brüggenwirth IMA, McDaid J, Hertl M, Kawai T, Elias N, Chung RT, Markmann JFExperimental and clinical transplantation : official journal of the Middle East Society for Organ TransplantationHeat Stroke as a Cause of Liver Failure and Evaluation of Liver Transplant. Exp Clin Transplant. 2022 06; 20(6):621-626.Exp Clin Transplant2018-08-17T00:00:002018Heat Stroke as a Cause of Liver Failure and Evaluation of Liver Transplant.30141205Allegretti AS, Vela Parada X, Ortiz GA, Long J, Krinsky S, Zhao S, Fuchs BC, Sojoodi M, Zhang D, Karumanchi SA, Kalim S, Nigwekar SU, Thadhani RI, Parikh SM, Chung RTHepatology (Baltimore, Md.)Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis. Hepatology. 2019 02; 69(2):729-741.Hepatology2019-01-04T00:00:002019Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis.Authorship 108893415Authorship 1089193830138735Bethea ED, Samur S, Kanwal F, Ayer T, Hur C, Roberts MS, Terrault N, Chung RT, Chhatwal JClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationCost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy. Clin Gastroenterol Hepatol. 2019 03; 17(4):739-747.e8.Clin Gastroenterol Hepatol2018-08-21T00:00:002018Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy.19674285Corey KE, Mendez-Navarro J, Gorospe EC, Zheng H, Chung RTJournal of viral hepatitisEarly treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis. J Viral Hepat. 2010 Mar; 17(3):201-7.J Viral Hepat2009-08-06T00:00:002009Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis.19743901Corey KE, Servoss JC, Casson DR, Kim AY, Robbins GK, Franzini J, Twitchell K, Loomis SC, Abraczinskas DR, Terella AM, Dienstag JL, Chung RTInfection control and hospital epidemiologyPilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers. Infect Control Hosp Epidemiol. 2009 Oct; 30(10):1000-5.Infect Control Hosp Epidemiol2009-10-01T00:00:002009Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers.19960257Méndez-Navarro J, Chirino RA, Corey KE, Gorospe EC, Zheng H, Morán S, Juarez JA, Chung RT, Dehesa-Violante MDigestive diseases and sciencesA randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients. Dig Dis Sci. 2010 Sep; 55(9):2629-35.Dig Dis Sci2009-12-04T00:00:002009A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.Authorship 1091665630179294Long MT, Gurary EB, Massaro JM, Ma J, Hoffmann U, Chung RT, Benjamin EJ, Loomba RLiver international : official journal of the International Association for the Study of the LiverParental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring. Liver Int. 2019 04; 39(4):740-747.Liver Int2018-09-25T00:00:002018Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring.20531022Delgado-Borrego A, Healey D, Negre B, Christofi M, Sabharwal S, Ludwig DA, Chung RT, Jonas MMJournal of pediatric gastroenterology and nutritionInfluence of body mass index on outcome of pediatric chronic hepatitis C virus infection. J Pediatr Gastroenterol Nutr. 2010 Aug; 51(2):191-7.J Pediatr Gastroenterol Nutr2010-08-01T00:00:002010Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection.21146890Jang JY, Shao RX, Lin W, Weinberg E, Chung WJ, Tsai WL, Zhao H, Goto K, Zhang L, Mendez-Navarro J, Jilg N, Peng LF, Brockman MA, Chung RTJournal of hepatologyHIV infection increases HCV-induced hepatocyte apoptosis. J Hepatol. 2011 Apr; 54(4):612-20.J Hepatol2010-09-29T00:00:002010HIV infection increases HCV-induced hepatocyte apoptosis.22213804Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L, Kasprowicz V, Nolan BE, Streeck H, Aneja J, Reyor LL, Allen TM, Lohse AW, McGovern B, Chung RT, Kwok WW, Kim AY, Lauer GMThe Journal of experimental medicineBroadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med. 2012 Jan 16; 209(1):61-75.J Exp Med2012-01-02T00:00:002012Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.22359532Corey KE, Zheng H, Mendez-Navarro J, Delgado-Borrego A, Dienstag JL, Chung RTPloS oneSerum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis. PLoS One. 2012; 7(2):e27144.PLoS One2012-02-16T00:00:002012Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis.22765955Delgado-Borrego A, Smith L, Jonas MM, Hall CA, Negre B, Jordan SH, Ogrodowicz M, Raza R, Ludwig DA, Miller T, Lipshultz SE, Gonzalez-Peralta R, Chung RTThe Journal of pediatricsExpected and actual case ascertainment and treatment rates for children infected with hepatitis C in Florida and the United States: epidemiologic evidence from statewide and nationwide surveys. J Pediatr. 2012 Nov; 161(5):915-21.J Pediatr2012-07-03T00:00:002012Expected and actual case ascertainment and treatment rates for children infected with hepatitis C in Florida and the United States: epidemiologic evidence from statewide and nationwide surveys.19549523Kim AY, Chung RTGastroenterologyCoinfection with HIV-1 and HCV--a one-two punch. Gastroenterology. 2009 Sep; 137(3):795-814.Gastroenterology2009-06-21T00:00:002009Coinfection with HIV-1 and HCV--a one-two punch.Authorship 109429213Authorship 109293115Authorship 10927182130218669Bhan I, Mosesso K, Goyal L, Philipp J, Kalinich M, Franses JW, Choz M, Oklu R, Toner M, Maheswaran S, Haber DA, Zhu AX, Chung RT, Aryee M, Ting DTGastroenterologyDetection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease. Gastroenterology. 2018 12; 155(6):2016-2018.e11.Gastroenterology2018-09-13T00:00:002018Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease.30202815Luther J, Gala MK, Borren N, Masia R, Goodman RP, Moeller IH, DiGiacomo E, Ehrlich A, Warren A, Yarmush ML, Ananthakrishnan A, Corey K, Kaplan LM, Bhatia S, Chung RT, Patel SJHepatology communicationsHepatic connexin 32 associates with nonalcoholic fatty liver disease severity. Hepatol Commun. 2018 Jul; 2(7):786-797.Hepatol Commun2018-07-16T00:00:002018Hepatic connexin 32 associates with nonalcoholic fatty liver disease severity.30199576Liu X, Duan X, Holmes JA, Li W, Lee SH, Tu Z, Zhu C, Salloum S, Lidofsky A, Schaefer EA, Cai D, Li S, Wang H, Huang Y, Zhao Y, Yu ML, Xu Z, Chen L, Hong J, Lin W, Chung RTHepatology (Baltimore, Md.)A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6. Hepatology. 2019 03; 69(3):1004-1019.Hepatology2019-02-13T00:00:002019A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6.21440548Abu Dayyeh BK, Yang M, Fuchs BC, Karl DL, Yamada S, Sninsky JJ, O'Brien TR, Dienstag JL, Tanabe KK, Chung RTGastroenterologyA functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology. 2011 Jul; 141(1):141-9.Gastroenterology2011-03-24T00:00:002011A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.23323249Jeong SW, Jang JY, Chung RTClinical and molecular hepatologyHepatitis C virus and hepatocarcinogenesis. Clin Mol Hepatol. 2012 Dec; 18(4):347-56.Clin Mol Hepatol2012-12-21T00:00:002012Hepatitis C virus and hepatocarcinogenesis.6830439Chung R, Lewis JWArchives of surgery (Chicago, Ill. : 1960)Cost of treatment of bleeding esophageal varices. Arch Surg. 1983 Apr; 118(4):482-5.Arch Surg1983-04-01T00:00:001983Cost of treatment of bleeding esophageal varices.Authorship 1095371930286235Simon TG, Ma Y, Ludvigsson JF, Chong DQ, Giovannucci EL, Fuchs CS, Meyerhardt JA, Corey KE, Chung RT, Zhang X, Chan ATJAMA oncologyAssociation Between Aspirin Use and Risk of Hepatocellular Carcinoma. JAMA Oncol. 2018 12 01; 4(12):1683-1690.JAMA Oncol2018-12-01T00:00:002018Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.16136646Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DRJournal of hepatologySerum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol. 2005 Sep; 43(3):434-41.J Hepatol2005-09-01T00:00:002005Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.17439522Timm J, Neukamm M, Kuntzen T, Kim AY, Chung RT, Brander C, Lauer GM, Walker BD, Allen TMJournal of viral hepatitisCharacterization of full-length hepatitis C virus genotype 4 sequences. J Viral Hepat. 2007 May; 14(5):330-7.J Viral Hepat2007-05-01T00:00:002007Characterization of full-length hepatitis C virus genotype 4 sequences.Authorship 11037252430312106Nikolic I, Yung LM, Yang P, Malhotra R, Paskin-Flerlage SD, Dinter T, Bocobo GA, Tumelty KE, Faugno AJ, Troncone L, McNeil ME, Huang X, Coser KR, Lai CSC, Upton PD, Goumans MJ, Zamanian RT, Elliott CG, Lee A, Zheng W, Berasi SP, Huard C, Morrell NW, Chung RT, Channick RW, Roberts KE, Yu PBAmerican journal of respiratory and critical care medicineBone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension. Am J Respir Crit Care Med. 2019 04 01; 199(7):891-902.Am J Respir Crit Care Med2019-04-01T00:00:002019Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.7788540Chung RT, Jaffe DL, Friedman LSCritical care clinicsComplications of chronic liver disease. Crit Care Clin. 1995 Apr; 11(2):431-63.Crit Care Clin1995-04-01T00:00:001995Complications of chronic liver disease.Authorship 105134720087331Monto A, Schooley RT, Lai JC, Sulkowski MS, Chung RT, Pawlotsky JM, McHutchison JG, Jacobson IMThe American journal of gastroenterologyLessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop. Am J Gastroenterol. 2010 May; 105(5):989-1004; quiz 988, 1005.Am J Gastroenterol2010-01-19T00:00:002010Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop.20088833Contreras AM, Ochoa-Jiménez RJ, Celis A, Méndez C, Olivares L, Rebolledo CE, Hernandez-Lugo I, Aguirre-Zavala AI, Jiménez-Méndez R, Chung RTTransfusionHigh antibody level: an accurate serologic marker of viremia in asymptomatic people with hepatitis C infection. Transfusion. 2010 Jun; 50(6):1335-43.Transfusion2010-01-15T00:00:002010High antibody level: an accurate serologic marker of viremia in asymptomatic people with hepatitis C infection.20228847Tsai WL, Chung RTOncogeneViral hepatocarcinogenesis. Oncogene. 2010 Apr 22; 29(16):2309-24.Oncogene2010-03-15T00:00:002010Viral hepatocarcinogenesis.Authorship 1210216Authorship 1111360730410040Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MGThe American journal of gastroenterologySpectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study. Am J Gastroenterol. 2019 05; 114(5):746-757.Am J Gastroenterol2019-05-01T00:00:002019Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study.10919611Farrell JJ, Cosimi AB, Chung RTTransplantationIdiopathic giant esophageal ulcers in a renal transplant patient responsive to steroid therapy. Transplantation. 2000 Jul 15; 70(1):230-2.Transplantation2000-07-15T00:00:002000Idiopathic giant esophageal ulcers in a renal transplant patient responsive to steroid therapy.11579302Baid S, Cosimi AB, Farrell ML, Schoenfeld DA, Feng S, Chung RT, Tolkoff-Rubin N, Pascual MTransplantationPosttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation. 2001 Sep 27; 72(6):1066-72.Transplantation2001-09-27T00:00:002001Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality.Authorship 11148461630450781Holmes JA, Carlton-Smith C, Kim AY, Dumas EO, Brown J, Gustafson JL, Lauer GM, Silva ST, Robidoux M, Kvistad D, Alatrakchi N, Tonnerre P, Cohen DE, Zhang H, Shulman NS, Chung RTJournal of viral hepatitisDynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection. J Viral Hepat. 2019 03; 26(3):362-372.J Viral Hepat2019-01-03T00:00:002019Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection.11923691Dellon ES, Szczepiorkowski ZM, Dzik WH, Graeme-Cook F, Ades A, Bloomer JR, Cosimi AB, Chung RTTransplantationTreatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation. 2002 Mar 27; 73(6):911-5.Transplantation2002-03-27T00:00:002002Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria.16317672Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Cheng B, Bodenheimer H, Thung SN, Chung RT, Schwartz ME, Bodian C, Branch ADHepatology (Baltimore, Md.)Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology. 2005 Dec; 42(6):1420-8.Hepatology2005-12-01T00:00:002005Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors.7748095Obeid F, Saba A, Fath J, Guslits B, Chung R, Sorensen V, Buck J, Horst MArchives of surgery (Chicago, Ill. : 1960)Increases in intra-abdominal pressure affect pulmonary compliance. Arch Surg. 1995 May; 130(5):544-7; discussion 547-8.Arch Surg1995-05-01T00:00:001995Increases in intra-abdominal pressure affect pulmonary compliance.16967041Servoss JC, Kitch DW, Andersen JW, Reisler RB, Chung RT, Robbins GKJournal of acquired immune deficiency syndromes (1999)Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999). J Acquir Immune Defic Syndr. 2006 Nov 01; 43(3):320-3.J Acquir Immune Defic Syndr2006-11-01T00:00:002006Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).17065644Chung RT, Misdraji J, Sahani DVThe New England journal of medicineCase records of the Massachusetts General Hospital. Case 33-2006. A 43-year-old man with diabetes, hypogonadism, cirrhosis, arthralgias, and fatigue. N Engl J Med. 2006 Oct 26; 355(17):1812-9.N Engl J Med2006-10-26T00:00:002006Case records of the Massachusetts General Hospital. Case 33-2006. A 43-year-old man with diabetes, hypogonadism, cirrhosis, arthralgias, and fatigue.Authorship 11178752530510168Eddowes LA, Al-Hourani K, Ramamurthy N, Frankish J, Baddock HT, Sandor C, Ryan JD, Fusco DN, Arezes J, Giannoulatou E, Boninsegna S, Chevaliez S, Owens BMJ, Sun CC, Fabris P, Giordani MT, Martines D, Vukicevic S, Crowe J, Lin HY, Rehwinkel J, McHugh PJ, Binder M, Babitt JL, Chung RT, Lawless MW, Armitage AE, Webber C, Klenerman P, Drakesmith HNature microbiologyAntiviral activity of bone morphogenetic proteins and activins. Nat Microbiol. 2019 02; 4(2):339-351.Nat Microbiol2018-12-03T00:00:002018Antiviral activity of bone morphogenetic proteins and activins.17681193Tai AW, Chung RTGastroenterologyp53 restoration leads to tumor senescence and regression: implications for cancer therapy. Gastroenterology. 2007 Aug; 133(2):722-3.Gastroenterology2007-08-01T00:00:002007p53 restoration leads to tumor senescence and regression: implications for cancer therapy.2019-03-29T00:00:002018-03-01T00:00:00Metformin Use is Associated with Hepatic Fibrosis Regression Independent of Weight Loss in Nonalcoholic Fatty Liver Disease
Soma Weiss21784050Jilg N, Chung RTJournal of hepatologyAdding to the toolbox: receptor tyrosine kinases as potential targets in the treatment of hepatitis C. J Hepatol. 2012 Jan; 56(1):282-4.J Hepatol2011-07-22T00:00:002011Adding to the toolbox: receptor tyrosine kinases as potential targets in the treatment of hepatitis C.Authorship 1120997530549279Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok ASHepatology (Baltimore, Md.)Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection. Hepatology. 2019 06; 69(6):2338-2348.Hepatology2019-03-14T00:00:002019Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.Authorship 112196910Authorship 1122064230580250Hoogeveen RC, Robidoux MP, Schwarz T, Heydmann L, Cheney JA, Kvistad D, Aneja J, Melgaço JG, Fernandes CA, Chung RT, Boonstra A, Kim AY, Baumert TF, Timm J, Lewis-Ximenez LL, Tonnerre P, Lauer GMGutPhenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection. Gut. 2019 05; 68(5):893-904.Gut2018-12-22T00:00:002018Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection.30593615Li DK, Chung RTMethods in molecular biology (Clifton, N.J.)Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus. Methods Mol Biol. 2019; 1911:3-32.Methods Mol Biol2019-01-01T00:00:002019Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus.8192457Mayers DL, Japour AJ, Arduino JM, Hammer SM, Reichman R, Wagner KF, Chung R, Lane J, Crumpacker CS, McLeod GXAntimicrobial agents and chemotherapyDideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group. Antimicrob Agents Chemother. 1994 Feb; 38(2):307-14.Antimicrob Agents Chemother1994-02-01T00:00:001994Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group.Authorship 112315713Authorship 1122797430593799Vergara C, Thio CL, Johnson E, Kral AH, O'Brien TR, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Busch MP, Alexander G, Rosen HR, Murphy EL, Latanich R, Wojcik GL, Taub MA, Valencia A, Thomas DL, Duggal PGastroenterologyMulti-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. Gastroenterology. 2019 Apr; 156(5):1496-1507.e7.Gastroenterology2018-12-26T00:00:002018Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.30597691Simon TG, Deng X, Liu CT, Chung RT, Long MTLiver international : official journal of the International Association for the Study of the LiverThe immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study. Liver Int. 2019 06; 39(6):1022-1026.Liver Int2019-02-17T00:00:002019The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study.9918842Chung RT, Kaplan LMBiochemical and biophysical research communicationsHeterogeneous nuclear ribonucleoprotein I (hnRNP-I/PTB) selectively binds the conserved 3' terminus of hepatitis C viral RNA. Biochem Biophys Res Commun. 1999 Jan 19; 254(2):351-62.Biochem Biophys Res Commun1999-01-19T00:00:001999Heterogeneous nuclear ribonucleoprotein I (hnRNP-I/PTB) selectively binds the conserved 3' terminus of hepatitis C viral RNA.12099368Chung RT, Feng S, Delmonico FLAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsApproach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor. Am J Transplant. 2001 Jul; 1(2):185-91.Am J Transplant2001-07-01T00:00:002001Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor.12163570Contreras AM, Hiasa Y, He W, Terella A, Schmidt EV, Chung RTJournal of virologyViral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol. 2002 Sep; 76(17):8505-17.J Virol2002-09-01T00:00:002002Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.12466763Chung RTMedGenMed : Medscape general medicineNew developments in the management of hepatitis B virus/HIV coinfection. MedGenMed. 2002 Sep 03; 4(3):20.MedGenMed2002-09-03T00:00:002002New developments in the management of hepatitis B virus/HIV coinfection.15282352Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst CThe New England journal of medicinePeginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med. 2004 Jul 29; 351(5):451-9.N Engl J Med2004-07-29T00:00:002004Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.15641028Chung RTCancerCytokine polymorphisms and hepatocellular carcinoma: to B or not to B. Cancer. 2005 Feb 15; 103(4):654-6.Cancer2005-02-15T00:00:002005Cytokine polymorphisms and hepatocellular carcinoma: to B or not to B.16971263Andersson K, Chung RTClinics in liver diseaseHepatitis C Virus in the HIV-infected patient. Clin Liver Dis. 2006 May; 10(2):303-20, viii.Clin Liver Dis2006-05-01T00:00:002006Hepatitis C Virus in the HIV-infected patient.Authorship 11259465Authorship 11267808Authorship 11256851Authorship 1125896130554209Couri T, Cotter TG, Chen D, Hammes M, Reddy B, Josephson M, Yeh H, Chung RT, Paul SAmerican journal of nephrologyUse of Hepatitis C Positive Organs: Patient Attitudes in Urban Chicago. Am J Nephrol. 2019; 49(1):32-40.Am J Nephrol2018-12-14T00:00:002018Use of Hepatitis C Positive Organs: Patient Attitudes in Urban Chicago.30652157Chung R, Chawla A, Shikhare S, Babu SCVIR endovascularTrends and implications of 24/7 interventional radiology in a newly opened acute hospital. CVIR Endovasc. 2018; 1(1):26.CVIR Endovasc2018-10-29T00:00:002018Trends and implications of 24/7 interventional radiology in a newly opened acute hospital.28642963Chung R, Chawla A, Peh WCSingapore medical journalClinics in diagnostic imaging (178). Wünderlich syndrome and pseudoaneurysm. Singapore Med J. 2017 Jun; 58(6):289-293.Singapore Med J2017-06-01T00:00:002017Clinics in diagnostic imaging (178). Wünderlich syndrome and pseudoaneurysm.30364486Chawla A, Babu SB, Kannivelu A, Shikhare SS, Chung RBJR case reportsImaging features and transcatheter treatment of a giant pulmonary arteriovenous malformation in an elderly patient. BJR Case Rep. 2016; 2(1):20150005.BJR Case Rep2015-10-08T00:00:002015Imaging features and transcatheter treatment of a giant pulmonary arteriovenous malformation in an elderly patient.18171203O'Leary JG, Zachary K, Misdraji J, Chung RTClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaDe novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy. Clin Infect Dis. 2008 Jan 01; 46(1):e12-4.Clin Infect Dis2008-01-01T00:00:002008De novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy.19268724Shire NJ, Rao MB, Succop P, Buncher CR, Andersen JA, Butt AA, Chung RT, Sherman KEClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationImproving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. Clin Gastroenterol Hepatol. 2009 Apr; 7(4):471-80, 480.e1-2.Clin Gastroenterol Hepatol2008-12-25T00:00:002008Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection.21232563Fusco DN, Chung RTJournal of hepatologyNew protease inhibitors for HCV--help is on the way. J Hepatol. 2011 Jun; 54(6):1087-9.J Hepatol2011-01-11T00:00:002011New protease inhibitors for HCV--help is on the way.22359663Zhang L, Hong Z, Lin W, Shao RX, Goto K, Hsu VW, Chung RTPloS oneARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication. PLoS One. 2012; 7(2):e32135.PLoS One2012-02-16T00:00:002012ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication.23177160Rutherford A, King LY, Lee WM, Chung RTGastroenterologyReply: To PMID 22885329. Gastroenterology. 2013 Jan; 144(1):e26.Gastroenterology2012-11-20T00:00:002012Reply: To PMID 22885329.Authorship 1132645330765125Holmes JA, Rutledge SM, Chung RTLancet (London, England)Direct-acting antiviral treatment for hepatitis C. Lancet. 2019 04 06; 393(10179):1392-1394.Lancet2019-02-11T00:00:002019Direct-acting antiviral treatment for hepatitis C.Authorship 1133101630809903Ufere NN, Brahmania M, Sey M, Teriaky A, El-Jawahri A, Walley KR, Celi LA, Chung RT, Rush BLiver international : official journal of the International Association for the Study of the LiverOutcomes of in-hospital cardiopulmonary resuscitation for patients with end-stage liver disease. Liver Int. 2019 07; 39(7):1256-1262.Liver Int2019-03-26T00:00:002019Outcomes of in-hospital cardiopulmonary resuscitation for patients with end-stage liver disease.30885884Ufere NN, Donlan J, Waldman L, Dienstag JL, Friedman LS, Corey KE, Hashemi N, Carolan P, Mullen AC, Thiim M, Bhan I, Nipp R, Greer JA, Temel JS, Chung RT, El-Jawahri AClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationBarriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease. Clin Gastroenterol Hepatol. 2019 11; 17(12):2592-2599.Clin Gastroenterol Hepatol2019-03-15T00:00:002019Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease.Authorship 113559810Authorship 11373876Authorship 1136188830854694Corey KE, Wilson LA, Altinbas A, Yates KP, Kleiner DE, Chung RT, Krauss RM, Chalasani NAlimentary pharmacology & therapeuticsRelationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial. Aliment Pharmacol Ther. 2019 05; 49(9):1205-1213.Aliment Pharmacol Ther2019-03-10T00:00:002019Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial.30827414Ajmera V, Huang H, Dao D, Feld JJ, Lau DT, Patel K, Rule JA, Daly M, Lee WM, Chung RTCellular and molecular gastroenterology and hepatologyHost Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver Failure. Cell Mol Gastroenterol Hepatol. 2019; 7(2):477-479.e4.Cell Mol Gastroenterol Hepatol2018-10-17T00:00:002018Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver Failure.30963669Ufere NN, Donlan J, Waldman L, Patel A, Dienstag JL, Friedman LS, Corey KE, Hashemi N, Carolan P, Mullen AC, Thiim M, Bhan I, Nipp R, Greer J, Temel J, Chung RT, El-Jawahri ALiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyPhysicians' Perspectives on Palliative Care for Patients With End-Stage Liver Disease: A National Survey Study. Liver Transpl. 2019 06; 25(6):859-869.Liver Transpl2019-05-03T00:00:002019Physicians' Perspectives on Palliative Care for Patients With End-Stage Liver Disease: A National Survey Study.D000998Chemicals & Drugs113629710.400857Antiviral AgentsAuthorship 114041215Authorship 114134016Authorship 11437622Authorship 114418021Authorship 11471975Authorship 1148028230992776Li DK, Chung RTClinical liver diseaseUse of proton pump inhibitors in chronic liver diseases. Clin Liver Dis (Hoboken). 2017 Dec; 10(6):148-151.Clin Liver Dis (Hoboken)2018-01-02T00:00:002018Use of proton pump inhibitors in chronic liver diseases.30992888Lin MV, Chung RClinical liver diseaseRecent FDA approval of sofosbuvir and simeprevir. Implications for current HCV treatment. Clin Liver Dis (Hoboken). 2014 Mar; 3(3):65-68.Clin Liver Dis (Hoboken)2014-04-01T00:00:002014Recent FDA approval of sofosbuvir and simeprevir. Implications for current HCV treatment.31001828Sise ME, Wojciechowski D, Chute DF, Gustafson J, Chung RT, Williams WW, Elias NArtificial organsProcess of selecting and educating HCV-uninfected kidney waiting-list candidates for HCV-infected kidney transplantation. Artif Organs. 2019 Sep; 43(9):913-920.Artif Organs2019-05-29T00:00:002019Process of selecting and educating HCV-uninfected kidney waiting-list candidates for HCV-infected kidney transplantation.30974864Duan X, Liu X, Li W, Holmes JA, Kruger AJ, Yang C, Li Y, Xu M, Ye H, Li S, Liao X, Sheng Q, Chen D, Shao T, Cheng Z, Kaj B, Schaefer EA, Li S, Chen L, Lin W, Chung RTCellsMicrorna-130a Downregulates HCV Replication through an atg5-Dependent Autophagy Pathway. Cells. 2019 04 10; 8(4).Cells2019-04-10T00:00:002019Microrna-130a Downregulates HCV Replication through an atg5-Dependent Autophagy Pathway.D019698Disorders31110260.533882Hepatitis C, ChronicAuthorship 1148403531008739Sise ME, Strohbehn IA, Bethea E, Gustafson JL, Chung RTCurrent opinion in organ transplantationBalancing the risk and rewards of utilizing organs from hepatitis C viremic donors. Curr Opin Organ Transplant. 2019 Apr 16.Curr Opin Organ Transplant2019-04-16T00:00:002019Balancing the risk and rewards of utilizing organs from hepatitis C viremic donors.D006526Disorders49715800.465942Hepatitis CD016174Living Beings37213710.567015HepacivirusD008103Disorders68618380.470232Liver CirrhosisMedicineRadiologyGastroenterologyNephrologyBeth Israel Deaconess Medical CenterBrigham and Women's HospitalMassachusetts General HospitalGL13GeorgLauerGeorg Lauer, M.D., Ph.D.42.36241700000000-71.0689370000000025189Lauer, GeorgAssociate Professor of MedicineDRA1DianeAbraczinskasDiane Renee Abraczinskas, M.D.42.36241700000000-71.0689370000000083306Abraczinskas, DianeAssistant Professor of MedicineKEC4KathleenCoreyKathleen Corey, M.D.42.36241700000000-71.0689370000000038751Corey, KathleenAssociate Professor of MedicineMPC3MichaelCurryMichael Patrick Curry, M.D.42.33700000000000-71.1100000000000082885Curry, MichaelProfessor of MedicineAuthorship 11541597Authorship 11531105Authorship 1153023631082876Bzowej NH, Tran TT, Li R, Belle SH, Smith CI, Khalili M, Chung R, Tsai N, Terrault NThe American journal of gastroenterologyTotal Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study. Am J Gastroenterol. 2019 08; 114(8):1283-1291.Am J Gastroenterol2019-08-01T00:00:002019Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.31090648Sise ME, Strohbehn IA, Bethea E, Gustafson JL, Chung RTCurrent opinion in organ transplantationBalancing the risk and rewards of utilizing organs from hepatitis C viremic donors. Curr Opin Organ Transplant. 2019 06; 24(3):351-357.Curr Opin Organ Transplant2019-06-01T00:00:002019Balancing the risk and rewards of utilizing organs from hepatitis C viremic donors.31077838Simon TG, Henson J, Osganian S, Masia R, Chan AT, Chung RT, Corey KEClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationDaily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019 12; 17(13):2776-2784.e4.Clin Gastroenterol Hepatol2019-05-09T00:00:002019Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.Authorship 1155945931120995Allegretti AS, Frenk NE, Li DK, Seethapathy H, Vela Parada XF, Long J, Endres P, Pratt DS, Chung RT, Ganguli S, Irani Z, Yamada KPloS oneEvaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. PLoS One. 2019; 14(5):e0217442.PLoS One2019-05-23T00:00:002019Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement.TGS4TraceySimonTracey Simon, M.D.109258Simon, TraceyAssistant Professor of MedicineAuthorship 1156957231134647Bloom PP, Chung RTAlimentary pharmacology & therapeuticsEditorial: mind the gaps - an important first step towards improving hepatic encephalopathy care. Aliment Pharmacol Ther. 2019 06; 49(12):1534-1535.Aliment Pharmacol Ther2019-06-01T00:00:002019Editorial: mind the gaps - an important first step towards improving hepatic encephalopathy care.MES54MeghanSiseMeghan Elizabeth Sise, M.D.42.36241700000000-71.0689370000000083676Sise, MeghanAssociate Professor of MedicineAuthorship 1487506BJN1BarbaraNathBarbara Joyce Nath, M.D.42.36241700000000-71.0689370000000028133Nath, BarbaraAssistant Professor of MedicineEAS37EsperanceSchaeferEsperance Anne Kreek Schaefer, M.D.42.36241700000000-71.0689370000000044096Schaefer, EsperanceInstructor in MedicineAuthorship 1265871Authorship 1319363Authorship 116069410Authorship 116150014Authorship 1163091731216276Perez S, Kaspi A, Domovitz T, Davidovich A, Lavi-Itzkovitz A, Meirson T, Alison Holmes J, Dai CY, Huang CF, Chung RT, Nimer A, El-Osta A, Yaari G, Stemmer SM, Yu ML, Haviv I, Gal-Tanamy MPLoS geneticsHepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals. PLoS Genet. 2019 06; 15(6):e1008181.PLoS Genet2019-06-19T00:00:002019Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.31220357Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MGHepatology (Baltimore, Md.)Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults. Hepatology. 2020 02; 71(2):411-421.Hepatology2019-08-19T00:00:002019Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults.31220220Naggie S, Fierer DS, Hughes MD, Kim AY, Luetkemeyer A, Vu V, Roa J, Rwema S, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Marks KM, Chung RTClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaLedipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals. Clin Infect Dis. 2019 07 18; 69(3):514-522.Clin Infect Dis2019-07-18T00:00:002019Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.11637selected publications20.32430.002159331299research areas9.547280.00773358307coauthor of793.47274.43960similar toACM10AlanMullenAlan Cyril Mullen, M.D.,Ph.D.42.36241700000000-71.0689370000000026951Mullen, AlanAssociate Professor of MedicineKDS4KYLESTALLERKYLE STALLER, M.D.42.36241700000000-71.0689370000000047029STALLER, KYLEAssistant Professor of MedicineNHA1NezamAfdhalNezam Hassan Afdhal, M.D.42.33700000000000-71.110000000000004694Afdhal, NezamCharlotte F. and Irving W. Rabb Professor of MedicineCJB4CherylBunkerCheryl Jean Bunker, M.D.42.36241700000000-71.0689370000000071162Bunker, CherylAssistant Professor of Medicine31326503Ufere NN, O'Riordan DL, Bischoff KE, Marks AK, Eneanya N, Chung RT, Jackson V, Pantilat SZ, El-Jawahri AJournal of pain and symptom managementOutcomes of Palliative Care Consultations for Hospitalized Patients With Liver Disease. J Pain Symptom Manage. 2019 11; 58(5):766-773.J Pain Symptom Manage2019-07-19T00:00:002019Outcomes of Palliative Care Consultations for Hospitalized Patients With Liver Disease.Authorship 117432512Authorship 1175380631337501Sise ME, Chute DF, Oppong Y, Davis MI, Long JD, Silva ST, Rusibamayila N, Jean-Francois D, Raji S, Zhao S, Thadhani R, Chung RTKidney internationalDirect-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease. Kidney Int. 2020 01; 97(1):193-201.Kidney Int2019-05-15T00:00:002019Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease.Authorship 11772287Authorship 11762833131363954Bloom PP, Mojtahed A, Bethea ED, Knooihuizen SA, Choi J, Dienstag JL, Chung RT, Hur CDigestive diseases and sciencesComputed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes. Dig Dis Sci. 2020 01; 65(1):312-321.Dig Dis Sci2019-07-30T00:00:002019Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes.31353243Bethea ED, Gaj K, Gustafson JL, Axtell A, Lebeis T, Schoenike M, Turvey K, Coglianese E, Thomas S, Newton-Cheh C, Ibrahim N, Carlson W, Ho JE, Shah R, Nayor M, Gift T, Shao S, Dugal A, Markmann J, Elias N, Yeh H, Andersson K, Pratt D, Bhan I, Safa K, Fishman J, Kotton C, Myoung P, Villavicencio MA, D'Alessandro D, Chung RT, Lewis GDThe lancet. Gastroenterology & hepatologyPre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study. Lancet Gastroenterol Hepatol. 2019 10; 4(10):771-780.Lancet Gastroenterol Hepatol2019-07-26T00:00:002019Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.Authorship 1179947631390615Couri T, Katz J, Stoeckle K, Nugooru A, Yeh H, Chung R, Paul SAmerican journal of nephrologyProvider Attitudes toward the Use of Hepatitis C Virus-Positive Organs in Kidney Transplantation. Am J Nephrol. 2019; 50(3):168-176.Am J Nephrol2019-08-07T00:00:002019Provider Attitudes toward the Use of Hepatitis C Virus-Positive Organs in Kidney Transplantation.GS14GyongyiSzaboGyongyi Szabo, M.D., Ph.D.28770Szabo, GyongyiProfessor of MedicineAuthorship 11830203Authorship 11842507Authorship 1182963431453368Rutledge SM, Zheng H, Li DK, Chung RTHepatoma researchNo evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis. Hepatoma Res. 2019; 5.Hepatoma Res2019-08-07T00:00:002019No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis.31426090Simon TG, Duberg AS, Aleman S, Hagstrom H, Nguyen LH, Khalili H, Chung RT, Ludvigsson JFAnnals of internal medicineLipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population. Ann Intern Med. 2019 09 03; 171(5):318-327.Ann Intern Med2019-08-20T00:00:002019Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.31449156Bajaj JS, Bloom PP, Chung RT, Hassanein TI, Padilla-Martinez M, Kayali Z, Rockey DC, Sasso R, Muthukumar AR, Lee WM, Denney WS, Gavis EA, Anderson C, Blankstein L, Brennan AM, Puurunen MK, Lawitz EThe American journal of gastroenterologyVariability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice. Am J Gastroenterol. 2020 05; 115(5):783-785.Am J Gastroenterol2020-05-01T00:00:002020Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice.Authorship 1160512Authorship 141809231611038Stanley TL, Fourman LT, Feldpausch MN, Purdy J, Zheng I, Pan CS, Aepfelbacher J, Buckless C, Tsao A, Kellogg A, Branch K, Lee H, Liu CY, Corey KE, Chung RT, Torriani M, Kleiner DE, Hadigan CM, Grinspoon SKThe lancet. HIVEffects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV. 2019 12; 6(12):e821-e830.Lancet HIV2019-10-11T00:00:002019Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.Authorship 11970995Authorship 11972871531613956Chihota BV, Wandeler G, Chilengi R, Mulenga L, Chung RT, Bhattacharya D, Egger M, Vinikoor MJThe Journal of infectious diseasesHigh Rates of Hepatitis B Virus (HBV) Functional Cure Among Human Immunodeficiency Virus-HBV Coinfected Patients on Antiretroviral Therapy in Zambia. J Infect Dis. 2020 01 02; 221(2):218-222.J Infect Dis2020-01-02T00:00:002020High Rates of Hepatitis B Virus (HBV) Functional Cure Among Human Immunodeficiency Virus-HBV Coinfected Patients on Antiretroviral Therapy in Zambia.31655192Ufere NN, Halford JL, Caldwell J, Jang MY, Bhatt S, Donlan J, Ho J, Jackson V, Chung RT, El-Jawahri AJournal of pain and symptom managementHealth Care Utilization and End-of-Life Care Outcomes for Patients With Decompensated Cirrhosis Based on Transplant Candidacy. J Pain Symptom Manage. 2020 03; 59(3):590-598.J Pain Symptom Manage2019-10-23T00:00:002019Health Care Utilization and End-of-Life Care Outcomes for Patients With Decompensated Cirrhosis Based on Transplant Candidacy.31665575DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA, Huntley MH, Turbett S, Chung RT, Chen YB, Hohmann ELThe New England journal of medicineDrug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. N Engl J Med. 2019 11 21; 381(21):2043-2050.N Engl J Med2019-10-30T00:00:002019Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant.Authorship 12005589Authorship 12004428true1Associate Professor of MedicineAssociate Professor of Medicinetrue1Assistant Professor of MedicineAssistant Professor of Medicinetrue1Assistant Professor of MedicineAssistant Professor of Medicinetrue1Assistant Professor of MedicineAssistant Professor of Medicinetrue1Assistant Professor of MedicineAssistant Professor of MedicineAuthorship 1226134Authorship 1224151Authorship 12119401031839486Cai B, Dongiovanni P, Corey KE, Wang X, Shmarakov IO, Zheng Z, Kasikara C, Davra V, Meroni M, Chung RT, Rothlin CV, Schwabe RF, Blaner WS, Birge RB, Valenti L, Tabas ICell metabolismMacrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis. Cell Metab. 2020 02 04; 31(2):406-421.e7.Cell Metab2019-12-12T00:00:002019Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.Authorship 12146352931887236Bethea E, Arvind A, Gustafson J, Andersson K, Pratt D, Bhan I, Thiim M, Corey K, Bloom P, Markmann J, Yeh H, Elias N, Kimura S, Dageforde LA, Cuenca A, Kawai T, Safa K, Williams W, Gilligan H, Sise M, Fishman J, Kotton C, Kim A, Rogers CC, Shao S, Cote M, Irwin L, Myoung P, Chung RTAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsImmediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning. Am J Transplant. 2020 06; 20(6):1619-1628.Am J Transplant2020-02-03T00:00:002020Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.Authorship 1216450231915372Holmes JA, Chung RTNature reviews. Gastroenterology & hepatologyNew approaches in viraemic organ transplantation and antiviral therapies. Nat Rev Gastroenterol Hepatol. 2020 02; 17(2):78-79.Nat Rev Gastroenterol Hepatol2020-02-01T00:00:002020New approaches in viraemic organ transplantation and antiviral therapies.Authorship 12196631031954204Simon TG, Kim MN, Luo X, Yang W, Ma Y, Chong DQ, Fuchs CS, Meyerhardt JA, Corey KE, Chung RT, Stampfer M, Zhang X, Giovannucci EL, Chan ATJournal of hepatologyPhysical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts. J Hepatol. 2020 06; 72(6):1062-1069.J Hepatol2020-01-15T00:00:002020Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts.Authorship 1221216832005510Ozturk A, Mohammadi R, Pierce TT, Kamarthi S, Dhyani M, Grajo JR, Corey KE, Chung RT, Bhan AK, Chhatwal J, Samir AEUltrasound in medicine & biologyDiagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound Med Biol. 2020 04; 46(4):972-980.Ultrasound Med Biol2020-01-29T00:00:002020Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease.Authorship 1581337Authorship 122746915Authorship 1227416332061869Yeh ML, Huang CF, Huang CI, Holmes JA, Hsieh MH, Tsai YS, Liang PC, Tsai PC, Hsieh MY, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Chung RT, Yu MLJournal of hepatologyHepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection. J Hepatol. 2020 07; 73(1):62-71.J Hepatol2020-02-14T00:00:002020Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.32037715Babu SB, Srinivasan S, Chung R, Chawla A, Tan HK, Lohan RJournal of medical imaging and radiation oncologyTract sealing with normal saline after percutaneous transthoracic lung biopsies. J Med Imaging Radiat Oncol. 2020 Apr; 64(2):211-214.J Med Imaging Radiat Oncol2020-02-09T00:00:002020Tract sealing with normal saline after percutaneous transthoracic lung biopsies.32145257Shao T, Chen Z, Belov V, Wang X, Rwema SH, Kumar V, Fu H, Deng X, Rong J, Yu Q, Lang L, Lin W, Josephson L, Samir AE, Chen X, Chung RT, Liang SHJournal of hepatology[18F]-Alfatide PET imaging of integrin avß3 for the non-invasive quantification of liver fibrosis. J Hepatol. 2020 07; 73(1):161-169.J Hepatol2020-03-05T00:00:002020[18F]-Alfatide PET imaging of integrin avß3 for the non-invasive quantification of liver fibrosis.Authorship 123230016Authorship 1232768432160663Simon TG, Duberg AS, Aleman S, Chung RT, Chan AT, Ludvigsson JFThe New England journal of medicineAssociation of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality. N Engl J Med. 2020 03 12; 382(11):1018-1028.N Engl J Med2020-03-12T00:00:002020Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.Authorship 12384711132270862Fourman LT, Stanley TL, Zheng I, Pan CS, Feldpausch MN, Purdy J, Aepfelbacher J, Buckless C, Tsao A, Corey KE, Chung RT, Torriani M, Kleiner DE, Hadigan CM, Grinspoon SKClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaClinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease. Clin Infect Dis. 2021 06 15; 72(12):2087-2094.Clin Infect Dis2021-06-15T00:00:002021Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease.32298473Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, Pratt DS, Russo MW, Schilsky ML, Verna EC, Loomba R, Cohen DE, Bezerra JA, Reddy KR, Chung RTHepatology (Baltimore, Md.)Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement. Hepatology. 2020 07; 72(1):287-304.Hepatology2020-07-01T00:00:002020Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.32280841Sise ME, Strohbehn IA, Chute DF, Gustafson J, Van Deerlin VM, Smith JR, Gentile C, Wojciechowski D, Williams WW, Elias N, Chung RTKidney international reportsPreemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C-Viremic Donor to Uninfected Recipient Kidney Transplantation. Kidney Int Rep. 2020 Apr; 5(4):459-467.Kidney Int Rep2020-01-13T00:00:002020Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C-Viremic Donor to Uninfected Recipient Kidney Transplantation.Authorship 124077515Authorship 124102811Authorship 12456041532374849Yu Y, Jiang L, Wang H, Shen Z, Cheng Q, Zhang P, Wang J, Wu Q, Fang X, Duan L, Wang S, Wang K, An P, Shao T, Chung RT, Zheng S, Min J, Wang FBloodHepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood. 2020 08 06; 136(6):726-739.Blood2020-08-06T00:00:002020Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis.2025-04-30CHUNG, RAYMOND T;LAUER, GEORG MICHAEL2020-05-22Immunologic correlates of functional cure of HBV with immune checkpoint blockadeR01AI148648Co-Principal InvestigatorAuthorship 124714816Authorship 124916018Authorship 1249381832393626Luther J, Khan S, Gala MK, Kedrin D, Sridharan G, Goodman RP, Garber JJ, Masia R, Diagacomo E, Adams D, King KR, Piaker S, Reinecker HC, Yarmush ML, Argemi J, Bataller R, Dienstag JL, Chung RT, Patel SJProceedings of the National Academy of Sciences of the United States of AmericaHepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation. Proc Natl Acad Sci U S A. 2020 05 26; 117(21):11667-11673.Proc Natl Acad Sci U S A2020-05-11T00:00:002020Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation.32331919Gogna A, Punamiya S, Gopinathan A, Irani F, Toh LHW, Wen Cheong LH, Babu S, Wee B, Goh P, Tan BP, Damodharan K, Venkatanarasimha N, Chan SJM, Chandramohan S, Too CW, Chung R, Ong SJ, Tan A, Tan BS, Tay KHJournal of vascular and interventional radiology : JVIRPreparing IR for COVID-19: The Singapore Experience. J Vasc Interv Radiol. 2020 06; 31(6):869-875.J Vasc Interv Radiol2020-04-09T00:00:002020Preparing IR for COVID-19: The Singapore Experience.32415860Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RTHepatology (Baltimore, Md.)Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology. 2021 03; 73(3):890-900.Hepatology2020-11-04T00:00:002020Liver Biochemistries in Hospitalized Patients With COVID-19.Authorship 1252634432489653Schaefer EAK, Arvind A, Bloom PP, Chung RTClinical liver diseaseInterrelationship Between Coronavirus Infection and Liver Disease. Clin Liver Dis (Hoboken). 2020 May; 15(5):175-180.Clin Liver Dis (Hoboken)2020-05-21T00:00:002020Interrelationship Between Coronavirus Infection and Liver Disease.Authorship 17932610Authorship 12544667Authorship 1255434232507734Lisker-Melman M, Khalili M, Belle SH, Terrault NA, Lin HS, Smith CI, Chung RT, Tsai N, Bzowej NH, Tran TT, Schwarzenberg SJAnnals of hepatologyMaternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B. Ann Hepatol. 2020 Jul - Aug; 19(4):388-395.Ann Hepatol2020-05-20T00:00:002020Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B.32553139Holmes JA, Chung RTThe lancet. Gastroenterology & hepatologyShortening treatment with direct-acting antivirals in HCV-positive organ transplantation. Lancet Gastroenterol Hepatol. 2020 07; 5(7):626-627.Lancet Gastroenterol Hepatol2020-07-01T00:00:002020Shortening treatment with direct-acting antivirals in HCV-positive organ transplantation.2025-06-30CHUNG, RAYMOND T ;LIN, WENYU2020-07-15Cooperative mechanisms of HIV-enhanced liver fibrogenesis in HBV CoinfectionR01AI155140Principal InvestigatorAuthorship 16357440Authorship 12673771432701508Fourman LT, Billingsley JM, Agyapong G, Ho Sui SJ, Feldpausch MN, Purdy J, Zheng I, Pan CS, Corey KE, Torriani M, Kleiner DE, Hadigan CM, Stanley TL, Chung RT, Grinspoon SKJCI insightEffects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD. JCI Insight. 2020 08 20; 5(16).JCI Insight2020-08-20T00:00:002020Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD.Authorship 127326115Authorship 12732218Authorship 1273828232740969Verna EC, Serper M, Chu J, Corey K, Fix OK, Hoyt K, Page KA, Loomba R, Li M, Everson GT, Fried MW, Garcia-Tsao G, Terrault N, Lok AS, Chung RT, Reddy KRHepatology (Baltimore, Md.)Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation. Hepatology. 2020 11; 72(5):1819-1837.Hepatology2020-11-01T00:00:002020Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation.32766479Sise ME, Strohbehn I, Chute D, Corey KE, Fusco DN, Sabbisetti VS, Waikar SS, Chung RTHepatology communicationsLow Complement C4 Predicts Improvement of Kidney Function After Direct-Acting Antiviral Therapy for Hepatitis C Virus. Hepatol Commun. 2020 Aug; 4(8):1206-1217.Hepatol Commun2020-06-04T00:00:002020Low Complement C4 Predicts Improvement of Kidney Function After Direct-Acting Antiviral Therapy for Hepatitis C Virus.32767776Bloom PP, Chung RTHepatology (Baltimore, Md.)Reply. Hepatology. 2021 02; 73(2):875-876.Hepatology2021-02-01T00:00:002021Reply.Authorship 127583525Authorship 1278761432775831Seethapathy H, Sharma S, Zhao S, Chung RT, Connor MJ, Leaf DE, Allegretti ASKidney international reportsAcute Kidney Injury Following Paracentesis Among Inpatients With Cirrhosis. Kidney Int Rep. 2020 Aug; 5(8):1305-1308.Kidney Int Rep2020-05-20T00:00:002020Acute Kidney Injury Following Paracentesis Among Inpatients With Cirrhosis.32817366Alsamman S, Christenson SA, Yu A, Ayad NME, Mooring MS, Segal JM, Hu JK, Schaub JR, Ho SS, Rao V, Marlow MM, Turner SM, Sedki M, Pantano L, Ghoshal S, Ferreira DDS, Ma HY, Duwaerts CC, Espanol-Suner R, Wei L, Newcomb B, Mileva I, Canals D, Hannun YA, Chung RT, Mattis AN, Fuchs BC, Tager AM, Yimlamai D, Weaver VM, Mullen AC, Sheppard D, Chen JYScience translational medicineTargeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice. Sci Transl Med. 2020 08 19; 12(557).Sci Transl Med2020-08-19T00:00:002020Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice.true1Charlotte F. and Irving W. Rabb Professor of MedicineCharlotte F. and Irving W. Rabb Professor of MedicineAuthorship 1891101Authorship 128069728Authorship 12802035Authorship 12797711732843477Sise ME, Goldberg DS, Kort JJ, Schaubel DE, Alloway RR, Durand CM, Fontana RJ, Brown RS, Friedewald JJ, Prenner S, Landis JR, Fernando M, Phillips CC, Woodle ES, Rike-Shields A, Sherman KE, Elias N, Williams WW, Gustafson JL, Desai NM, Barnaba B, Norman SP, Doshi M, Sultan ST, Aull MJ, Levitsky J, Belshe DS, Chung RT, Reese PPJournal of the American Society of Nephrology : JASNMulticenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection. J Am Soc Nephrol. 2020 11; 31(11):2678-2687.J Am Soc Nephrol2020-08-25T00:00:002020Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection.32860463Lau DTY, Ganova-Raeva L, Wang J, Mogul D, Chung RT, Lisker-Melman M, Chang KM, Shaikh OS, Janssen HLA, Wahed AS, Lok ASHepatology (Baltimore, Md.)Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes. Hepatology. 2021 05; 73(5):1637-1651.Hepatology2021-05-01T00:00:002021Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes.32838106Shao T, Tong Y, Lu S, Jeyarajan AJ, Su F, Dai J, Shi J, Huang J, Hu C, Wu L, Dai X, Cheng Z, Yan J, Huang P, Tian Y, Li S, Chung RT, Chen DHepatology communicationsGamma-Glutamyltransferase Elevation Is Frequent in Patients With COVID-19: A Clinical Epidemiologic Study. Hepatol Commun. 2020 Dec; 4(12):1744-1750.Hepatol Commun2020-09-09T00:00:002020Gamma-Glutamyltransferase Elevation Is Frequent in Patients With COVID-19: A Clinical Epidemiologic Study.Authorship 1282760532869840Khalili M, King WC, Kleiner DE, Jain MK, Chung RT, Sulkowski M, Lisker-Melman M, Wong DK, Ghany M, Sanyal A, Sterling RKClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaFatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection. Clin Infect Dis. 2021 11 02; 73(9):e3275-e3285.Clin Infect Dis2021-11-02T00:00:002021Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection.Authorship 2237294Authorship 1288293732898922Russo MW, Fix OK, Koteish AA, Duggan K, Ditmyer M, Fuchs M, Chung RT, Reddy GHepatology (Baltimore, Md.)Modeling the Hepatology Workforce in the United States: A Predicted Critical Shortage. Hepatology. 2020 10; 72(4):1444-1454.Hepatology2020-10-01T00:00:002020Modeling the Hepatology Workforce in the United States: A Predicted Critical Shortage.32964286Ufere NN, Donlan J, Indriolo T, Richter J, Thompson R, Jackson V, Volandes A, Chung RT, Traeger L, El-Jawahri ADigestive diseases and sciencesBurdensome Transitions of Care for Patients with End-Stage Liver Disease and Their Caregivers. Dig Dis Sci. 2021 09; 66(9):2942-2955.Dig Dis Sci2020-09-22T00:00:002020Burdensome Transitions of Care for Patients with End-Stage Liver Disease and Their Caregivers.Authorship 1290282832996824Donlan J, Ufere NN, Indriolo T, Jackson V, Chung RT, El-Jawahri A, Traeger LJournal of palliative medicinePatient and Caregiver Perspectives on Palliative Care in End-Stage Liver Disease. J Palliat Med. 2021 05; 24(5):719-724.J Palliat Med2020-09-30T00:00:002020Patient and Caregiver Perspectives on Palliative Care in End-Stage Liver Disease.Authorship 1291656533058756Wang L, Sinnott-Armstrong N, Wagschal A, Wark AR, Camporez JP, Perry RJ, Ji F, Sohn Y, Oh J, Wu S, Chery J, Moud BN, Saadat A, Dankel SN, Mellgren G, Tallapragada DSP, Strobel SM, Lee MJ, Tewhey R, Sabeti PC, Schaefer A, Petri A, Kauppinen S, Chung RT, Soukas A, Avruch J, Fried SK, Hauner H, Sadreyev RI, Shulman GI, Claussnitzer M, Näär AMCellA MicroRNA Linking Human Positive Selection and Metabolic Disorders. Cell. 2020 10 29; 183(3):684-701.e14.Cell2020-10-14T00:00:002020A MicroRNA Linking Human Positive Selection and Metabolic Disorders.Authorship 12959989Authorship 12976612433069882Lake JE, Overton T, Naggie S, Sulkowski M, Loomba R, Kleiner DE, Price JC, Chew KW, Chung RT, Corey KEClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationExpert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus. Clin Gastroenterol Hepatol. 2022 02; 20(2):256-268.Clin Gastroenterol Hepatol2020-10-16T00:00:002020Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus.true1Assistant Professor of MedicineAssistant Professor of MedicineAuthorship 12989586Authorship 12997718Authorship 129952923Authorship 12997411433125080Stanley TL, Fourman LT, Zheng I, McClure CM, Feldpausch MN, Torriani M, Corey KE, Chung RT, Lee H, Kleiner DE, Hadigan CM, Grinspoon SKThe Journal of clinical endocrinology and metabolismRelationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab. 2021 01 23; 106(2):e520-e533.J Clin Endocrinol Metab2021-01-23T00:00:002021Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.33125745Long MT, Zhang X, Xu H, Liu CT, Corey KE, Chung RT, Loomba R, Benjamin EJHepatology (Baltimore, Md.)Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. Hepatology. 2021 02; 73(2):548-559.Hepatology2021-02-06T00:00:002021Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.33116245Vergara C, Duggal P, Thio CL, Valencia A, O'Brien TR, Latanich R, Timp W, Johnson EO, Kral AH, Mangia A, Goedert JJ, Piazzola V, Mehta SH, Kirk GD, Peters MG, Donfield SM, Edlin BR, Busch MP, Alexander G, Murphy EL, Kim AY, Lauer GM, Chung RT, Cramp ME, Cox AL, Khakoo SI, Rosen HR, Alric L, Wheelan SJ, Wojcik GL, Thomas DL, Taub MAGenes and immunityMulti-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection. Genes Immun. 2020 11; 21(5):348-359.Genes Immun2020-10-28T00:00:002020Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection.33119750Vergara C, Valencia A, Thio CL, Goedert JJ, Mangia A, Piazzolla V, Johnson E, Kral AH, O'Brien TR, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Busch MP, Alexander G, Rosen HR, Murphy EL, Wojcik GL, Taub MA, Thomas DL, Duggal PThe Journal of infectious diseasesA Multiancestry Sex-Stratified Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. J Infect Dis. 2021 06 15; 223(12):2090-2098.J Infect Dis2021-06-15T00:00:002021A Multiancestry Sex-Stratified Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.Authorship 13047427Authorship 13029962Authorship 130370523Authorship 13046971233226787Shokr A, Pacheco LGC, Thirumalaraju P, Kanakasabapathy MK, Gandhi J, Kartik D, Silva FSR, Erdogmus E, Kandula H, Luo S, Yu XG, Chung RT, Li JZ, Kuritzkes DR, Shafiee HACS nanoMobile Health (mHealth) Viral Diagnostics Enabled with Adaptive Adversarial Learning. ACS Nano. 2021 01 26; 15(1):665-673.ACS Nano2020-11-23T00:00:002020Mobile Health (mHealth) Viral Diagnostics Enabled with Adaptive Adversarial Learning.33140112Bloom PP, Miller SJ, Nayak RK, Hussain MS, Arvind A, Bay C, Chung RTSouthern medical journalCognitive Tests and Stool Frequency at Hospital Discharge Do Not Predict Outcomes in Hepatic Encephalopathy. South Med J. 2020 11; 113(11):578-584.South Med J2020-11-01T00:00:002020Cognitive Tests and Stool Frequency at Hospital Discharge Do Not Predict Outcomes in Hepatic Encephalopathy.33230236Vergara C, Duggal P, Thio CL, Valencia A, O'Brien TR, Latanich R, Timp W, Johnson EO, Kral AH, Mangia A, Goedert JJ, Piazzola V, Mehta SH, Kirk GD, Peters MG, Donfield SM, Edlin BR, Busch MP, Alexander G, Murphy EL, Kim AY, Lauer GM, Chung RT, Cramp ME, Cox AL, Khakoo SI, Rosen HR, Alric L, Wheelan SJ, Wojcik GL, Thomas DL, Taub MAGenes and immunityCorrection: Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection. Genes Immun. 2020 Dec; 21(6-8):420.Genes Immun2020-12-01T00:00:002020Correction: Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection.33245355Jeyarajan AJ, Chung RTThe Journal of infectious diseasesInsights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure? J Infect Dis. 2020 11 27; 222(Suppl 9):S802-S813.J Infect Dis2020-11-27T00:00:002020Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?33328239Draz MS, Vasan A, Muthupandian A, Kanakasabapathy MK, Thirumalaraju P, Sreeram A, Krishnakumar S, Yogesh V, Lin W, Yu XG, Chung RT, Shafiee HScience advancesVirus detection using nanoparticles and deep neural network-enabled smartphone system. Sci Adv. 2020 12; 6(51).Sci Adv2020-12-16T00:00:002020Virus detection using nanoparticles and deep neural network-enabled smartphone system.Authorship 131085111Authorship 13174541433410581Jiang Y, Chen P, Hu K, Dai G, Li J, Zheng D, Yuan H, He L, Xie P, Tu M, Peng S, Qu C, Lin W, Chung RT, Hong JJournal of cellular and molecular medicineInflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation. J Cell Mol Med. 2021 02; 25(3):1568-1582.J Cell Mol Med2021-01-07T00:00:002021Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.Authorship 2154915Authorship 1320682533437907Memel ZN, Arvind A, Moninuola O, Philpotts L, Chung RT, Corey KE, Simon TGHepatology communicationsAspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Hepatol Commun. 2021 01; 5(1):133-143.Hepatol Commun2020-11-13T00:00:002020Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.Authorship 1325675433528915Li BT, Simon TG, Wang N, Chung RT, Corey KE, Dichtel LE, Samelson EJ, Kiel DP, Long MTObesity (Silver Spring, Md.)Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community-Based Cohort. Obesity (Silver Spring). 2021 03; 29(3):595-600.Obesity (Silver Spring)2021-02-02T00:00:002021Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community-Based Cohort.Authorship 16087810Authorship 13284135Authorship 1328648733559089Sterling RK, King WC, Khalili M, Kleiner DE, Hinerman AS, Sulkowski M, Chung RT, Jain MK, Lisker-Melman MA, Wong DK, Ghany MGDigestive diseases and sciencesPerformance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults. Dig Dis Sci. 2022 02; 67(2):676-688.Dig Dis Sci2021-02-08T00:00:002021Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.33577086Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, McGuire BM, Mulligan DC, Price JC, Reau NS, Reddy KR, Reynolds A, Rosen HR, Russo MW, Schilsky ML, Verna EC, Ward JW, Fontana RJHepatology (Baltimore, Md.)American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. Hepatology. 2021 08; 74(2):1049-1064.Hepatology2021-08-01T00:00:002021American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.Authorship 1334717433621653Bloom PP, Luévano JM, Miller KJ, Chung RTAnnals of hepatologyDeep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy. Ann Hepatol. 2021 Nov-Dec; 25:100333.Ann Hepatol2021-02-20T00:00:002021Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy.33681682Knooihuizen SAI, Alexander NJ, Hopke A, Barros N, Viens A, Scherer A, Atallah NJ, Dagher Z, Irimia D, Chung RT, Mansour MKHepatology communicationsLoss of Coordinated Neutrophil Responses to the Human Fungal Pathogen, Candida albicans, in Patients With Cirrhosis. Hepatol Commun. 2021 03; 5(3):502-515.Hepatol Commun2021-01-05T00:00:002021Loss of Coordinated Neutrophil Responses to the Human Fungal Pathogen, Candida albicans, in Patients With Cirrhosis.Authorship 133774010true1Professor of MedicineProfessor of MedicineAuthorship 13412154Authorship 13421891233743541Sterling RK, King WC, Khalili M, Chung RT, Sulkowski M, Jain MK, Lisker-Melman M, Ghany MG, Wong DK, Hinerman AS, Bhan AK, Wahed AS, Kleiner DEHepatology (Baltimore, Md.)A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America. Hepatology. 2021 09; 74(3):1174-1189.Hepatology2021-08-25T00:00:002021A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America.33758894Kim MH, Salloum S, Wang JY, Wong LP, Regan J, Lefteri K, Manickas-Hill Z, Li JZ, Sadreyev RI, Yu XG, Chung RTmedRxiv : the preprint server for health sciencesType I, II, and III interferon signatures correspond to COVID-19 disease severity. medRxiv. 2021 Mar 12.medRxiv2021-03-12T00:00:002021Type I, II, and III interferon signatures correspond to COVID-19 disease severity.Authorship 13449601033784424Ghany MG, Lok ASF, Dienstag JL, Feinstone SM, Hoofnagle JH, Jake Liang T, Seeff LB, Cohen DE, Bezerra JA, Chung RTHepatology (Baltimore, Md.)The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence. Hepatology. 2021 11; 74(5):2813-2823.Hepatology2021-10-05T00:00:002021The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence.Authorship 13465676Authorship 134865614Authorship 1349553433840726Khalili M, Kleiner DE, King WC, Sterling RK, Ghany MG, Chung RT, Bhan AK, Rosenthal P, Lisker-Melman M, Ramachandran R, Lok ASThe American journal of gastroenterologyHepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B. Am J Gastroenterol. 2021 08 01; 116(8):1686-1697.Am J Gastroenterol2021-08-01T00:00:002021Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.33852720Stanley TL, Fourman LT, Wong LP, Sadreyev R, Billingsley JM, Feldpausch MN, Zheng I, Pan CS, Boutin A, Lee H, Corey KE, Torriani M, Kleiner DE, Chung RT, Hadigan CM, Grinspoon SKClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaGrowth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease. Clin Infect Dis. 2021 08 16; 73(4):621-630.Clin Infect Dis2021-08-16T00:00:002021Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease.33851192Memel ZN, Lee JJ, Foulkes AS, Chung RT, Thaweethai T, Bloom PPmedRxiv : the preprint server for health sciencesStatins Are Associated with Improved 28-day Mortality in Patients Hospitalized with SARS-CoV-2 Infection. medRxiv. 2021 Apr 06.medRxiv2021-04-06T00:00:002021Statins Are Associated with Improved 28-day Mortality in Patients Hospitalized with SARS-CoV-2 Infection.33979307Allegretti AS, Parada XV, Endres P, Zhao S, Krinsky S, St Hillien SA, Kalim S, Nigwekar SU, Flood JG, Nixon A, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Regner KR, Belcher JM, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RTClinical and translational gastroenterologyUrinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study. Clin Transl Gastroenterol. 2021 05 11; 12(5):e00359.Clin Transl Gastroenterol2021-05-11T00:00:002021Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study.Authorship 135406221Authorship 13546111334006921Fourman LT, Stanley TL, Billingsley JM, Sui SJH, Feldpausch MN, Boutin A, Zheng I, McClure CM, Corey KE, Torriani M, Kleiner DE, Hadigan CM, Chung RT, Grinspoon SKScientific reportsDelineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach. Sci Rep. 2021 05 18; 11(1):10485.Sci Rep2021-05-18T00:00:002021Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach.Authorship 135937312Authorship 13595321334051040Huang P, Wang Y, Yue M, Ge Z, Xia X, Jeyarajan AJ, Holmes JA, Yu R, Zhu C, Yang S, Lin W, Chung RTLiver international : official journal of the International Association for the Study of the LiverThe risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis. Liver Int. 2021 10; 41(10):2341-2357.Liver Int2021-06-16T00:00:002021The risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis.34036353Kim MH, Salloum S, Wang JY, Lai Ping W, Regan J, Lefteri K, Manickas-Hill Z, Gao C, Li JZ, Sadreyev RI, Yu XG, Chung RTThe Journal of infectious diseasesType I, II, and III interferon signatures correspond to COVID-19 disease severity. J Infect Dis. 2021 May 24.J Infect Dis2021-05-24T00:00:002021Type I, II, and III interferon signatures correspond to COVID-19 disease severity.Authorship 13645068Authorship 136388916Authorship 1364683834118353Vannier AGL, Wardwell B, Fomin V, PeBenito A, Wolczynski N, Piaker S, Kedrin D, Chung RT, Schaefer E, Goodman R, Patel SJ, Luther JAlcohol (Fayetteville, N.Y.)Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder. Alcohol. 2021 09; 95:37-43.Alcohol2021-06-10T00:00:002021Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder.34118488Salloum S, Jeyarajan AJ, Kruger AJ, Holmes JA, Shao T, Sojoodi M, Kim MH, Zhuo Z, Shroff SG, Kassa A, Corey KE, Khan SK, Lin W, Alatrakchi N, Schaefer EAK, Chung RTCellular and molecular gastroenterology and hepatologyFatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase. Cell Mol Gastroenterol Hepatol. 2021; 12(4):1297-1310.Cell Mol Gastroenterol Hepatol2021-06-09T00:00:002021Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase.34133774Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RKHepatology (Baltimore, Md.)Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America. Hepatology. 2021 11; 74(5):2395-2409.Hepatology2021-09-09T00:00:002021Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.Authorship 1370476434212294Vannier AGL, PeBenito A, Fomin V, Chung RT, Schaefer E, Goodman RP, Luther JClinical and experimental medicineAn exploratory analysis of the competing effects of alcohol use and advanced hepatic fibrosis on serum HDL. Clin Exp Med. 2022 Feb; 22(1):103-110.Clin Exp Med2021-07-01T00:00:002021An exploratory analysis of the competing effects of alcohol use and advanced hepatic fibrosis on serum HDL.true1Associate Professor of MedicineAssociate Professor of MedicineAuthorship 137878626Authorship 137897510Authorship 13800121834312544Tonnerre P, Wolski D, Subudhi S, Aljabban J, Hoogeveen RC, Damasio M, Drescher HK, Bartsch LM, Tully DC, Sen DR, Bean DJ, Brown J, Torres-Cornejo A, Robidoux M, Kvistad D, Alatrakchi N, Cui A, Lieb D, Cheney JA, Gustafson J, Lewis-Ximenez LL, Massenet-Regad L, Eisenhaure T, Aneja J, Haining WN, Chung RT, Hacohen N, Allen TM, Kim AY, Lauer GMNature immunologyDifferentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory. Nat Immunol. 2021 08; 22(8):1030-1041.Nat Immunol2021-07-26T00:00:002021Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory.34318286Fujiwara N, Kobayashi M, Fobar AJ, Hoshida A, Marquez CA, Koneru B, Panda G, Taguri M, Qian T, Raman I, Li QZ, Hoshida H, Sezaki H, Kumada H, Tateishi R, Yokoo T, Yopp AC, Chung RT, Fuchs BC, Baumert TF, Marrero JA, Parikh ND, Zhu S, Singal AG, Hoshida YMed (New York, N.Y.)A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis. Med (N Y). 2021 07 09; 2(7):836-850.e10.Med (N Y)2021-04-21T00:00:002021A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis.34312547Yates KB, Tonnerre P, Martin GE, Gerdemann U, Al Abosy R, Comstock DE, Weiss SA, Wolski D, Tully DC, Chung RT, Allen TM, Kim AY, Fidler S, Fox J, Frater J, Lauer GM, Haining WN, Sen DRNature immunologyEpigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans. Nat Immunol. 2021 08; 22(8):1020-1029.Nat Immunol2021-07-26T00:00:002021Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans.34465696Bloom PP, Robin J, Xu M, Arvind A, Daidone M, Gupta AS, Chung RTThe American journal of gastroenterologyHepatic Encephalopathy is Associated With Slow Speech on Objective Assessment. Am J Gastroenterol. 2021 09 01; 116(9):1950-1953.Am J Gastroenterol2021-09-01T00:00:002021Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment.Authorship 138969212Authorship 1389769734467988Kim MH, Salloum S, Wang JY, Wong LP, Regan J, Lefteri K, Manickas-Hill Z, Gao C, Li JZ, Sadreyev RI, Yu XG, Chung RTThe Journal of infectious diseasesType I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity. J Infect Dis. 2021 09 01; 224(5):777-782.J Infect Dis2021-09-01T00:00:002021Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity.2026-08-31CHUNG, RAYMOND T ;HOSHIDA, YUJIN2021-09-01Trial of Statins for Chemoprevention in Hepatocellular CarcinomaR01CA255621Principal InvestigatorAuthorship 1784977Authorship 1738713Authorship 139250640Authorship 13923511234535664Crouchet E, Bandiera S, Fujiwara N, Li S, El Saghire H, Fernández-Vaquero M, Riedl T, Sun X, Hirschfield H, Jühling F, Zhu S, Roehlen N, Ponsolles C, Heydmann L, Saviano A, Qian T, Venkatesh A, Lupberger J, Verrier ER, Sojoodi M, Oudot MA, Duong FHT, Masia R, Wei L, Thumann C, Durand SC, González-Motos V, Heide D, Hetzer J, Nakagawa S, Ono A, Song WM, Higashi T, Sanchez R, Kim RS, Bian CB, Kiani K, Croonenborghs T, Subramanian A, Chung RT, Straub BK, Schuppan D, Ankavay M, Cocquerel L, Schaeffer E, Goossens N, Koh AP, Mahajan M, Nair VD, Gunasekaran G, Schwartz ME, Bardeesy N, Shalek AK, Rozenblatt-Rosen O, Regev A, Felli E, Pessaux P, Tanabe KK, Heikenwälder M, Schuster C, Pochet N, Zeisel MB, Fuchs BC, Hoshida Y, Baumert TFNature communicationsA human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery. Nat Commun. 2021 09 17; 12(1):5525.Nat Commun2021-09-17T00:00:002021A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.34508113Pantano L, Agyapong G, Shen Y, Zhuo Z, Fernandez-Albert F, Rust W, Knebel D, Hill J, Boustany-Kari CM, Doerner JF, Rippmann JF, Chung RT, Ho Sui SJ, Simon E, Corey KEScientific reportsMolecular characterization and cell type composition deconvolution of fibrosis in NAFLD. Sci Rep. 2021 09 10; 11(1):18045.Sci Rep2021-09-10T00:00:002021Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD.Authorship 13969815Authorship 1396716934558862Arvind A, Henson JB, Osganian SA, Nath C, Steinhagen LM, Memel ZN, Donovan A, Balogun O, Chung RT, Simon TG, Corey KEHepatology communicationsRisk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2022 02; 6(2):309-319.Hepatol Commun2021-09-02T00:00:002021Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.34558849Subudhi S, Drescher HK, Dichtel LE, Bartsch LM, Chung RT, Hutter MM, Gee DW, Meireles OR, Witkowski ER, Gelrud L, Masia R, Osganian SA, Gustafson JL, Rwema S, Bredella MA, Bhatia SN, Warren A, Miller KK, Lauer GM, Corey KEHepatology communicationsDistinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity. Hepatol Commun. 2022 01; 6(1):77-89.Hepatol Commun2021-08-11T00:00:002021Distinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity.Authorship 18489814Authorship 140042310Authorship 14001731334613666Molnar MZ, Potluri VS, Schaubel DE, Sise ME, Concepcion BP, Forbes RC, Blumberg E, Bloom RD, Shaffer D, Chung RT, Strohbehn IA, Elias N, Azhar A, Shah M, Sawinski D, Binari LA, Talwar M, Balaraman V, Bhalla A, Eason JD, Besharatian B, Trofe-Clark J, Goldberg DS, Reese PPAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsAssociation of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation. Am J Transplant. 2022 02; 22(2):599-609.Am J Transplant2021-10-06T00:00:002021Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation.34606933Belcher JM, Parada XV, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Sharma P, Regner KR, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, Allegretti ASAmerican journal of kidney diseases : the official journal of the National Kidney FoundationTerlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward. Am J Kidney Dis. 2022 05; 79(5):737-745.Am J Kidney Dis2021-10-02T00:00:002021Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward.Authorship 19226Authorship 140404923Authorship 1404945434669440Cazanave SC, Warren AD, Pacula M, Touti F, Zagorska A, Gural N, Huang EK, Sherman S, Cheema M, Ibarra S, Bates J, Billin AN, Liles JT, Budas GR, Breckenridge DG, Tiniakos D, Ratziu V, Daly AK, Govaere O, Anstee QM, Gelrud L, Luther J, Chung RT, Corey KE, Winckler W, Bhatia S, Kwong GAScience translational medicinePeptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors. Sci Transl Med. 2021 Oct 20; 13(616):eabe8939.Sci Transl Med2021-10-20T00:00:002021Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors.34665852Memel ZN, Lee JJ, Foulkes AS, Chung RT, Thaweethai T, Bloom PPThe Journal of infectious diseasesAssociation of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2022 01 05; 225(1):19-29.J Infect Dis2022-01-05T00:00:002022Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.Authorship 1406241434698347Khalili M, King WC, Kleiner DE, Chung RT, Bhan AK, Ghany MG, Sulkowski MS, Lisker-Melman M, Jain MK, Janssen HLA, Hinerman AS, Sanyal AJ, Sterling RKClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaEvolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. Clin Infect Dis. 2022 06 10; 74(11):1914-1924.Clin Infect Dis2022-06-10T00:00:002022Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection.Authorship 201740534718173Ufere NN, Robinson B, Donlan J, Indriolo T, Bloom J, Scherrer A, Mason NM, Patel A, Lai JC, Chung RT, Volandes A, El-Jawahri AClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationPilot Randomized Controlled Trial of an Advance Care Planning Video Decision Tool for Patients With Advanced Liver Disease. Clin Gastroenterol Hepatol. 2022 10; 20(10):2287-2295.e3.Clin Gastroenterol Hepatol2021-10-27T00:00:002021Pilot Randomized Controlled Trial of an Advance Care Planning Video Decision Tool for Patients With Advanced Liver Disease.Authorship 141003010Authorship 14120558Authorship 14121668Authorship 1411232534767815Douroudis K, Ramessur R, Barbosa IA, Baudry D, Duckworth M, Angit C, Capon F, Chung R, Curtis CJ, Di Meglio P, Goulding JMR, Griffiths CEM, Lee SH, Mahil SK, Parslew R, Reynolds NJ, Shipman AR, Warren RB, Yiu ZZN, Simpson MA, Barker JN, Dand N, Smith CHThe Journal of investigative dermatologyDifferences in Clinical Features and Comorbid Burden between HLA-C*06:02 Carrier Groups in >9,000 People with Psoriasis. J Invest Dermatol. 2022 06; 142(6):1617-1628.e10.J Invest Dermatol2021-11-10T00:00:002021Differences in Clinical Features and Comorbid Burden between HLA-C*06:02 Carrier Groups in >9,000 People with Psoriasis.34859470Aronsohn AI, Bhattacharya D, Morgan TR, Wyles DL, Chung RT, McQuillen DPHepatology (Baltimore, Md.)Reply. Hepatology. 2022 04; 75(4):1055-1056.Hepatology2021-12-19T00:00:002021Reply.34800047Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RKHepatology (Baltimore, Md.)Reply. Hepatology. 2022 03; 75(3):761-763.Hepatology2021-12-21T00:00:002021Reply.Authorship 1536726Authorship 14202135834951993Qian T, Fujiwara N, Koneru B, Ono A, Kubota N, Jajoriya AK, Tung MG, Crouchet E, Song WM, Marquez CA, Panda G, Hoshida A, Raman I, Li QZ, Lewis C, Yopp A, Rich NE, Singal AG, Nakagawa S, Goossens N, Higashi T, Koh AP, Bian CB, Hoshida H, Tabrizian P, Gunasekaran G, Florman S, Schwarz ME, Hiotis SP, Nakahara T, Aikata H, Murakami E, Beppu T, Baba H, Bhatia S, Kobayashi M, Kumada H, Fobar AJ, Parikh ND, Marrero JA, Rwema SH, Nair V, Patel M, Kim-Schulze S, Corey K, O'Leary JG, Klintmalm GB, Thomas DL, Dibas M, Rodriguez G, Zhang B, Friedman SL, Baumert TF, Fuchs BC, Chayama K, Zhu S, Chung RT, Hoshida YGastroenterologyMolecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development. Gastroenterology. 2022 04; 162(4):1210-1225.Gastroenterology2021-12-22T00:00:002021Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.Authorship 1880282Authorship 1422455134973459Chung RT, King WC, Ghany MG, Lisker-Melman M, Hinerman AS, Khalili M, Sulkowski M, Jain MK, Choi EK, Nalesnik MA, Bhan AK, Cloherty G, Wong DK, Sterling RKClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationA Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection. Clin Gastroenterol Hepatol. 2023 01; 21(1):125-135.e8.Clin Gastroenterol Hepatol2021-12-29T00:00:002021A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection.true1Associate Professor of MedicineAssociate Professor of Medicine15496054Chung R, Yu E, Incarvito CD, Austin DJOrganic lettersHypervalent iodine-mediated vicinal syn diazidation: application to the total synthesis of (+/-)-dibromophakellstatin. Org Lett. 2004 Oct 28; 6(22):3881-4.Org Lett2004-10-28T00:00:002004Hypervalent iodine-mediated vicinal syn diazidation: application to the total synthesis of (+/-)-dibromophakellstatin.35051705Shao T, Chen Z, Cheng R, Collier L, Josephson L, Chung RT, Liang SHBioorganic chemistryPreliminary evaluation of [11C]MAGL-0519 as a promising PET ligand for the diagnosis of Hepatocellular carcinoma. Bioorg Chem. 2022 03; 120:105620.Bioorg Chem2022-01-12T00:00:002022Preliminary evaluation of [11C]MAGL-0519 as a promising PET ligand for the diagnosis of Hepatocellular carcinoma.35022275Li W, Duan X, Zhu C, Liu X, Jeyarajan AJ, Xu M, Tu Z, Sheng Q, Chen D, Zhu C, Shao T, Cheng Z, Salloum S, Schaefer EA, Kruger AJ, Holmes JA, Chung RT, Lin WJournal of immunology (Baltimore, Md. : 1950)Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-ß1-Induced OCT4/Nanog Pathway. J Immunol. 2022 02 01; 208(3):672-684.J Immunol2022-01-12T00:00:002022Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-ß1-Induced OCT4/Nanog Pathway.Authorship 14274741Authorship 14266026Authorship 142559417Authorship 142762310Authorship 1428418334743343Terrault NA, Wahed AS, Feld JJ, Cooper SL, Ghany MG, Lisker-Melman M, Perrillo R, Sterling RK, Khalili M, Chung RT, Rosenthal P, Fontana RJ, Sarowar A, Lau DTY, Wang J, Lok AS, Janssen HLAHepatology (Baltimore, Md.)Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort. Hepatology. 2022 03; 75(3):709-723.Hepatology2022-01-26T00:00:002022Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort.35085527Xu M, Lin W, Chung RTCellular and molecular gastroenterology and hepatologyA New Model to Assess Hepatitis B Virus Covalently Closed Circular DNA: A Window Into a Previously Hidden Space? Cell Mol Gastroenterol Hepatol. 2022; 13(4):1255-1256.Cell Mol Gastroenterol Hepatol2022-01-25T00:00:002022A New Model to Assess Hepatitis B Virus Covalently Closed Circular DNA: A Window Into a Previously Hidden Space?35093588Sojoodi M, Erstad DJ, Barrett SC, Salloum S, Zhu S, Qian T, Colon S, Gale EM, Jordan VC, Wang Y, Li S, Ataeinia B, Jalilifiroozinezhad S, Lanuti M, Zukerberg L, Caravan P, Hoshida Y, Chung RT, Bhave G, Lauer GM, Fuchs BC, Tanabe KKCellular and molecular gastroenterology and hepatologyPeroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver. Cell Mol Gastroenterol Hepatol. 2022; 13(5):1483-1509.Cell Mol Gastroenterol Hepatol2022-01-28T00:00:002022Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver.Authorship 143130217Authorship 143236514Authorship 143081118Authorship 1430234835090584Valencia A, Vergara C, Thio CL, Vince N, Douillard V, Grifoni A, Cox AL, Johnson EO, Kral AH, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Price JC, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Busch MP, Alexander G, Rosen HR, Murphy EL, Wojcik GL, Carrington M, Gourraud PA, Sette A, Thomas DL, Duggal PAmerican journal of human geneticsTrans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQß1. Am J Hum Genet. 2022 02 03; 109(2):299-310.Am J Hum Genet2022-01-31T00:00:002022Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQß1.35123089Volk ML, Clarke C, Asrani SK, Khaderi S, Bansal MB, Tapper EB, Ho C, Chung RT, Lake J, Lim N, Fortune BE, Kim R, Dronamraju D, Kanwal FClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationCirrhosis Quality Collaborative. Clin Gastroenterol Hepatol. 2022 05; 20(5):970-972.Clin Gastroenterol Hepatol2022-02-02T00:00:002022Cirrhosis Quality Collaborative.35127387Shao T, Chen Z, Rong J, Belov V, Chen J, Jeyarajan A, Deng X, Fu H, Yu Q, Rwema SH, Lin W, Papisov M, Josephson L, Chung RT, Liang SHActa pharmaceutica Sinica. B[18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models. Acta Pharm Sin B. 2022 Jan; 12(1):308-315.Acta Pharm Sin B2021-07-17T00:00:002021[18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models.Authorship 2581962Authorship 2625203Authorship 14357506Authorship 143546721Authorship 14400956Authorship 14411176Authorship 14418651331331011Huang D, Sokal-Gutierrez K, Chung K, Lin W, Khanh LN, Chung R, Hoang HT, Ivey SLInternational journal of environmental research and public healthMaternal and Child Nutrition and Oral Health in Urban Vietnam. Int J Environ Res Public Health. 2019 07 19; 16(14).Int J Environ Res Public Health2019-07-19T00:00:002019Maternal and Child Nutrition and Oral Health in Urban Vietnam.35188674Perrillo R, Lin HS, Schwarz KB, Rosenthal P, Lisker-Melman M, Chung RT, Prokunina-Olsson L, Cloherty G, Feld JHepatology (Baltimore, Md.)Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B. Hepatology. 2022 09; 76(3):775-787.Hepatology2022-03-14T00:00:002022Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B.35320000Patel SJ, Liu N, Piaker S, Gulko A, Andrade ML, Heyward FD, Sermersheim T, Edinger N, Srinivasan H, Emont MP, Westcott GP, Luther J, Chung RT, Yan S, Kumari M, Thomas R, Deleye Y, Tchernof A, White PJ, Baselli GA, Meroni M, De Jesus DF, Ahmad R, Kulkarni RN, Valenti L, Tsai L, Rosen EDScience translational medicineHepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b. Sci Transl Med. 2022 03 23; 14(637):eabh3831.Sci Transl Med2022-03-23T00:00:002022Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b.35158369Khalili M, Kleiner DE, King WC, Sterling RK, Ghany MG, Chung RT, Bhan AK, Rosenthal P, Lisker-Melman M, Ramachandran R, Lok ASThe American journal of gastroenterologyReply to Li, Henry, and Nguyen. Am J Gastroenterol. 2022 04 01; 117(4):688.Am J Gastroenterol2022-04-01T00:00:002022Reply to Li, Henry, and Nguyen.35155863Sise ME, Goldberg DS, Schaubel DE, Fontana RJ, Kort JJ, Alloway RR, Durand CM, Blumberg EA, Woodle ES, Sherman KE, Brown RS, Friedewald JJ, Desai NM, Sultan ST, Levitsky J, Lee MD, Strohbehn IA, Landis JR, Fernando M, Gustafson JL, Chung RT, Reese PPKidney international reportsOne-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial. Kidney Int Rep. 2022 Feb; 7(2):241-250.Kidney Int Rep2021-12-01T00:00:002021One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial.Authorship 14489343Authorship 1449535635474707Vannier AGL, Fomin V, Chung RT, Patel SJ, Schaefer E, Goodman RP, Luther JGastro hep advancesSubstance use disorder is associated with alcohol-associated liver disease in patients with alcohol use disorder. Gastro Hep Adv. 2022; 1(3):403-408.Gastro Hep Adv2022-03-30T00:00:002022Substance use disorder is associated with alcohol-associated liver disease in patients with alcohol use disorder.35384391Bloom PP, Donlan J, Torres Soto M, Daidone M, Hohmann E, Chung RTHepatology communicationsFecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient. Hepatol Commun. 2022 08; 6(8):2079-2089.Hepatol Commun2022-04-05T00:00:002022Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient.Authorship 3160412Authorship 1452378435578388Gizaw A, King WC, Hinerman AS, Chung RT, Lisker-Melman M, Ghany MG, Khalili M, Jain MK, Graham J, Swift-Scanlan T, Kleiner DE, Sulkowski M, Wong DK, Sterling RKHIV medicineA prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)-HIV co-infection with high prevalence of tenofovir-based antiretroviral therapy use. HIV Med. 2023 01; 24(1):55-74.HIV Med2022-05-16T00:00:002022A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)-HIV co-infection with high prevalence of tenofovir-based antiretroviral therapy use.Authorship 3340623Authorship 352515535657750Shih AR, Hatipoglu D, Wilechansky R, Goiffon R, Deshpande V, Misdraji J, Chung RTArchives of pathology & laboratory medicinePersistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients. Arch Pathol Lab Med. 2022 10 01; 146(10):1184-1193.Arch Pathol Lab Med2022-10-01T00:00:002022Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients.Authorship 14601514Authorship 146586513Authorship 14628695Authorship 14665034Authorship 14682777Authorship 14651957Authorship 146858313Authorship 14585261935786977Altinbas A, Holmes JA, Salloum S, Lidofsky A, Alatrakchi N, Somsouk M, Hunt P, Deeks S, Chew KW, Lauer G, Kruger A, Lin W, Chung RTBiomarkers in medicineLOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients. Biomark Med. 2022 08; 16(11):839-846.Biomark Med2022-07-05T00:00:002022LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients.35801591Crouchet E, Li S, Sojoodi M, Bandiera S, Fujiwara N, El Saghire H, Zhu S, Qian T, Rasha FA, Del Zompo F, Barrett SC, Schaeffer E, Oudot MA, Ponsolles C, Durand SC, Ghoshal S, Arora G, Giannone F, Chung RT, Slovic N, Van Renne N, Felli E, Pessaux P, Lupberger J, Pochet N, Schuster C, Tanabe KK, Hoshida Y, Fuchs BC, Baumert TFJCI insightHepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation. JCI Insight. 2022 07 08; 7(13).JCI Insight2022-07-08T00:00:002022Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.35780715Osganian SA, Subudhi S, Masia R, Drescher HK, Bartsch LM, Chicote ML, Chung RT, Gee DW, Witkowski ER, Bredella MA, Lauer GM, Corey KE, Dichtel LEGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research SocietyExpression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Growth Horm IGF Res. 2022 08; 65:101482.Growth Horm IGF Res2022-06-19T00:00:002022Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.35850413King WC, Sterling RK, Hinerman AS, Lok ASF, Cloherty GA, Ghany MGClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationHepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1957-1959.Clin Gastroenterol Hepatol2022-07-16T00:00:002022Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance.35770681Lisker-Melman M, Wahed AS, Ghany MG, Chung RT, King WC, Kleiner DE, Bhan AK, Khalili M, Jain MK, Sulkowski M, Wong DK, Cloherty G, Sterling RKHepatology (Baltimore, Md.)HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapy. Hepatology. 2023 02 01; 77(2):594-605.Hepatology2022-07-21T00:00:002022HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapy.35712812Kim MH, Kim MY, Salloum S, Qian T, Wong LP, Xu M, Lee Y, Shroff SG, Sadreyev RI, Corey KE, Baumert TF, Hoshida Y, Chung RTHepatology communicationsAtorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature. Hepatol Commun. 2022 09; 6(9):2581-2593.Hepatol Commun2022-06-16T00:00:002022Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature.35736236Barnes E, Cooke GS, Lauer GM, Chung RTHepatology (Baltimore, Md.)Implementation of a controlled human infection model for evaluation of HCV vaccine candidates. Hepatology. 2023 05 01; 77(5):1757-1772.Hepatology2023-04-17T00:00:002023Implementation of a controlled human infection model for evaluation of HCV vaccine candidates.36026454Li DK, Chaudhari SN, Lee Y, Sojoodi M, Adhikari AA, Zukerberg L, Shroff S, Barrett SC, Tanabe K, Chung RT, Devlin ASScience advancesInhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury. Sci Adv. 2022 08 26; 8(34):eabo2794.Sci Adv2022-08-26T00:00:002022Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury.Authorship 1611408Authorship 1659865true1Associate Professor of RadiologyAssociate Professor of Radiology36187374Woodrell CD, Patel AA, Wilder JM, Sundaram V, Chung RT, Ufere NNClinical liver diseaseCultural humility and end-of-life communication with people with advanced liver disease. Clin Liver Dis (Hoboken). 2022 Sep; 20(3):81-85.Clin Liver Dis (Hoboken)2022-07-16T00:00:002022Cultural humility and end-of-life communication with people with advanced liver disease.Authorship 14951125Authorship 148492010Authorship 437928Authorship 4447427true1Associate Professor of MedicineAssociate Professor of Medicinetrue1Professor of MedicineProfessor of MedicineAuthorship 4613507Authorship 1506918736461941Fourman LT, Stanley TL, Ockene MW, McClure CM, Toribio M, Corey KE, Chung RT, Torriani M, Kleiner DE, Hadigan CM, Grinspoon SKThe Journal of infectious diseasesProteomic Analysis of Hepatic Fibrosis in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease Demonstrates Up-regulation of Immune Response and Tissue Repair Pathways. J Infect Dis. 2023 02 14; 227(4):565-576.J Infect Dis2023-02-14T00:00:002023Proteomic Analysis of Hepatic Fibrosis in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease Demonstrates Up-regulation of Immune Response and Tissue Repair Pathways.Authorship 15145381436599136Terrault NA, Lok AS, Wahed AS, Ghany MG, Perrillo RP, Fried MW, Wong DK, Khalili M, Lau DTY, Sterling RK, Di Bisceglie AM, Lisker-Melman M, Cooper SL, Chung RT, Patel K, Roberts LR, Belle SH, Janssen HLAThe American journal of gastroenterologyRandomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B. Am J Gastroenterol. 2023 07 01; 118(7):1214-1225.Am J Gastroenterol2022-12-23T00:00:002022Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B.Authorship 1516852736633476Aby ES, Moafa G, Latt N, Sultan MT, Cacioppo PA, Kumar S, Chung RT, Bloom PP, Gustafson J, Daidone M, Reinus Z, Debes JD, Sandhu S, Sohal A, Khalid S, Roytman M, Catana AM, Wegermann K, Carr RM, Saiman Y, Kassab I, Chen VL, Rabiee A, Rosenberg C, Nguyen V, Gainey C, Zhou K, Chavin K, Lizaola-Mayo BC, Chascsa DM, Varelas L, Moghe A, Dhanasekaran RHepatology communicationsLong-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. Hepatol Commun. 2023 01 01; 7(1):e8874.Hepatol Commun2023-01-01T00:00:002023Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.Authorship 2349414Authorship 152453913Authorship 152353516Authorship 15246789Authorship 15256921336816340Hatipoglu D, Mulligan C, Wang J, Peticco J, Grinspoon R, Gadi S, Mills C, Luther J, Chung RTGastro hep advancesDifferential Effects of COVID-19 Hospitalization on the Trajectory of Liver Disease Progression. Gastro Hep Adv. 2023; 2(4):480-486.Gastro Hep Adv2023-02-12T00:00:002023Differential Effects of COVID-19 Hospitalization on the Trajectory of Liver Disease Progression.36752566Kim MH, Sise ME, Xu M, Goldberg DS, Fontana RJ, Kort JJ, Alloway RR, Durand CM, Brown RS, Levitsky J, Gustafson JL, Reese PP, Chung RTClinical transplantationEarly initiation of glecaprevir/pibrentasvir after transplantation of HCV-viremic kidneys into HCV-negative recipients is associated with normalization in the altered inflammatory milieu. Clin Transplant. 2023 04; 37(4):e14926.Clin Transplant2023-02-17T00:00:002023Early initiation of glecaprevir/pibrentasvir after transplantation of HCV-viremic kidneys into HCV-negative recipients is associated with normalization in the altered inflammatory milieu.36763643Gawrieh S, Corey KE, Lake JE, Samala N, Desai AP, Debroy P, Sjoquist JA, Robison M, Tann M, Akisik F, Bhamidipalli SS, Saha CK, Zachary K, Robbins GK, Gupta SK, Chung RT, Chalasani NPloS oneNon-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus. PLoS One. 2023; 18(2):e0279685.PLoS One2023-02-10T00:00:002023Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus.36805976Gawrieh S, Lake JE, Debroy P, Sjoquist JA, Robison M, Tann M, Akisik F, Bhamidipalli SS, Saha CK, Zachary K, Robbins GK, Gupta SK, Chung RT, Chalasani N, Corey KEHepatology (Baltimore, Md.)Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study. Hepatology. 2023 08 01; 78(2):578-591.Hepatology2023-02-22T00:00:002023Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study.Authorship 1712474Authorship 15326149Authorship 1530394936910479Kim MH, Elbaz J, Jilg N, Gustafson JL, Xu M, Hatipoglu D, Nohelty E, Kim AY, Chung RTFrontiers in medicinePeginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial. Front Med (Lausanne). 2023; 10:1095828.Front Med (Lausanne)2023-02-24T00:00:002023Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial.36890337Kleiner DE, Lisker-Melman M, Wahed AS, Bhan AK, Nalesnik MA, Choi EK, Leonard KK, Ghany MG, Chung RT, Di Bisceglie AMJournal of gastroenterology and hepatologyImmunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease. J Gastroenterol Hepatol. 2023 Jun; 38(6):989-998.J Gastroenterol Hepatol2023-04-09T00:00:002023Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease.36972796Cui A, Li B, Wallace MS, Gonye ALK, Oetheimer C, Patel H, Tonnerre P, Holmes JA, Lieb D, Yao BS, Ma A, Roberts K, Damasio M, Chen JH, Piou D, Carlton-Smith C, Brown J, Mylvaganam R, Hon Fung JM, Sade-Feldman M, Aneja J, Gustafson J, Epstein ET, Salloum S, Brisac C, Thabet A, Kim AY, Lauer GM, Hacohen N, Chung RT, Alatrakchi NJournal of hepatologySingle-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis. J Hepatol. 2024 Feb; 80(2):251-267.J Hepatol2023-03-25T00:00:002023Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis.37158243Genshaft AS, Subudhi S, Keo A, Sanchez Vasquez JD, Conceição-Neto N, Mahamed D, Boeijen LL, Alatrakchi N, Oetheimer C, Vilme M, Drake R, Fleming I, Tran N, Tzouanas C, Joseph-Chazan J, Arreola Villanueva M, van de Werken HJG, van Oord GW, Groothuismink ZMA, Beudeker BJ, Osmani Z, Nkongolo S, Mehrotra A, Spittaels K, Feld J, Chung RT, de Knegt RJ, Janssen HLA, Aerssens J, Bollekens J, Hacohen N, Lauer GM, Boonstra A, Shalek AK, Gehring AJHepatology (Baltimore, Md.)Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients. Hepatology. 2023 11 01; 78(5):1525-1541.Hepatology2023-05-10T00:00:002023Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients.Authorship 156749531Authorship 155760930Authorship 15680502Authorship 156821115Authorship 156042926Authorship 15514607Authorship 15693984Authorship 156459231Authorship 15692489Authorship 1566371637278302Lisker-Melman M, King WC, Ghany MG, Chung RT, Hinerman AS, Cloherty GA, Khalili M, Jain MK, Sulkowski M, Sterling RKJournal of viral hepatitisHuman immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremia. J Viral Hepat. 2023 08; 30(8):700-709.J Viral Hepat2023-06-06T00:00:002023Human immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremia.36972232McLean Diaz P, Vannier A, Joshi AD, Mahle RE, Przybyszewski EM, Corey K, Chung RT, Luther J, Goodman RP, Schaefer EAKClinical and translational gastroenterologySerum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis. Clin Transl Gastroenterol. 2023 06 01; 14(6):e00585.Clin Transl Gastroenterol2023-06-01T00:00:002023Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis.37255856Ebhohon E, Chung RTTherapeutic advances in gastroenterologySystematic review: efficacy of therapies for cholestatic pruritus. Therap Adv Gastroenterol. 2023; 16:17562848231172829.Therap Adv Gastroenterol2023-05-25T00:00:002023Systematic review: efficacy of therapies for cholestatic pruritus.37046084Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, Dichtel L, Griffin G, Uddin MM, Gibson CJ, Kovalcik V, Lin AE, McConkey ME, Vromman A, Sellar RS, Kim PG, Agrawal M, Weinstock J, Long MT, Yu B, Banerjee R, Nicholls RC, Dennis A, Kelly M, Loh PR, McCarroll S, Boerwinkle E, Vasan RS, Jaiswal S, Johnson AD, Chung RT, Corey K, Levy D, Ballantyne C, Ebert BL, Natarajan PNatureClonal haematopoiesis and risk of chronic liver disease. Nature. 2023 04; 616(7958):747-754.Nature2023-04-12T00:00:002023Clonal haematopoiesis and risk of chronic liver disease.37074026Ghany MG, King WC, Hinerman AS, Lok AS, Lisker-Melman M, Chung RT, Terrault N, Janssen HLA, Khalili M, Lee WM, Lau DTY, Cloherty GA, Sterling RKHepatology (Baltimore, Md.)Use of HBV RNA and to predict change in serological status and disease activity in CHB. Hepatology. 2023 11 01; 78(5):1542-1557.Hepatology2023-04-20T00:00:002023Use of HBV RNA and to predict change in serological status and disease activity in CHB.37400552Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, Dichtel L, Griffin G, Uddin MM, Gibson CJ, Kovalcik V, Lin AE, McConkey ME, Vromman A, Sellar RS, Kim PG, Agrawal M, Weinstock J, Long MT, Yu B, Banerjee R, Nicholls RC, Dennis A, Kelly M, Loh PR, McCarroll S, Boerwinkle E, Vasan RS, Jaiswal S, Johnson AD, Chung RT, Corey K, Levy D, Ballantyne C, Ebert BL, Natarajan PNatureAuthor Correction: Clonal haematopoiesis and risk of chronic liver disease. Nature. 2023 Jul; 619(7970):E47.Nature2023-07-01T00:00:002023Author Correction: Clonal haematopoiesis and risk of chronic liver disease.37425441Villavicencio MA, Li SS, Leifer AM, Gustafson JL, Osho A, Wolfe S, Raz Y, Griffith J, Neuringer I, Bethea E, Gift T, Waldman G, Astor T, Langer NB, Chung RTJTCVS openPreemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response. JTCVS Open. 2023 Jun; 14:602-614.JTCVS Open2023-03-10T00:00:002023Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response.37467044Muula GK, Bosomprah S, Sinkala E, Nsokolo B, Musonda T, Hamusonde K, Bhattacharya D, Lauer G, Chung RT, Mulenga LB, Wandeler G, Vinikoor MJAIDS (London, England)Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia. AIDS. 2023 11 01; 37(13):2015-2020.AIDS2023-07-17T00:00:002023Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia.Authorship 2114726Authorship 2347129Authorship 3207557Authorship 3396906Authorship 3502252Authorship 15825026Authorship 158301012Authorship 15848337Authorship 1587830237579208Liang TJ, Law JLM, Pietschmann T, Ray SC, Bukh J, Bull R, Chung RT, Tyrrell DL, Houghton M, Rice CMClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaChallenge Inoculum for Hepatitis C Virus Controlled Human Infection Model. Clin Infect Dis. 2023 08 14; 77(Suppl 3):S257-S261.Clin Infect Dis2023-08-14T00:00:002023Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model.37517455Patidar KR, Belcher JM, Regner KR, St Hillien SA, Simonetto DA, Asrani SK, Neyra JA, Sharma P, Velez JCQ, Wadei H, Nadim MK, Chung RT, Seethapathy R, Parada XV, Ouyang T, Ufere NN, Robinson JE, McLean Diaz P, Wilechansky RM, Przybyszewski EM, Smith TN, Ali AA, Orman ES, Schulz P, Siddiqui SM, Shabbir R, Liu LJ, Cama-Olivares A, Flannery AH, Baker ML, Gunasekaran D, Aswine A, Issa R, Li J, Verma S, Chalmers D, Varghese V, Lam W, Mohamed M, Kovacic R, Gaddy A, Attieh RM, Cortes P, Semnani S, Wang L, Khemichian S, Allegretti ASJournal of hepatologyIncidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US. J Hepatol. 2023 12; 79(6):1408-1417.J Hepatol2023-07-28T00:00:002023Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US.37703341Przybyszewski EM, Chung RTThe Journal of infectious diseasesUnmet Needs in the Post-Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication. J Infect Dis. 2023 09 13; 228(Suppl 3):S226-S231.J Infect Dis2023-09-13T00:00:002023Unmet Needs in the Post-Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication.37739799Fricker GP, Ghany MG, Mera J, Pinsky BA, Ward JW, Chung RTThe Journal of infectious diseasesTools Needed to Support Same-day Diagnosis and Treatment of Current Hepatitis C Infection. J Infect Dis. 2023 Sep 22.J Infect Dis2023-09-22T00:00:002023Tools Needed to Support Same-day Diagnosis and Treatment of Current Hepatitis C Infection.true1Instructor in MedicineInstructor in MedicineAuthorship 1597024837818152Jordan VC, Sojoodi M, Shroff S, Pagan PG, Barrett SC, Wellen J, Tanabe KK, Chung RT, Caravan P, Gale EMJHEP reports : innovation in hepatologyMolecular magnetic resonance imaging of liver inflammation using an oxidatively activated probe. JHEP Rep. 2023 Oct; 5(10):100850.JHEP Rep2023-07-18T00:00:002023Molecular magnetic resonance imaging of liver inflammation using an oxidatively activated probe.true1Professor of MedicineProfessor of MedicineAuthorship 4117952Authorship 4433133Authorship 4508574Authorship 160222518Authorship 1602835337869072Baumert LS, Shih A, Chung RTJHEP reports : innovation in hepatologyManagement of liver disease and portal hypertension in common variable immunodeficiency (CVID). JHEP Rep. 2023 Nov; 5(11):100882.JHEP Rep2023-08-13T00:00:002023Management of liver disease and portal hypertension in common variable immunodeficiency (CVID).37873414Dand N, Stuart PE, Bowes J, Ellinghaus D, Nititham J, Saklatvala JR, Teder-Laving M, Thomas LF, Traks T, Uebe S, Assmann G, Baudry D, Behrens F, Billi AC, Brown MA, Burkhardt H, Capon F, Chung R, Curtis CJ, Duckworth M, Ellinghaus E, FitzGerald O, Gerdes S, Griffiths CEM, Gulliver S, Helliwell P, Ho P, Hoffmann P, Holmen OL, Huang ZM, Hveem K, Jadon D, Köhm M, Kraus C, Lamacchia C, Lee SH, Ma F, Mahil SK, McHugh N, McManus R, Modalsli EH, Nissen MJ, Nöthen M, Oji V, Oksenberg JR, Patrick MT, Perez-White BE, Ramming A, Rech J, Rosen C, Sarkar MK, Schett G, Schmidt B, Tejasvi T, Traupe H, Voorhees JJ, Wacker EM, Warren RB, Wasikowski R, Weidinger S, Wen X, Zhang Z, Barton A, Chandran V, Esko T, Foerster J, Franke A, Gladman DD, Gudjonsson JE, Gulliver W, Hüffmeier U, Kingo K, Kõks S, Liao W, Løset M, Mägi R, Nair RP, Rahman P, Reis A, Smith CH, Di Meglio P, Barker JN, Tsoi LC, Simpson MA, Elder JTmedRxiv : the preprint server for health sciencesGWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. medRxiv. 2023 Oct 05.medRxiv2023-10-05T00:00:002023GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.Authorship 47339110Authorship 161009110Authorship 16108651137997691Vinikoor MJ, Hamusonde K, Muula G, Asombang M, Riebensahm C, Chitundu H, Sunkuntu-Sichizya V, Bhattacharya D, Sinkala E, Lauer G, Chung R, Mbewe W, Egger M, Bosomprah S, Wandeler GClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaLong-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV/HIV coinfection in Zambia. Clin Infect Dis. 2023 Nov 24.Clin Infect Dis2023-11-24T00:00:002023Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV/HIV coinfection in Zambia.37961334Wang Y, Leaker B, Qiao G, Sojoodi M, Eissa IR, Epstein ET, Eddy J, Dimowo O, Lauer GM, Chung RT, Qadan M, Lanuti M, Fuchs BC, Tanabe KKbioRxiv : the preprint server for biologyPrecision-Cut Liver Slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis. bioRxiv. 2023 Nov 05.bioRxiv2023-11-05T00:00:002023Precision-Cut Liver Slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis.Authorship 51113882028-07-31CHUNG, RAYMOND T2023-09-26YAP signaling in the pathogenesis of NAFLD in people living with HIVR01DK1384742027-08-31HOSHIDA, YUJIN2023-09-25Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosisU01CA288375Co-Principal InvestigatorPrincipal InvestigatorAuthorship 5473951Authorship 1626274738294274Chua C, Mahamed D, Nkongolo S, Sanchez Vasquez JD, Mehrotra A, Wong DKH, Chung RT, Feld JJ, Janssen HLA, Gehring AJJournal of immunology (Baltimore, Md. : 1950)Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy. J Immunol. 2024 Mar 15; 212(6):1002-1011.J Immunol2024-03-15T00:00:002024Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy.Authorship 579714Authorship 162707612Authorship 16282021138311121Xu M, Warner C, Duan X, Cheng Z, Jeyarajan AJ, Li W, Wang Y, Shao T, Salloum S, Chen PJ, Yu X, Chung RT, Lin WJournal of hepatologyHIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1a- and TGF-ß1-dependent pathway. J Hepatol. 2024 Feb 02.J Hepatol2024-02-02T00:00:002024HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1a- and TGF-ß1-dependent pathway.38332750Musonda T, Wallace MS, Patel H, Martin OP, Oetheimer C, Mwakamui S, Sinkala E, Nsokolo B, Kanunga A, Lauer G, Chung RT, Wandeler G, Bhattacharya D, Kelly P, Alatrakchi N, Vinikoor MJThe Journal of infectious diseasesNew window into hepatitis B in Africa: Liver sampling combined with single cell omics enables deep and longitudinal assessment of intrahepatic immunity in Zambia. J Infect Dis. 2024 Feb 09.J Infect Dis2024-02-09T00:00:002024New window into hepatitis B in Africa: Liver sampling combined with single cell omics enables deep and longitudinal assessment of intrahepatic immunity in Zambia.Authorship 1630714338340708Baumert LS, Shih AR, Chung RTMed (New York, N.Y.)HBV reactivation and clinical resolution in an isolated anti-HBc-positive patient during immune checkpoint inhibition. Med. 2024 Feb 09; 5(2):126-131.e1.Med2024-02-09T00:00:002024HBV reactivation and clinical resolution in an isolated anti-HBc-positive patient during immune checkpoint inhibition.Authorship 52569Authorship 3983252Authorship 241293Authorship 335762423784735Bai H, Chen T, Ming J, Sun H, Cao P, Fusco DN, Chung RT, Chorev M, Jin Q, Aktas BHChembiochem : a European journal of chemical biologyDual activators of protein kinase R (PKR) and protein kinase R-like kinase PERK identify common and divergent catalytic targets. Chembiochem. 2013 Jul 08; 14(10):1255-62.Chembiochem2013-06-19T00:00:002013Dual activators of protein kinase R (PKR) and protein kinase R-like kinase PERK identify common and divergent catalytic targets.Authorship 6368563Authorship 6377444Authorship 6502795Authorship 6570392Authorship 6643242Authorship 6507902Authorship 64201812Authorship 6423852Authorship 6538132Authorship 6414848Authorship 6603332Authorship 6547597Authorship 6580474Authorship 6433842Authorship 6459332Authorship 6425412Authorship 65734012Authorship 64800910Authorship 6567302Authorship 6422799Authorship 6417439Authorship 6446091Authorship 6450682Authorship 6444526Authorship 64973310Authorship 65284714Authorship 6481892Authorship 6412012Authorship 6500727Authorship 66284327Authorship 64593413Authorship 6513515Authorship 6663687Authorship 6541022Authorship 6573118Authorship 6607956Authorship 6483693Authorship 64429013Authorship 6561537Authorship 64762110Authorship 6547221Authorship 6631083Authorship 6541441Authorship 6551757Authorship 6427243Authorship 64366216Authorship 6579107Authorship 6488671Authorship 65918315Authorship 6558112Authorship 65057510Authorship 6545517Authorship 6609885Authorship 6490735Authorship 65656214Authorship 6592264Authorship 6646633Authorship 6681105Authorship 6512467Authorship 6529477Authorship 6611096Authorship 6617734Authorship 6407127Authorship 66009111Authorship 6585414Authorship 65919710Authorship 64469714Authorship 6682357Authorship 668189516300886Morgan L, Neame SJ, Child H, Chung R, Shah B, Barden L, Staddon JM, Patel TRNeuroscience lettersDevelopment of a pentylenetetrazole-induced seizure model to evaluate kinase inhibitor efficacy in the central nervous system. Neurosci Lett. 2006 Mar 06; 395(2):143-8.Neurosci Lett2005-11-21T00:00:002005Development of a pentylenetetrazole-induced seizure model to evaluate kinase inhibitor efficacy in the central nervous system.20710056Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard JT, Kupfer B, Luechters G, Chung RT, Rockstroh JK, Spengler UAntiviral therapyGB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antivir Ther. 2010; 15(5):745-52.Antivir Ther2010-01-01T00:00:002010GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells.12828057Glehen O, Mithieux F, Traverse-Glehen A, Isaac S, Bienvenu J, François Y, Chung R, Gilly FNHepato-gastroenterologyEnteral immunotherapy in the treatment of chronic enterocolitis in interleukin-10-deficient mice. Hepatogastroenterology. 2003 May-Jun; 50(51):670-5.Hepatogastroenterology2003-05-01T00:00:002003Enteral immunotherapy in the treatment of chronic enterocolitis in interleukin-10-deficient mice.23333348Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, Chung RT, Gould J, Kojima K, Gupta S, Taylor B, Crenshaw A, Gabriel S, Minguez B, Iavarone M, Friedman SL, Colombo M, Llovet JM, Golub TRGastroenterologyPrognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology. 2013 May; 144(5):1024-30.Gastroenterology2013-01-17T00:00:002013Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis.23390300Lin W, Weinberg EM, Chung RTThe Journal of infectious diseasesPathogenesis of accelerated fibrosis in HIV/HCV co-infection. J Infect Dis. 2013 Mar; 207 Suppl 1:S13-8.J Infect Dis2013-03-01T00:00:002013Pathogenesis of accelerated fibrosis in HIV/HCV co-infection.22510354Chung RT, Umbleja T, Chen JY, Andersen JW, Butt AA, Sherman KEHIV clinical trialsExtended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients. HIV Clin Trials. 2012 Mar-Apr; 13(2):70-82.HIV Clin Trials2012-03-01T00:00:002012Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.23739141Branch AD, Kang M, Hollabaugh K, Wyatt CM, Chung RT, Glesby MJThe American journal of clinical nutritionIn HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. Am J Clin Nutr. 2013 Aug; 98(2):423-9.Am J Clin Nutr2013-06-05T00:00:002013In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.21077950Han SH, Reddy KR, Keeffe EB, Soldevila-Pico C, Gish R, Chung RT, Degertekin B, Lok AClinical transplantationClinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study. Clin Transplant. 2011 Mar-Apr; 25(2):E152-62.Clin Transplant2010-11-16T00:00:002010Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study.15757057Hoehne F, Ozaeta M, Chung RThe American surgeonRoutine chest X-ray after percutaneous tracheostomy is unnecessary. Am Surg. 2005 Jan; 71(1):51-3.Am Surg2005-01-01T00:00:002005Routine chest X-ray after percutaneous tracheostomy is unnecessary.22306586Opravil M, Rodriguez-Torres M, Rockstroh J, Snoeck E, Chung RT, Tietz A, Torriani FJHIV clinical trialsThe dose-response relationship of peginterferon alfa-2a and ribavirin in the treatment of patients coinfected with HIV-HCV. HIV Clin Trials. 2012 Jan-Feb; 13(1):33-45.HIV Clin Trials2012-01-01T00:00:002012The dose-response relationship of peginterferon alfa-2a and ribavirin in the treatment of patients coinfected with HIV-HCV.22256811Chung RTThe New England journal of medicineA watershed moment in the treatment of hepatitis C. N Engl J Med. 2012 Jan 19; 366(3):273-5.N Engl J Med2012-01-19T00:00:002012A watershed moment in the treatment of hepatitis C.20924208Jang JY, Chung RTThe Korean journal of hepatologyNew treatments for chronic hepatitis C. Korean J Hepatol. 2010 Sep; 16(3):263-77.Korean J Hepatol2010-09-01T00:00:002010New treatments for chronic hepatitis C.22796239Chung RT, Stravitz RT, Fontana RJ, Schiodt FV, Mehal WZ, Reddy KR, Lee WMGastroenterologyPathogenesis of liver injury in acute liver failure. Gastroenterology. 2012 Sep; 143(3):e1-e7.Gastroenterology2012-07-13T00:00:002012Pathogenesis of liver injury in acute liver failure.21760886O'Brien TR, Everhart JE, Morgan TR, Lok AS, Chung RT, Shao Y, Shiffman ML, Dotrang M, Sninsky JJ, Bonkovsky HL, Pfeiffer RMPloS oneAn IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C. PLoS One. 2011; 6(7):e20904.PLoS One2011-07-08T00:00:002011An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.20921898Sherman KE, Andersen JW, Butt AA, Umbleja T, Alston B, Koziel MJ, Peters MG, Sulkowski M, Goodman ZD, Chung RTJournal of acquired immune deficiency syndromes (1999)Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C). J Acquir Immune Defic Syndr. 2010 Dec 15; 55(5):597-605.J Acquir Immune Defic Syndr2010-12-15T00:00:002010Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).20812362Moriguchi H, Chung RT, Mihara M, Sato CHepatology (Baltimore, Md.)Generation of human induced pluripotent stem cells from liver progenitor cells by only small molecules. Hepatology. 2010 Sep; 52(3):1169; author reply 1169-70.Hepatology2010-09-01T00:00:002010Generation of human induced pluripotent stem cells from liver progenitor cells by only small molecules.20647389King LY, Chung RTThe oncologistWhen treating cancer, please don't forget hepatitis B. Oncologist. 2010; 15(8):826-9.Oncologist2010-07-20T00:00:002010When treating cancer, please don't forget hepatitis B.21898501Sherman KE, Thomas DL, Chung RTHepatology (Baltimore, Md.)Human immunodeficiency virus and liver disease forum 2010: conference proceedings. Hepatology. 2011 Dec; 54(6):2245-53.Hepatology2011-12-01T00:00:002011Human immunodeficiency virus and liver disease forum 2010: conference proceedings.21948394Taylor RM, Tujios S, Jinjuvadia K, Davern T, Shaikh OS, Han S, Chung RT, Lee WM, Fontana RJDigestive diseases and sciencesShort and long-term outcomes in patients with acute liver failure due to ischemic hepatitis. Dig Dis Sci. 2012 Mar; 57(3):777-85.Dig Dis Sci2011-09-27T00:00:002011Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis.21256845Chen JY, Chung RTGastroenterologyCan we use the "C" word with confidence? Cure for chronic hepatitis C. Gastroenterology. 2011 Mar; 140(3):766-8.Gastroenterology2011-01-21T00:00:002011Can we use the "C" word with confidence? Cure for chronic hepatitis C.23659183Bailey CM, Sullivan TJ, Iyidogan P, Tirado-Rives J, Chung R, Ruiz-Caro J, Mohamed E, Jorgensen WL, Jorgensen W, Hunter R, Anderson KSJournal of medicinal chemistryBifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy. J Med Chem. 2013 May 23; 56(10):3959-68.J Med Chem2013-05-09T00:00:002013Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy.23416431King LY, Chung RTJournal of hepatologyIL28B testing in a rapidly changing world: Still relevant? J Hepatol. 2013 May; 58(5):847-9.J Hepatol2013-02-14T00:00:002013IL28B testing in a rapidly changing world: Still relevant?23658732Corey KE, Misdraji J, Zheng H, Malecki KM, Kneeman J, Gelrud L, Chung RTPloS oneThe absence of obstructive sleep apnea may protect against non-alcoholic fatty liver in patients undergoing bariatric surgery. PLoS One. 2013; 8(5):e62504.PLoS One2013-05-03T00:00:002013The absence of obstructive sleep apnea may protect against non-alcoholic fatty liver in patients undergoing bariatric surgery.23083826Chen JY, Chung RTInfectious disease clinics of North AmericaFuture classes of hepatitis C virus therapeutic agents. Infect Dis Clin North Am. 2012 Dec; 26(4):949-66.Infect Dis Clin North Am2012-12-01T00:00:002012Future classes of hepatitis C virus therapeutic agents.22973419Huang YW, Chung RTTherapeutic advances in gastroenterologyManagement of hepatitis B reactivation in patients receiving cancer chemotherapy. Therap Adv Gastroenterol. 2012 Sep; 5(5):359-70.Therap Adv Gastroenterol2012-09-01T00:00:002012Management of hepatitis B reactivation in patients receiving cancer chemotherapy.21814590Jang JY, Chung RTGut and liverChronic hepatitis C. Gut Liver. 2011 Jun; 5(2):117-32.Gut Liver2011-06-24T00:00:002011Chronic hepatitis C.23844083Watanabe T, Hiasa Y, Tokumoto Y, Hirooka M, Abe M, Ikeda Y, Matsuura B, Chung RT, Onji MPloS oneProtein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infection. PLoS One. 2013; 8(7):e67750.PLoS One2013-07-02T00:00:002013Protein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infection.23814610John S, Andersson KL, Kotton CN, Hertl M, Markmann JF, Cosimi AB, Chung RTTherapeutic advances in gastroenterologyProphylaxis of hepatitis B infection in solid organ transplant recipients. Therap Adv Gastroenterol. 2013 Jul; 6(4):309-19.Therap Adv Gastroenterol2013-07-01T00:00:002013Prophylaxis of hepatitis B infection in solid organ transplant recipients.23462180Fusco DN, Brisac C, John SP, Huang YW, Chin CR, Xie T, Zhao H, Jilg N, Zhang L, Chevaliez S, Wambua D, Lin W, Peng L, Chung RT, Brass ALGastroenterologyA genetic screen identifies interferon-a effector genes required to suppress hepatitis C virus replication. Gastroenterology. 2013 Jun; 144(7):1438-49, 1449.e1-9.Gastroenterology2013-02-24T00:00:002013A genetic screen identifies interferon-a effector genes required to suppress hepatitis C virus replication.21064034Chung RT, Poordad FF, Hassanein T, Zhou X, Lentz E, Prabhakar A, Di Bisceglie AMHepatology (Baltimore, Md.)Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C. Hepatology. 2010 Dec; 52(6):1906-14.Hepatology2010-11-09T00:00:002010Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C.22563020Butt AA, Umbleja T, Andersen JW, Sherman KE, Chung RTClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaImpact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study. Clin Infect Dis. 2012 Sep; 55(5):631-8.Clin Infect Dis2012-05-04T00:00:002012Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.Authorship 9441211Authorship 1825672Authorship 6701491123665281Uzi D, Barda L, Scaiewicz V, Mills M, Mueller T, Gonzalez-Rodriguez A, Valverde AM, Iwawaki T, Nahmias Y, Xavier R, Chung RT, Tirosh B, Shibolet OJournal of hepatologyCHOP is a critical regulator of acetaminophen-induced hepatotoxicity. J Hepatol. 2013 Sep; 59(3):495-503.J Hepatol2013-05-09T00:00:002013CHOP is a critical regulator of acetaminophen-induced hepatotoxicity.Authorship 5596025Authorship 5685314Authorship 5741081Authorship 2589751Authorship 6815951123831117Goto K, Lin W, Zhang L, Jilg N, Shao RX, Schaefer EA, Zhao H, Fusco DN, Peng LF, Kato N, Chung RTJournal of hepatologyThe AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-ß signaling. J Hepatol. 2013 Nov; 59(5):942-8.J Hepatol2013-07-02T00:00:002013The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-ß signaling.Authorship 2913975Authorship 2988076Authorship 3446638Authorship 692321224222093Schaefer EA, Chung RTSeminars in liver diseaseHCV and host lipids: an intimate connection. Semin Liver Dis. 2013 Nov; 33(4):358-68.Semin Liver Dis2013-11-12T00:00:002013HCV and host lipids: an intimate connection.Authorship 6939951624259050Rottiers V, Obad S, Petri A, McGarrah R, Lindholm MW, Black JC, Sinha S, Goody RJ, Lawrence MS, deLemos AS, Hansen HF, Whittaker S, Henry S, Brookes R, Najafi-Shoushtari SH, Chung RT, Whetstine JR, Gerszten RE, Kauppinen S, Näär AMScience translational medicinePharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR. Sci Transl Med. 2013 Nov 20; 5(212):212ra162.Sci Transl Med2013-11-20T00:00:002013Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.Authorship 36408915Authorship 695938224218111Zator ZA, Chung RTCurrent HIV/AIDS reportsAfter the cure: management of HCV after achievement of SVR. Curr HIV/AIDS Rep. 2013 Dec; 10(4):428-35.Curr HIV/AIDS Rep2013-12-01T00:00:002013After the cure: management of HCV after achievement of SVR.Authorship 6988019Authorship 699255324339898Scaiewicz V, Nahmias A, Chung RT, Mueller T, Tirosh B, Shibolet OPloS oneCCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model. PLoS One. 2013; 8(12):e81065.PLoS One2013-12-05T00:00:002013CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.24334180Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters MGHIV clinical trialsAddition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. HIV Clin Trials. 2013 Nov-Dec; 14(6):274-83.HIV Clin Trials2013-11-01T00:00:002013Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.Authorship 7002943Authorship 700169523904401Sherman KE, Thomas D, Chung RTHepatology (Baltimore, Md.)Human immunodeficiency virus and liver disease forum 2012. Hepatology. 2014 Jan; 59(1):307-17.Hepatology2013-11-22T00:00:002013Human immunodeficiency virus and liver disease forum 2012.24138212Bailey CM, Sullivan TJ, Iyidogan P, Tirado-Rives J, Chung R, Ruiz-Caro J, Mohamed E, Jorgensen WL, Hunter R, Anderson KSJournal of medicinal chemistryCorrection to Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-Concept as a Novel Therapeutic Design Strategy. J Med Chem. 2013 Nov 14; 56(21):8953.J Med Chem2013-10-18T00:00:002013Correction to Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-Concept as a Novel Therapeutic Design Strategy.24391478Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, Quintana C, Osorio JC, Wang Z, Zhao Y, Lawler LA, Christie JD, Meyer NJ, Mc Causland FR, Waikar SS, Waxman AB, Chung RT, Bueno R, Rosas IO, Fredenburgh LE, Baron RM, Christiani DC, Hunninghake GM, Choi AMPLoS medicineCirculating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2013 Dec; 10(12):e1001577; discussion e1001577.PLoS Med2013-12-31T00:00:002013Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation.Authorship 22110820Authorship 70216717Authorship 2609293Authorship 261492Authorship 2355658Authorship 2422853Authorship 70517211Authorship 7051481123990035Johnson KB, Campbell EJ, Chi H, Zheng H, King LY, Wu Y, Delemos A, Hurairah A, Corey K, Richter JM, Chung RTDigestive diseases and sciencesAdvanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort. Dig Dis Sci. 2014 Jan; 59(1):174-82.Dig Dis Sci2013-08-30T00:00:002013Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort.24148617Kroy DC, Ciuffreda D, Cooperrider JH, Tomlinson M, Hauck GD, Aneja J, Berger C, Wolski D, Carrington M, Wherry EJ, Chung RT, Tanabe KK, Elias N, Freeman GJ, de Kruyff RH, Misdraji J, Kim AY, Lauer GMGastroenterologyLiver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors. Gastroenterology. 2014 Feb; 146(2):550-61.Gastroenterology2013-10-19T00:00:002013Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.Authorship 2299607Authorship 2685931Authorship 207632224535328Chen JY, Feeney ER, Chung RTNature reviews. Gastroenterology & hepatologyHCV and HIV co-infection: mechanisms and management. Nat Rev Gastroenterol Hepatol. 2014 Jun; 11(6):362-71.Nat Rev Gastroenterol Hepatol2014-02-18T00:00:002014HCV and HIV co-infection: mechanisms and management.Authorship 3187511Authorship 28768910Authorship 7241643Authorship 72432314Authorship 7141813Authorship 7168941724477596Hong J, Yuan Y, Wang J, Liao Y, Zou R, Zhu C, Li B, Liang Y, Huang P, Wang Z, Lin W, Zeng Y, Dai JL, Chung RTCancer researchExpression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma. Cancer Res. 2014 Mar 15; 74(6):1845-56.Cancer Res2014-01-29T00:00:002014Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma.24525381Fofana I, Jilg N, Chung RT, Baumert TFAntiviral researchEntry inhibitors and future treatment of hepatitis C. Antiviral Res. 2014 Apr; 104:136-42.Antiviral Res2014-02-10T00:00:002014Entry inhibitors and future treatment of hepatitis C.23913866Jilg N, Lin W, Hong J, Schaefer EA, Wolski D, Meixong J, Goto K, Brisac C, Chusri P, Fusco DN, Chevaliez S, Luther J, Kumthip K, Urban TJ, Peng LF, Lauer GM, Chung RTHepatology (Baltimore, Md.)Kinetic differences in the induction of interferon stimulated genes by interferon-a and interleukin 28B are altered by infection with hepatitis C virus. Hepatology. 2014 Apr; 59(4):1250-61.Hepatology2014-02-14T00:00:002014Kinetic differences in the induction of interferon stimulated genes by interferon-a and interleukin 28B are altered by infection with hepatitis C virus.24525470Marks KM, Kitch D, Chung RT, Hadigan C, Andersen J, Tien P, Luetkemeyer A, Alston-Smith B, Glesby MJJournal of acquired immune deficiency syndromes (1999)Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239. J Acquir Immune Defic Syndr. 2014 Mar 01; 65(3):345-9.J Acquir Immune Defic Syndr2014-03-01T00:00:002014Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.Authorship 7272829Authorship 726588124623438Li H, Yang X, Yang G, Hong Z, Zhou L, Yin P, Xiao Y, Chen L, Chung RT, Zhang LJournal of virologyHepatitis C virus NS5A hijacks ARFGAP1 to maintain a phosphatidylinositol 4-phosphate-enriched microenvironment. J Virol. 2014 Jun; 88(11):5956-66.J Virol2014-03-12T00:00:002014Hepatitis C virus NS5A hijacks ARFGAP1 to maintain a phosphatidylinositol 4-phosphate-enriched microenvironment.24720678Chung RT, Baumert TFThe New England journal of medicineCuring chronic hepatitis C--the arc of a medical triumph. N Engl J Med. 2014 Apr 24; 370(17):1576-8.N Engl J Med2014-04-10T00:00:002014Curing chronic hepatitis C--the arc of a medical triumph.Authorship 73291710Authorship 7325333Authorship 733690624732869Wu Y, Johnson KB, Roccaro G, Lopez J, Zheng H, Muiru A, Ufere N, Rajbhandari R, Kattan O, Chung RTThe American journal of gastroenterologyPoor adherence to AASLD guidelines for chronic hepatitis B Management and treatment in a large academic medical center. Am J Gastroenterol. 2014 Jun; 109(6):867-75.Am J Gastroenterol2014-04-15T00:00:002014Poor adherence to AASLD guidelines for chronic hepatitis B Management and treatment in a large academic medical center.23872239Schmidt WN, Nelson DR, Pawlotsky JM, Sherman KE, Thomas DL, Chung RTClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationDirect-acting antiviral agents and the path to interferon independence. Clin Gastroenterol Hepatol. 2014 May; 12(5):728-37.Clin Gastroenterol Hepatol2013-07-18T00:00:002013Direct-acting antiviral agents and the path to interferon independence.Authorship 7362051324927176Jang JY, Kim SJ, Cho EK, Jeong SW, Park EJ, Lee WC, Lee SH, Kim SG, Kim YS, Kim HS, Kim BS, Lin W, Chung RTPloS oneTRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications. PLoS One. 2014; 9(6):e98171.PLoS One2014-06-13T00:00:002014TRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications.Authorship 3257113Authorship 7393702Authorship 741046524952382Corey KE, Misdraji J, Gelrud L, Zheng H, Chung RT, Krauss RMLipids in health and diseaseNonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile. Lipids Health Dis. 2014 Jun 21; 13:100.Lipids Health Dis2014-06-21T00:00:002014Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile.24861100Rajbhandari R, Chung RTAnnals of internal medicineScreening for hepatitis B virus infection: a public health imperative. Ann Intern Med. 2014 Jul 01; 161(1):76-7.Ann Intern Med2014-07-01T00:00:002014Screening for hepatitis B virus infection: a public health imperative.Authorship 7417682Authorship 743799424718650Strazzula L, Pratt DS, Zardas J, Chung RT, Thiim M, Kroshinsky DJAMA dermatologyWidespread morbilliform eruption associated with telaprevir: use of dermatologic consultation to increase tolerability. JAMA Dermatol. 2014 Jul; 150(7):756-9.JAMA Dermatol2014-07-01T00:00:002014Widespread morbilliform eruption associated with telaprevir: use of dermatologic consultation to increase tolerability.24636306deLemos AS, Chung RTTrends in molecular medicineHepatitis C treatment: an incipient therapeutic revolution. Trends Mol Med. 2014 Jun; 20(6):315-21.Trends Mol Med2014-03-11T00:00:002014Hepatitis C treatment: an incipient therapeutic revolution.Authorship 3883192Authorship 433520725002352Feeney ER, Chung RTBMJ (Clinical research ed.)Antiviral treatment of hepatitis C. BMJ. 2014 Jul 07; 348:g3308.BMJ2014-07-07T00:00:002014Antiviral treatment of hepatitis C.Authorship 3242871Authorship 31634210Authorship 4676462Authorship 4805112Authorship 7466494Authorship 7490831Authorship 7502481Authorship 7527712Authorship 753250125117963Kelly P, Saloojee H, Chen JY, Chung RTJournal of acquired immune deficiency syndromes (1999)Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects. J Acquir Immune Defic Syndr. 2014 Sep 01; 67 Suppl 1:S79-86.J Acquir Immune Defic Syndr2014-09-01T00:00:002014Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.22879636Chung RBMJ (Clinical research ed.)Coronal oblique proton density weighted magnetic resonance imaging of the right shoulder. BMJ. 2012 Aug 09; 345:e5270.BMJ2012-08-09T00:00:002012Coronal oblique proton density weighted magnetic resonance imaging of the right shoulder.22885398Chung RBMJ (Clinical research ed.)Magnetic resonance imaging of the axial structures of the brain. BMJ. 2012 Aug 10; 345:e5268.BMJ2012-08-10T00:00:002012Magnetic resonance imaging of the axial structures of the brain.22879635Chung RBMJ (Clinical research ed.)Magnetic resonance imaging of sagittal structures in the knee. BMJ. 2012 Aug 09; 345:e5266.BMJ2012-08-09T00:00:002012Magnetic resonance imaging of sagittal structures in the knee.Authorship 3542175Authorship 571457132014-08-01T00:00:002014-06-12T00:00:00Evaluating the Prognostic Power of Three SNP Loci for Patients with Early Chronic Hepatitis CSummer2014-08-11T00:00:002014-06-23T00:00:00Retrospective Review of Acetaminophen/ Diphenhydramine Overdose: Toxicity Features and Outcomes Reported to California Poison Control System Over 15 YearsSummerAuthorship 990175Authorship 2277961Authorship 2297271Authorship 3705822Authorship 3713387Authorship 4967071Authorship 455038Authorship 7757044Authorship 7765792Authorship 7750391425504078King LY, Johnson KB, Zheng H, Wei L, Gudewicz T, Hoshida Y, Corey KE, Ajayi T, Ufere N, Baumert TF, Chan AT, Tanabe KK, Fuchs BC, Chung RTPloS oneHost genetics predict clinical deterioration in HCV-related cirrhosis. PLoS One. 2014; 9(12):e114747.PLoS One2014-12-12T00:00:002014Host genetics predict clinical deterioration in HCV-related cirrhosis.25135867Simon TG, King LY, Zheng H, Chung RTJournal of hepatologyStatin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C. J Hepatol. 2015 Jan; 62(1):18-23.J Hepatol2014-08-15T00:00:002014Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C.25514300Abramson JS, Chung RTJAMAOptimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma. JAMA. 2014 Dec 17; 312(23):2505-7.JAMA2014-12-17T00:00:002014Optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma.Authorship 4889851Authorship 4906565Authorship 5062982Authorship 778262325261839Curry MP, Forns X, Chung RT, Terrault NA, Brown R, Fenkel JM, Gordon F, O'Leary J, Kuo A, Schiano T, Everson G, Schiff E, Befeler A, Gane E, Saab S, McHutchison JG, Subramanian GM, Symonds WT, Denning J, McNair L, Arterburn S, Svarovskaia E, Moonka D, Afdhal NGastroenterologySofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Gastroenterology. 2015 Jan; 148(1):100-107.e1.Gastroenterology2014-09-28T00:00:002014Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.Authorship 548056225840922Corey KE, Misdraji J, Gelrud L, King LY, Zheng H, Malhotra A, Chung RTDigestive diseases and sciencesObstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology. Dig Dis Sci. 2015 Aug; 60(8):2523-8.Dig Dis Sci2015-04-04T00:00:002015Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.Authorship 658179Authorship 75276325393946Samir AE, Dhyani M, Vij A, Bhan AK, Halpern EF, Méndez-Navarro J, Corey KE, Chung RTRadiologyShear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement. Radiology. 2015 Mar; 274(3):888-96.Radiology2014-11-13T00:00:002014Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement.Authorship 4394729Authorship 4751306Authorship 440352Authorship 4886296Authorship 2218484Authorship 1771211Authorship 2247283Authorship 5929911Authorship 4010022Authorship 675382Authorship 3121488Authorship 54645113Authorship 1881411Authorship 1877064Authorship 933442Authorship 910187Authorship 29433710Authorship 3116725Authorship 2375743Authorship 32132Authorship 3753602Authorship 2940801Authorship 42621212Authorship 2199662Authorship 4381061Authorship 2893813Authorship 3173265Authorship 3291893Authorship 3957756Authorship 5040332Authorship 1290194Authorship 1315912Authorship 2280043Authorship 2060561Authorship 5478023Authorship 5655014Authorship 5659937Authorship 685474Authorship 25250312Authorship 2586491Authorship 1391106Authorship 1405755Authorship 26632213Authorship 2656442Authorship 4003526Authorship 2607262Authorship 2623214Authorship 4557606Authorship 5334266Authorship 5354948Authorship 54439812Authorship 3210511Authorship 5222991Authorship 5446997Authorship 78674718Authorship 7955786Authorship 79635210Authorship 8016586Authorship 8008104Authorship 8010653Authorship 7887615Authorship 79185712Authorship 8039478Authorship 79430716Authorship 8039824Authorship 8072488Authorship 78873013Authorship 807429725388655Cheng D, Zhang L, Yang G, Zhao L, Peng F, Tian Y, Xiao X, Chung RT, Gong GLiver international : official journal of the International Association for the Study of the LiverHepatitis C virus NS5A drives a PTEN-PI3K/Akt feedback loop to support cell survival. Liver Int. 2015 Jun; 35(6):1682-91.Liver Int2014-12-04T00:00:002014Hepatitis C virus NS5A drives a PTEN-PI3K/Akt feedback loop to support cell survival.25313851Delgado-Borrego A, Gonzalez-Peralta RP, Raza R, Negre B, Goodman ZD, Jonas MM, Chung RT, Ludwig DAJournal of pediatric gastroenterology and nutritionCorrelates of adiponectin in hepatitis C-infected children: the importance of body mass index. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2):165-70.J Pediatr Gastroenterol Nutr2015-02-01T00:00:002015Correlates of adiponectin in hepatitis C-infected children: the importance of body mass index.25387053Lin MV, King LY, Chung RTAnnual review of pathologyHepatitis C virus-associated cancer. Annu Rev Pathol. 2015; 10:345-70.Annu Rev Pathol2014-11-05T00:00:002014Hepatitis C virus-associated cancer.25039930Fontana RJ, Ellerbe C, Durkalski VE, Rangnekar A, Reddy RK, Stravitz T, McGuire B, Davern T, Reuben A, Liou I, Fix O, Ganger DR, Chung RT, Schilsky M, Han S, Hynan LS, Sanders C, Lee WMLiver international : official journal of the International Association for the Study of the LiverTwo-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int. 2015 Feb; 35(2):370-80.Liver Int2014-07-28T00:00:002014Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study.25878102Zhu C, Xiao F, Hong J, Wang K, Liu X, Cai D, Fusco DN, Zhao L, Jeong SW, Brisac C, Chusri P, Schaefer EA, Zhao H, Peng LF, Lin W, Chung RTJournal of virologyEFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway. J Virol. 2015 Jul; 89(13):6608-18.J Virol2015-04-15T00:00:002015EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.25443348Hoshida Y, Fuchs BC, Bardeesy N, Baumert TF, Chung RTJournal of hepatologyPathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. J Hepatol. 2014 Nov; 61(1 Suppl):S79-90.J Hepatol2014-11-03T00:00:002014Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.25264664Pakula AM, Skinner R, Jones A, Chung R, Martin MThe American surgeonRole of drains in laparoscopic appendectomy for complicated appendicitis at a busy county hospital. Am Surg. 2014 Oct; 80(10):1078-81.Am Surg2014-10-01T00:00:002014Role of drains in laparoscopic appendectomy for complicated appendicitis at a busy county hospital.25761432Gogela NA, Lin MV, Wisocky JL, Chung RTCurrent HIV/AIDS reportsEnhancing our understanding of current therapies for hepatitis C virus (HCV). Curr HIV/AIDS Rep. 2015 Mar; 12(1):68-78.Curr HIV/AIDS Rep2015-03-01T00:00:002015Enhancing our understanding of current therapies for hepatitis C virus (HCV).25481564Lin W, Zhu C, Hong J, Zhao L, Jilg N, Fusco DN, Schaefer EA, Brisac C, Liu X, Peng LF, Xu Q, Chung RTJournal of hepatologyThe spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing. J Hepatol. 2015 May; 62(5):1024-32.J Hepatol2014-12-03T00:00:002014The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.26045439Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD, Ndung'u T, Ruxrungtham K, Sanchez J, Brander C, Chung RT, O'Connor KC, Walker B, Larman HB, Elledge SJScience (New York, N.Y.)Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science. 2015 Jun 05; 348(6239):aaa0698.Science2015-06-05T00:00:002015Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome.25734172Chew KW, Hua L, Bhattacharya D, Butt AA, Bornfleth L, Chung RT, Andersen JW, Currier JSOpen forum infectious diseasesThe effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection. Open Forum Infect Dis. 2014 Dec; 1(3):ofu104.Open Forum Infect Dis2014-12-03T00:00:002014The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection.16153829Graczyk PP, Khan A, Bhatia GS, Palmer V, Medland D, Numata H, Oinuma H, Catchick J, Dunne A, Ellis M, Smales C, Whitfield J, Neame SJ, Shah B, Wilton D, Morgan L, Patel T, Chung R, Desmond H, Staddon JM, Sato N, Inoue ABioorganic & medicinal chemistry lettersThe neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold. Bioorg Med Chem Lett. 2005 Nov 01; 15(21):4666-70.Bioorg Med Chem Lett2005-11-01T00:00:002005The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold.25923243Sise ME, Backman ES, Wenger JB, Wood BR, Sax PE, Chung RT, Thadhani R, Kim AYPloS oneShort and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study. PLoS One. 2015; 10(4):e0124139.PLoS One2015-04-29T00:00:002015Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study.Authorship 658782Authorship 2727044Authorship 28951810Authorship 4816364Authorship 49319410Authorship 5023582Authorship 4285927Authorship 55402210Authorship 81281114Authorship 8131498Authorship 813274325728638Simon TG, King LY, Chung RTJournal of hepatologyReply to: "Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis". J Hepatol. 2015 Jul; 63(1):279.J Hepatol2015-02-26T00:00:002015Reply to: "Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis".25724164Johnson KB, Mueller JL, Simon TG, Zheng H, King LY, Makar RS, Gervais DA, Chung RTDigestive diseases and sciencesReduced Albumin Dosing During Large-Volume Paracentesis Is Not Associated with Adverse Clinical Outcomes. Dig Dis Sci. 2015 Jul; 60(7):2190-5.Dig Dis Sci2015-02-28T00:00:002015Reduced Albumin Dosing During Large-Volume Paracentesis Is Not Associated with Adverse Clinical Outcomes.26087980Andersson MI, Rajbhandari R, Kew MC, Vento S, Preiser W, Hoepelman AI, Theron G, Cotton M, Cohn J, Glebe D, Lesi O, Thursz M, Peters M, Chung R, Wiysonge CThe Lancet. Global healthMother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act. Lancet Glob Health. 2015 Jul; 3(7):e358-9.Lancet Glob Health2015-07-01T00:00:002015Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act.Authorship 8148942225143343King LY, Canasto-Chibuque C, Johnson KB, Yip S, Chen X, Kojima K, Deshmukh M, Venkatesh A, Tan PS, Sun X, Villanueva A, Sangiovanni A, Nair V, Mahajan M, Kobayashi M, Kumada H, Iavarone M, Colombo M, Fiel MI, Friedman SL, Llovet JM, Chung RT, Hoshida YGutA genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration. Gut. 2015 Aug; 64(8):1296-302.Gut2014-08-20T00:00:002014A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration.Authorship 8152592Authorship 816241726072321Feeney ER, Chung RTDigestive diseases and sciencesThe Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C. Dig Dis Sci. 2015 Aug; 60(8):2232-5.Dig Dis Sci2015-08-01T00:00:002015The Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C.Authorship 30706915Authorship 817285725847403Butt AA, Yan P, Bonilla H, Abou-Samra AB, Shaikh OS, Simon TG, Chung RT, Rogal SSHepatology (Baltimore, Md.)Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES. Hepatology. 2015 Aug; 62(2):365-74.Hepatology2015-05-23T00:00:002015Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.JC531JagpreetChhatwalJagpreet Chhatwal, Ph.D.141014Chhatwal, JagpreetAssociate Professor of RadiologyAuthorship 3895022Authorship 823227226248119Feeney ER, Chung RT, Yazdanpanah YCurrent opinion in HIV and AIDSCurrent guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients. Curr Opin HIV AIDS. 2015 Sep; 10(5):323-9.Curr Opin HIV AIDS2015-09-01T00:00:002015Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients.Authorship 823678826266048Allegretti AS, Ortiz G, Wenger J, Deferio JJ, Wibecan J, Kalim S, Tamez H, Chung RT, Karumanchi SA, Thadhani RIInternational journal of nephrologyPrognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study. Int J Nephrol. 2015; 2015:108139.Int J Nephrol2015-07-22T00:00:002015Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study.Authorship 825232226079399Li DK, Chung RTCancerImpact of hepatitis C virus eradication on hepatocellular carcinogenesis. Cancer. 2015 Sep 01; 121(17):2874-82.Cancer2015-06-16T00:00:002015Impact of hepatitis C virus eradication on hepatocellular carcinogenesis.Authorship 4798383Authorship 830504226058922Simon TG, Chung RTHepatology (Baltimore, Md.)The new hepatitis C virus bottleneck: Can delaying therapy be justified? Hepatology. 2015 Sep; 62(3):666-7.Hepatology2015-07-14T00:00:002015The new hepatitis C virus bottleneck: Can delaying therapy be justified?Authorship 5564702Authorship 833737726365684Hundemer GL, Sise ME, Wisocky J, Ufere N, Friedman LS, Corey KE, Chung RTInfectious diseases (London, England)Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency. Infect Dis (Lond). 2015; 47(12):924-9.Infect Dis (Lond)2015-08-18T00:00:002015Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.26254907Trifanov DS, Dhyani M, Bledsoe JR, Misdraji J, Bhan AK, Chung RT, Samir AEAbdominal imagingAmyloidosis of the liver on shear wave elastography: case report and review of literature. Abdom Imaging. 2015 Oct; 40(8):3078-83.Abdom Imaging2015-10-01T00:00:002015Amyloidosis of the liver on shear wave elastography: case report and review of literature.Authorship 8402351026448455Mueller JL, Feeney ER, Zheng H, Misdraji J, Kruger AJ, Alatrakchi N, King LY, Gelrud L, Corey KE, Chung RTClinical and translational gastroenterologyCirculating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol. 2015 Oct 08; 6:e114.Clin Transl Gastroenterol2015-10-08T00:00:002015Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.26405687Luther J, Garber JJ, Khalili H, Dave M, Bale SS, Jindal R, Motola DL, Luther S, Bohr S, Jeoung SW, Deshpande V, Singh G, Turner JR, Yarmush ML, Chung RT, Patel SJCellular and molecular gastroenterology and hepatologyHepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability. Cell Mol Gastroenterol Hepatol. 2015 Mar; 1(2):222-232.Cell Mol Gastroenterol Hepatol2015-03-01T00:00:002015Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability.Authorship 8425526Authorship 8426734Authorship 8428813Authorship 84409326Authorship 846062426262886Baumert TF, Verrier ER, Nassal M, Chung RT, Zeisel MBCurrent opinion in virologyHost-targeting agents for treatment of hepatitis B virus infection. Curr Opin Virol. 2015 Oct; 14:41-6.Curr Opin Virol2015-08-08T00:00:002015Host-targeting agents for treatment of hepatitis B virus infection.26359645Simon RE, Pearson SD, Hur C, Chung RTHepatology (Baltimore, Md.)Tackling the hepatitis C cost problem: A test case for tomorrow's cures. Hepatology. 2015 Nov; 62(5):1334-6.Hepatology2015-09-22T00:00:002015Tackling the hepatitis C cost problem: A test case for tomorrow's cures.26390278Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok ASHepatology (Baltimore, Md.)Diabetes and prediabetes in patients with hepatitis B residing in North America. Hepatology. 2015 Nov; 62(5):1364-74.Hepatology2015-09-29T00:00:002015Diabetes and prediabetes in patients with hepatitis B residing in North America.26501192Wagschal A, Najafi-Shoushtari SH, Wang L, Goedeke L, Sinha S, deLemos AS, Black JC, RamÃrez CM, Li Y, Tewhey R, Hatoum I, Shah N, Lu Y, Kristo F, Psychogios N, Vrbanac V, Lu YC, Hla T, de Cabo R, Tsang JS, Schadt E, Sabeti PC, Kathiresan S, Cohen DE, Whetstine J, Chung RT, Fernández-Hernando C, Kaplan LM, Bernards A, Gerszten RE, Näär AMNature medicineGenome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis. Nat Med. 2015 Nov; 21(11):1290-7.Nat Med2015-10-26T00:00:002015Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis.Authorship 8475894Authorship 849587925143523Della-Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, Wallace ZS, Carruthers M, Chung RT, Pillai S, Stone JHAnnals of the rheumatic diseasesB-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015 Dec; 74(12):2236-43.Ann Rheum Dis2014-08-20T00:00:002014B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease.26558512Butt AA, Yan P, Simon TG, Chung RT, Abou-Samra ABBMC infectious diseasesChanges in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES. BMC Infect Dis. 2015 Nov 11; 15:510.BMC Infect Dis2015-11-11T00:00:002015Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES.Authorship 85140917Authorship 850879226551051Everson GT, Towner WJ, Davis MN, Wyles DL, Nahass RG, Thuluvath PJ, Etzkorn K, Hinestrosa F, Tong M, Rabinovitz M, McNally J, Brainard DM, Han L, Doehle B, McHutchison JG, Morgan T, Chung RT, Tran TTAnnals of internal medicineSofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial. Ann Intern Med. 2015 Dec 01; 163(11):818-26.Ann Intern Med2015-11-10T00:00:002015Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.26287978Li DK, Chung RTCancerReply to direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution? Cancer. 2015 Dec 01; 121(23):4269-70.Cancer2015-08-19T00:00:002015Reply to direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?Authorship 546727426667495Bertero T, Cottrill KA, Annis S, Bhat B, Gochuico BR, Osorio JC, Rosas I, Haley KJ, Corey KE, Chung RT, Nelson Chau B, Chan SYScientific reportsA YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions. Sci Rep. 2015 Dec 15; 5:18277.Sci Rep2015-12-15T00:00:002015A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions.Authorship 85314210Authorship 4367362Authorship 48025432002-03-01T00:00:002002-01-01T00:00:00Pilot Protocol of Antiviral Prophylaxis Against HIV Recurrence in Orthotopic Liver Transplantation Recipients
PASTEURPart Time/Continuation2011-05-07T00:00:002010-05-01T00:00:00The Liver Health Project - Addressing Hepatitis B Infections in BostonCommunity ServiceAuthorship 5451543Authorship 8603552Authorship 8595251326474537Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, Steele D, Thiim M, Williams WW, Hashemi N, Kim AY, Thadhani R, Chung RTHepatology (Baltimore, Md.)Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology. 2016 Feb; 63(2):408-17.Hepatology2015-12-11T00:00:002015Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.26384130Li DK, Chung RTCancerReply to antiviral therapy and hepatocellular carcinogenesis. Cancer. 2016 Jan 01; 122(1):158.Cancer2015-09-18T00:00:002015Reply to antiviral therapy and hepatocellular carcinogenesis.2015-08-14T00:00:002015-06-15T00:00:00The Role of Intermittent Hypoxia in the Pathogenesis of Non-Alcoholic Fatty Liver DiseaseSummer2007-08-10T00:00:002007-06-18T00:00:00Investigation of the Effect of Hepatitis C Virus Infection on Serum Cholesterol Levels
Summer2008-08-11T00:00:002008-06-16T00:00:00Effects of n-acetylcysteine on clinical outcomes in acute liver failureSummer2000-08-18T00:00:002000-06-26T00:00:00Analysis of the Quasispecies Diversity of Hepatitis C Infection in HIV Co-infected Patients Undergoing Highly Active Antiretroviral Therapy
PASTEURSummerAuthorship 680436Authorship 738671026925881Corey KE, Kartoun U, Zheng H, Chung RT, Shaw SYThe American journal of gastroenterologyUsing an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2016 05; 111(5):671-6.Am J Gastroenterol2016-03-01T00:00:002016Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.Authorship 8678504Authorship 8666481426927933Chusri P, Kumthip K, Hong J, Zhu C, Duan X, Jilg N, Fusco DN, Brisac C, Schaefer EA, Cai D, Peng LF, Maneekarn N, Lin W, Chung RTScientific reportsHCV induces transforming growth factor ß1 through activation of endoplasmic reticulum stress and the unfolded protein response. Sci Rep. 2016 Mar 01; 6:22487.Sci Rep2016-03-01T00:00:002016HCV induces transforming growth factor ß1 through activation of endoplasmic reticulum stress and the unfolded protein response.26298293Yin P, Hong Z, Yang X, Chung RT, Zhang LCellular and molecular life sciences : CMLSA role for retromer in hepatitis C virus replication. Cell Mol Life Sci. 2016 Feb; 73(4):869-81.Cell Mol Life Sci2015-08-23T00:00:002015A role for retromer in hepatitis C virus replication.Authorship 9486882001-12-21T00:00:002001-09-17T00:00:00Pilot Protocol of Antiviral Prophylaxis Against HIV Recurrence in Orthotopic Liver Transplantation Recipients
PASTEURPart Time/ContinuationAuthorship 932726Authorship 2954291Authorship 3164491Authorship 871908726986653Patel SJ, Luther J, Bohr S, Iracheta-Vellve A, Li M, King KR, Chung RT, Yarmush MLClinical and translational gastroenterologyA Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity. Clin Transl Gastroenterol. 2016 Mar 17; 7:e153.Clin Transl Gastroenterol2016-03-17T00:00:002016A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.Authorship 34532Authorship 873028627007663Zhou C, York SR, Chen JY, Pondick JV, Motola DL, Chung RT, Mullen ACGenome medicineLong noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins. Genome Med. 2016 Mar 23; 8(1):31.Genome Med2016-03-23T00:00:002016Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins.Authorship 36798915Authorship 8754901926854475Mueller JL, King LY, Johnson KB, Gao T, Nephew LD, Kothari D, Simpson MA, Zheng H, Wei L, Corey KE, Misdraji J, Lee JH, Lin MV, Gogela NA, Fuchs BC, Tanabe KK, Gordon FD, Curry MP, Chung RTClinical transplantationImpact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. Clin Transplant. 2016 Apr; 30(4):452-60.Clin Transplant2016-03-01T00:00:002016Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.Authorship 876963726914713DePeralta DK, Wei L, Ghoshal S, Schmidt B, Lauwers GY, Lanuti M, Chung RT, Tanabe KK, Fuchs BCCancerMetformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis. Cancer. 2016 Apr 15; 122(8):1216-27.Cancer2016-02-23T00:00:002016Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.Authorship 8785334Authorship 879165226616353Butt AA, Yan P, Shaikh OS, Chung RT, Sherman KELiver international : official journal of the International Association for the Study of the LiverSofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES. Liver Int. 2016 05; 36(5):651-8.Liver Int2015-12-25T00:00:002015Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES.27006254Holmes JA, Chung RTNature reviews. Gastroenterology & hepatologyViral hepatitis: HCV compartmentalization in HCC: driver, passenger or both? Nat Rev Gastroenterol Hepatol. 2016 05; 13(5):254-6.Nat Rev Gastroenterol Hepatol2016-03-23T00:00:002016Viral hepatitis: HCV compartmentalization in HCC: driver, passenger or both?Authorship 87976642001-08-17T00:00:002001-06-25T00:00:00A Preliminary Trial of Oral Ribavirin to Reduce the Frequency of Liver Allograft Rejection in Subjects Undergoing Transplant for Hepatitis C-related Cirrhosis
PASTEURSummerAuthorship 8820916Authorship 8808968Authorship 881417426923436Saxena V, Koraishy FM, Sise ME, Lim JK, Schmidt M, Chung RT, Liapakis A, Nelson DR, Fried MW, Terrault NALiver international : official journal of the International Association for the Study of the LiverSafety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function. Liver Int. 2016 06; 36(6):807-16.Liver Int2016-03-24T00:00:002016Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function.27190762Guimaraes AR, Siqueira L, Uppal R, Alford J, Fuchs BC, Yamada S, Tanabe K, Chung RT, Lauwers G, Chew ML, Boland GW, Sahani DV, Vangel M, Hahn PF, Caravan PQuantitative imaging in medicine and surgeryT2 relaxation time is related to liver fibrosis severity. Quant Imaging Med Surg. 2016 Apr; 6(2):103-14.Quant Imaging Med Surg2016-04-01T00:00:002016T2 relaxation time is related to liver fibrosis severity.27193797Mukherjee P, Chawla A, Singh D, Chung RAbdominal radiology (New York)The "gallbladder pearl necklace" sign. Abdom Radiol (NY). 2016 05; 41(5):1001-2.Abdom Radiol (NY)2016-05-01T00:00:002016The "gallbladder pearl necklace" sign.Authorship 883995226316092Simon TG, Chung RTHepatology (Baltimore, Md.)Reply. Hepatology. 2016 06; 63(6):2066-7.Hepatology2015-11-26T00:00:002015Reply.Authorship 8856231927043883Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, Durkalski V, Larson AM, Liou I, Fix O, Schilsky M, McCashland T, Hay JE, Murray N, Shaikh OS, Ganger D, Zaman A, Han SB, Chung RT, Smith A, Brown R, Crippin J, Harrison ME, Koch D, Munoz S, Reddy KR, Rossaro L, Satyanarayana R, Hassanein T, Hanje AJ, Olson J, Subramanian R, Karvellas C, Hameed B, Sherker AH, Robuck P, Lee WMAnnals of internal medicineOutcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study. Ann Intern Med. 2016 Jun 07; 164(11):724-32.Ann Intern Med2016-04-05T00:00:002016Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study.Authorship 886849327301929Felmlee DJ, Coilly A, Chung RT, Samuel D, Baumert TFThe Lancet. Infectious diseasesNew perspectives for preventing hepatitis C virus liver graft infection. Lancet Infect Dis. 2016 06; 16(6):735-745.Lancet Infect Dis2016-06-01T00:00:002016New perspectives for preventing hepatitis C virus liver graft infection.Authorship 880322Authorship 5726572Authorship 8882194Authorship 888364426825843Corey KE, Klebanoff MJ, Tramontano AC, Chung RT, Hur CDigestive diseases and sciencesScreening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. Dig Dis Sci. 2016 07; 61(7):2108-17.Dig Dis Sci2016-01-29T00:00:002016Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.26891205Simon TG, Bonilla H, Yan P, Chung RT, Butt AAHepatology (Baltimore, Md.)Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES. Hepatology. 2016 07; 64(1):47-57.Hepatology2016-03-25T00:00:002016Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.2Assistant Professor1Associate Professor0Full Professor4InstructorAuthorship 692994Authorship 89136612Authorship 892354727415632Lin MV, Sise ME, Pavlakis M, Amundsen BM, Chute D, Rutherford AE, Chung RT, Curry MP, Hanifi JM, Gabardi S, Chandraker A, Heher EC, Elias N, Riella LVPloS oneEfficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLoS One. 2016; 11(7):e0158431.PLoS One2016-07-14T00:00:002016Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.26440471Simon TG, Kim AY, Stamm LM, Liu L, Mo H, Doehle B, Pang PS, Brainard DM, McHutchison JG, Gustafson J, Lauer GM, Chung RTAntiviral therapyThe safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease. Antivir Ther. 2016; 21(3):185-94.Antivir Ther2015-10-06T00:00:002015The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease.Authorship 754902Authorship 89655221Authorship 897174426928927Butt AA, Yan P, Shaikh OS, Chung RT, Sherman KELiver international : official journal of the International Association for the Study of the LiverTreatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES. Liver Int. 2016 09; 36(9):1275-83.Liver Int2016-03-24T00:00:002016Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.27506549Jourdain G, Ngo-Giang-Huong N, Cressey TR, Hua L, Harrison L, Tierney C, Salvadori N, Decker L, Traisathit P, Sirirungsi W, Khamduang W, Bowonwatanuwong C, Puthanakit T, Siberry GK, Watts DH, Murphy TV, Achalapong J, Hongsiriwon S, Klinbuayaem V, Thongsawat S, Chung RT, Pol S, Chotivanich NBMC infectious diseasesPrevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. BMC Infect Dis. 2016 08 09; 16:393.BMC Infect Dis2016-08-09T00:00:002016Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.Authorship 865037Authorship 908256626994685Allegretti AS, Ortiz G, Cui J, Wenger J, Bhan I, Chung RT, Thadhani RI, Irani ZAmerican journal of kidney diseases : the official journal of the National Kidney FoundationChanges in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis. Am J Kidney Dis. 2016 Sep; 68(3):381-91.Am J Kidney Dis2016-03-16T00:00:002016Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis.Authorship 909926426632214Chawla A, Shenoy J, Chokkappan K, Chung RCurrent problems in diagnostic radiologyImaging Features of Sinonasal Inverted Papilloma: A Pictorial Review. Curr Probl Diagn Radiol. 2016 Sep-Oct; 45(5):347-53.Curr Probl Diagn Radiol2015-11-11T00:00:002015Imaging Features of Sinonasal Inverted Papilloma: A Pictorial Review.1999-12-31CHUNG, RAYMOND T1994-01-10HEPATITIS C VIRUS-SPECIFIC REPLICASEK08DK0022092006-08-31CHUNG, RAYMOND T2004-09-30Chemical Genetics:Cellular Regulators of HCV (RMI)R03NS0508542017-08-31CHUNG, RAYMOND T2011-09-15Discovery and Assessment of Genetic Determinants of HCV and HIV ControlR01DA0335412021-05-31LAU, DARYL T2008-09-30Harvard Hepatitis B ConsortiumU01DK0829192016-08-31PATEL, SURAJ J2014-09-20Development of Gap Junction Inhibition Therapy for Alcoholic Liver DiseaseR43AA0237072024-05-31CHUNG, RAYMOND T ;WHERRY, E. JOHN2009-06-08Impact of Immunotherapy on Viral Immunity in HumansU19AI0826302021-08-31CHUNG, RAYMOND T2015-09-23HIV-Associated Macrophage Alterations and Progressive Liver DiseaseR01DK1083702012-06-30CHUNG, RAYMOND T2006-07-01HIV-Hepatitis C Virus Interactions and PathogenesisR01AI0699392019-08-31CHUNG, RAYMOND T2007-09-01Patient-Oriented Research on Hepatitis in Special PopulationsK24DK0787722005-08-31CHUNG, RAYMOND T1999-09-30NOVEL ANIMAL MODELS OF HCV-RELATED HEPATOCARCINOGENESISR01DK0578572011-02-28CHUNG, RAYMOND T2009-03-16Serum Apoptosis Markers as Biomarkers in Acute Liver FailureR21DK0777162013-08-31CHUNG, RAYMOND T2012-09-24HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease ProgressionR56DK0980792011-09-14CHUNG, RAYMOND T2010-09-15Discovery and Assessment of Genetic Determinants of HCV and HIV ControlR56AI0916492018-08-31CHUNG, RAYMOND T2013-09-01HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease ProgressionR01DK0980792026-06-30CHUNG, RAYMOND T ;GOESSLING, WOLFRAM1976-07-01Research Training in Digestive DiseasesT32DK007191Principal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorAuthorship 913620327497857Rajbhandari R, Simon RE, Chung RT, Ananthakrishnan ANMayo Clinic proceedingsRacial Disparities in Inhospital Outcomes for Hepatocellular Carcinoma in the United States. Mayo Clin Proc. 2016 Sep; 91(9):1173-82.Mayo Clin Proc2016-08-03T00:00:002016Racial Disparities in Inhospital Outcomes for Hepatocellular Carcinoma in the United States.Authorship 915292227628420Rajbhandari R, Chung RTClinical and translational gastroenterologyTreatment of Hepatitis B: A Concise Review. Clin Transl Gastroenterol. 2016 Sep 15; 7(9):e190.Clin Transl Gastroenterol2016-09-15T00:00:002016Treatment of Hepatitis B: A Concise Review.27655105Allegretti AS, Ortiz G, Kalim S, Wibecan J, Zhang D, Shan HY, Xu D, Chung RT, Karumanchi SA, Thadhani RIDigestive diseases and sciencesSiglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury. Dig Dis Sci. 2016 12; 61(12):3609-3620.Dig Dis Sci2016-09-21T00:00:002016Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.Authorship 917945426488311Liang HC, Russell C, Mitra V, Chung R, Hye A, Bazenet C, Lovestone S, Pike I, Ward MJournal of proteome researchGlycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease. J Proteome Res. 2015 Dec 04; 14(12):5063-76.J Proteome Res2015-11-04T00:00:002015Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease.Authorship 863921027401546Brisac C, Salloum S, Yang V, Schaefer EA, Holmes JA, Chevaliez S, Hong J, Carlton-Smith C, Alatrakchi N, Kruger A, Lin W, Chung RTJournal of hepatologyIQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-?B pathway. J Hepatol. 2016 11; 65(5):972-979.J Hepatol2016-07-09T00:00:002016IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-?B pathway.Authorship 3488912Authorship 349272727789799Sen DR, Kaminski J, Barnitz RA, Kurachi M, Gerdemann U, Yates KB, Tsao HW, Godec J, LaFleur MW, Brown FD, Tonnerre P, Chung RT, Tully DC, Allen TM, Frahm N, Lauer GM, Wherry EJ, Yosef N, Haining WNScience (New York, N.Y.)The epigenetic landscape of T cell exhaustion. Science. 2016 12 02; 354(6316):1165-1169.Science2016-10-27T00:00:002016The epigenetic landscape of T cell exhaustion.27531241Salloum S, Holmes JA, Jindal R, Bale SS, Brisac C, Alatrakchi N, Lidofsky A, Kruger AJ, Fusco DN, Luther J, Schaefer EA, Lin W, Yarmush ML, Chung RTHepatology (Baltimore, Md.)Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types. Hepatology. 2016 12; 64(6):1951-1968.Hepatology2016-10-05T00:00:002016Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types.Authorship 4101476Authorship 92133820Authorship 9204953Authorship 9193851Authorship 9232923Authorship 92641612Authorship 9230008Authorship 9260605Authorship 9269806Authorship 9227881427015107Chhatwal J, Wang X, Ayer T, Kabiri M, Chung RT, Hur C, Donohue JM, Roberts MS, Kanwal FHepatology (Baltimore, Md.)Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals. Hepatology. 2016 11; 64(5):1442-1450.Hepatology2016-06-01T00:00:002016Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals.26040255Chung R, Touska P, Morgan R, Belli AMCardiovascular and interventional radiologyEndovascular Management of True Renal Arterial Aneurysms: Results from a Single Centre. Cardiovasc Intervent Radiol. 2016 Jan; 39(1):36-43.Cardiovasc Intervent Radiol2015-06-04T00:00:002015Endovascular Management of True Renal Arterial Aneurysms: Results from a Single Centre.25396099Motola DL, Caravan P, Chung RT, Fuchs BCCurrent pathobiology reportsNoninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions. Curr Pathobiol Rep. 2014 Dec 01; 2(4):245-256.Curr Pathobiol Rep2014-12-01T00:00:002014Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.27714510Simon TG, Corey KE, Chung RT, Giugliano RDigestive diseases and sciencesCardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe. Dig Dis Sci. 2016 12; 61(12):3425-3435.Dig Dis Sci2016-10-06T00:00:002016Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.27729222Ma J, Hwang SJ, Pedley A, Massaro JM, Hoffmann U, Chung RT, Benjamin EJ, Levy D, Fox CS, Long MTJournal of hepatologyBi-directional analysis between fatty liver and cardiovascular disease risk factors. J Hepatol. 2017 02; 66(2):390-397.J Hepatol2016-10-10T00:00:002016Bi-directional analysis between fatty liver and cardiovascular disease risk factors.27486033Gane EJ, Kowdley KV, Pound D, Stedman CA, Davis M, Etzkorn K, Gordon SC, Bernstein D, Everson G, Rodriguez-Torres M, Tsai N, Khalid O, Yang JC, Lu S, Dvory-Sobol H, Stamm LM, Brainard DM, McHutchison JG, Tong M, Chung RT, Beavers K, Poulos JE, Kwo PY, Nguyen MHGastroenterologyEfficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial. Gastroenterology. 2016 11; 151(5):902-909.Gastroenterology2016-07-30T00:00:002016Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.Authorship 4507759Authorship 93526712Authorship 938078527880977Klebanoff MJ, Corey KE, Chhatwal J, Kaplan LM, Chung RT, Hur CHepatology (Baltimore, Md.)Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis. Hepatology. 2017 04; 65(4):1156-1164.Hepatology2017-02-21T00:00:002017Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis.Authorship 2480591Authorship 2979641155 Fruit StMassachusetts General HospitalWRN 1007C, GI Unit55 Fruit StBoston02114MAAuthorship 9403893Authorship 940099927906468Chhatwal J, Samur S, Kues B, Ayer T, Roberts MS, Kanwal F, Hur C, Donnell DM, Chung RTHepatology (Baltimore, Md.)Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list. Hepatology. 2017 03; 65(3):777-788.Hepatology2017-01-06T00:00:002017Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.27932478Shukha K, Mueller JL, Chung RT, Curry MP, Friedman DJ, Pollak MR, Berg AHJournal of the American Society of Nephrology : JASNMost ApoL1 Is Secreted by the Liver. J Am Soc Nephrol. 2017 Apr; 28(4):1079-1083.J Am Soc Nephrol2016-12-08T00:00:002016Most ApoL1 Is Secreted by the Liver.Authorship 3415493Authorship 94147918Authorship 94068741Authorship 941706727990496Sise ME, Wisocky J, Rosales IA, Chute D, Holmes JA, Corapi KM, Babitt JL, Tangren JS, Hashemi N, Lundquist AL, Williams WW, Mount DB, Andersson KL, Rennke HG, Smith RN, Colvin R, Thadhani RI, Chung RTKidney international reportsLupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy. Kidney Int Rep. 2016 Sep; 1(3):135-143.Kidney Int Rep2016-09-01T00:00:002016Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy.28000758Bility MT, Nio K, Li F, McGivern DR, Lemon SM, Feeney ER, Chung RT, Su LScientific reportsChronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation. Sci Rep. 2016 12 21; 6:39520.Sci Rep2016-12-21T00:00:002016Chronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation.27960085Nakagawa S, Wei L, Song WM, Higashi T, Ghoshal S, Kim RS, Bian CB, Yamada S, Sun X, Venkatesh A, Goossens N, Bain G, Lauwers GY, Koh AP, El-Abtah M, Ahmad NB, Hoshida H, Erstad DJ, Gunasekaran G, Lee Y, Yu ML, Chuang WL, Dai CY, Kobayashi M, Kumada H, Beppu T, Baba H, Mahajan M, Nair VD, Lanuti M, Villanueva A, Sangiovanni A, Iavarone M, Colombo M, Llovet JM, Subramanian A, Tager AM, Friedman SL, Baumert TF, Schwarz ME, Chung RT, Tanabe KK, Zhang B, Fuchs BC, Hoshida YCancer cellMolecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition. Cancer Cell. 2016 Dec 12; 30(6):879-890.Cancer Cell2016-12-12T00:00:002016Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.Authorship 4119912Authorship 9443891328018102Schaefer EA, Meixiong J, Mark C, Deik A, Motola DL, Fusco D, Yang A, Brisac C, Salloum S, Lin W, Clish CB, Peng LF, Chung RTWorld journal of gastroenterologyApolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C. World J Gastroenterol. 2016 Dec 07; 22(45):9954-9965.World J Gastroenterol2016-12-07T00:00:002016Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.Authorship 4861175Authorship 9485618Authorship 949360328068223Wang X, Zheng Z, Caviglia JM, Corey KE, Herfel TM, Cai B, Masia R, Chung RT, Lefkowitch JH, Schwabe RF, Tabas ICell metabolismHepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. Cell Metab. 2016 12 13; 24(6):848-862.Cell Metab2016-10-27T00:00:002016Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.27602492Goto K, Kato N, Chung RTOncotargetAnti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro. Oncotarget. 2016 Nov 15; 7(46):74987-74999.Oncotarget2016-11-15T00:00:002016Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.Authorship 496723428096363Kalinich M, Bhan I, Kwan TT, Miyamoto DT, Javaid S, LiCausi JA, Milner JD, Hong X, Goyal L, Sil S, Choz M, Ho U, Kapur R, Muzikansky A, Zhang H, Weitz DA, Sequist LV, Ryan DP, Chung RT, Zhu AX, Isselbacher KJ, Ting DT, Toner M, Maheswaran S, Haber DAProceedings of the National Academy of Sciences of the United States of AmericaAn RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2017 01 31; 114(5):1123-1128.Proc Natl Acad Sci U S A2017-01-17T00:00:002017An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.Authorship 95098119Authorship 952958328128878Davis BC, Tillman H, Chung RT, Stravitz RT, Reddy R, Fontana RJ, McGuire B, Davern T, Lee WMLiver international : official journal of the International Association for the Study of the LiverHeat stroke leading to acute liver injury & failure: A case series from the Acute Liver Failure Study Group. Liver Int. 2017 04; 37(4):509-513.Liver Int2017-02-17T00:00:002017Heat stroke leading to acute liver injury & failure: A case series from the Acute Liver Failure Study Group.Authorship 616593Authorship 634292Authorship 7859728804373Jaffe DL, Chung RT, Friedman LSThe Medical clinics of North AmericaManagement of portal hypertension and its complications. Med Clin North Am. 1996 Sep; 80(5):1021-34.Med Clin North Am1996-09-01T00:00:001996Management of portal hypertension and its complications.10507496Baid S, Pascual M, Cosimi AB, Chung RT, Colvin RB, Tolkoff-Rubin NTransplantationViruses and thrombotic microangiopathy. Transplantation. 1999 Sep 15; 68(5):710-1.Transplantation1999-09-15T00:00:001999Viruses and thrombotic microangiopathy.11218212Lo SC, Levin L, Ribas J, Chung R, Wang RY, Wear D, Shih JWEpidemiology and infectionLack of serological evidence for Mycoplasma fermentans infection in army Gulf War veterans: a large scale case-control study. Epidemiol Infect. 2000 Dec; 125(3):609-16.Epidemiol Infect2000-12-01T00:00:002000Lack of serological evidence for Mycoplasma fermentans infection in army Gulf War veterans: a large scale case-control study.11833007Sherman KE, Rouster SD, Chung RT, Rajicic NClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaHepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002 Mar 15; 34(6):831-7.Clin Infect Dis2002-02-06T00:00:002002Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group.12085363Moriguchi H, Uemura T, Kobayashi M, Chung RT, Sato CHepatology (Baltimore, Md.)Management strategies using pharmacogenomics in patients with severe HCV-1b infection: a decision analysis. Hepatology. 2002 Jul; 36(1):177-85.Hepatology2002-07-01T00:00:002002Management strategies using pharmacogenomics in patients with severe HCV-1b infection: a decision analysis.10790425Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BDThe Journal of experimental medicineAnalysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000 May 01; 191(9):1499-512.J Exp Med2000-05-01T00:00:002000Analysis of successful immune responses in persons infected with hepatitis C virus.Authorship 9590171514657767Chung RT, Casson DR, Murray G, Song S, Grinspoon S, Hadigan CJournal of acquired immune deficiency syndromes (1999)Alanine aminotransferase levels predict insulin resistance in HIV lipodystrophy. J Acquir Immune Defic Syndr. 2003 Dec 15; 34(5):534-6.J Acquir Immune Defic Syndr2003-12-15T00:00:002003Alanine aminotransferase levels predict insulin resistance in HIV lipodystrophy.10999223Kim AY, Chung RT, Polsky BAIDS clinical reviewHuman immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy. AIDS Clin Rev. 2000-2001; 263-306.AIDS Clin Rev2000-01-01T00:00:002000Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy.16265608Chung RTClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaAcute hepatitis C virus infection. Clin Infect Dis. 2005 Jul 01; 41 Suppl 1:S14-7.Clin Infect Dis2005-07-01T00:00:002005Acute hepatitis C virus infection.Authorship 9670292Authorship 9697235Authorship 9683371828211090Hogan JJ, Lim MA, Palmer MB, Bloom RD, Chung RT, Sise MEHepatology (Baltimore, Md.)Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infection. Hepatology. 2017 08; 66(2):658-660.Hepatology2017-06-22T00:00:002017Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infection.28263458Chan J, Chung RTClinical pharmacology in drug developmentPerspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions. Clin Pharmacol Drug Dev. 2017 Mar; 6(2):147-163.Clin Pharmacol Drug Dev2017-03-01T00:00:002017Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions.28265266Fusco DN, Pratt H, Kandilas S, Cheon SS, Lin W, Cronkite DA, Basavappa M, Jeffrey KL, Anselmo A, Sadreyev R, Yapp C, Shi X, O'Sullivan JF, Gerszten RE, Tomaru T, Yoshino S, Satoh T, Chung RTFrontiers in microbiologyHELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus. Front Microbiol. 2017; 8:240.Front Microbiol2017-02-20T00:00:002017HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus.11889439Ross AS, Graeme-Cook F, Cosimi AB, Chung RTTransplantationCombined liver and kidney transplantation in a patient with sickle cell disease. Transplantation. 2002 Feb 27; 73(4):605-8.Transplantation2002-02-27T00:00:002002Combined liver and kidney transplantation in a patient with sickle cell disease.18393287Nahmias Y, Goldwasser J, Casali M, van Poll D, Wakita T, Chung RT, Yarmush MLHepatology (Baltimore, Md.)Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology. 2008 May; 47(5):1437-45.Hepatology2008-05-01T00:00:002008Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.19528392Nelson AL, Millington TM, Sahani D, Chung RT, Bauer C, Hertl M, Warshaw AL, Conrad CArchives of surgery (Chicago, Ill. : 1960)Hepatic portal venous gas: the ABCs of management. Arch Surg. 2009 Jun; 144(6):575-81; discussion 581.Arch Surg2009-06-01T00:00:002009Hepatic portal venous gas: the ABCs of management.19673649McGovern BH, Nagami EH, Birch CE, Bowen MJ, Reyor LL, Chung RT, Kim AYThe Journal of infectious diseasesRate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infection. J Infect Dis. 2009 Sep 15; 200(6):877-81.J Infect Dis2009-09-15T00:00:002009Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infection.19877205Schiødt FV, Chung RT, Schilsky ML, Hay JE, Christensen E, Lee WMLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyOutcome of acute liver failure in the elderly. Liver Transpl. 2009 Nov; 15(11):1481-7.Liver Transpl2009-11-01T00:00:002009Outcome of acute liver failure in the elderly.Authorship 9735321628341490Dhyani M, Grajo JR, Bhan AK, Corey K, Chung R, Samir AEUltrasound in medicine & biologyValidation of Shear Wave Elastography Cutoff Values on the Supersonic Aixplorer for Practical Clinical Use in Liver Fibrosis Staging. Ultrasound Med Biol. 2017 06; 43(6):1125-1133.Ultrasound Med Biol2017-03-22T00:00:002017Validation of Shear Wave Elastography Cutoff Values on the Supersonic Aixplorer for Practical Clinical Use in Liver Fibrosis Staging.28322247Chen JY, Newcomb B, Zhou C, Pondick JV, Ghoshal S, York SR, Motola DL, Coant N, Yi JK, Mao C, Tanabe KK, Bronova I, Berdyshev EV, Fuchs BC, Hannun Y, Chung RT, Mullen ACScientific reportsTricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells. Sci Rep. 2017 03 21; 7:44867.Sci Rep2017-03-21T00:00:002017Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells.28329053Naggie S, Marks KM, Hughes M, Fierer DS, Macbrayne C, Kim A, Hollabaugh K, Roa J, Symonds B, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Chung RClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaSofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C. Clin Infect Dis. 2017 04 15; 64(8):1035-1042.Clin Infect Dis2017-04-15T00:00:002017Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.12784328Zhu AX, Chung RTCancerHepatic steatosis in patients with chronic hepatitis C virus infection. Another risk factor for hepatocellular carcinoma? Cancer. 2003 Jun 15; 97(12):2948-50.Cancer2003-06-15T00:00:002003Hepatic steatosis in patients with chronic hepatitis C virus infection. Another risk factor for hepatocellular carcinoma?15268739Cardarelli F, Pascual M, Chung RT, Tolkoff-Rubin N, Wong W, Cosimi AB, Saidman SLAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsInterferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies. Am J Transplant. 2004 Aug; 4(8):1352-6.Am J Transplant2004-08-01T00:00:002004Interferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies.15658867Yeo H, Li Y, Fu L, Zhu JL, Gullen EA, Dutschman GE, Lee Y, Chung R, Huang ES, Austin DJ, Cheng YCJournal of medicinal chemistrySynthesis and antiviral activity of helioxanthin analogues. J Med Chem. 2005 Jan 27; 48(2):534-46.J Med Chem2005-01-27T00:00:002005Synthesis and antiviral activity of helioxanthin analogues.9096613Kawamura T, Furusaka A, Koziel MJ, Chung RT, Wang TC, Schmidt EV, Liang TJHepatology (Baltimore, Md.)Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology. 1997 Apr; 25(4):1014-21.Hepatology1997-04-01T00:00:001997Transgenic expression of hepatitis C virus structural proteins in the mouse.12671922Moriguchi H, Kobayashi M, Chung RT, Sato CGastroenterologyOptimal IFN therapy for 40-year-old patients with severe HCV-1b infection. Gastroenterology. 2003 Apr; 124(4):1166-7.Gastroenterology2003-04-01T00:00:002003Optimal IFN therapy for 40-year-old patients with severe HCV-1b infection.16184570Schiødt FV, Rossaro L, Stravitz RT, Shakil AO, Chung RT, Lee WMLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyGc-globulin and prognosis in acute liver failure. Liver Transpl. 2005 Oct; 11(10):1223-7.Liver Transpl2005-10-01T00:00:002005Gc-globulin and prognosis in acute liver failure.16835462Chung RTTopics in HIV medicine : a publication of the International AIDS Society, USAHepatitis C and B viruses: the new opportunists in HIV infection. Top HIV Med. 2006 Jun-Jul; 14(2):78-83.Top HIV Med2006-06-01T00:00:002006Hepatitis C and B viruses: the new opportunists in HIV infection.16931171Corey KE, Ross AS, Wurcel A, Schulze Zur Wiesch J, Kim AY, Lauer GM, Chung RTClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationOutcomes and treatment of acute hepatitis C virus infection in a United States population. Clin Gastroenterol Hepatol. 2006 Oct; 4(10):1278-82.Clin Gastroenterol Hepatol2006-08-22T00:00:002006Outcomes and treatment of acute hepatitis C virus infection in a United States population.16343683Chung RTJournal of hepatologyAssessment of efficacy of treatment in HCV: infection and disease. J Hepatol. 2006; 44(1 Suppl):S56-9.J Hepatol2005-11-28T00:00:002005Assessment of efficacy of treatment in HCV: infection and disease.17301129Billington J, Hickling TP, Munro GH, Halai C, Chung R, Dodson GG, Daniels RSJournal of virologyStability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding. J Virol. 2007 May; 81(9):4604-14.J Virol2007-02-14T00:00:002007Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding.Authorship 97676114Authorship 9768475Authorship 977493527162167Chawla A, Bosco J, Lim TC, Gaikwad V, Chung RJournal of medical imaging and radiation oncologySystemic-pulmonary artery shunt: A rare cause of false-positive filling defect in the pulmonary arteries. J Med Imaging Radiat Oncol. 2017 Feb; 61(1):82-84.J Med Imaging Radiat Oncol2016-05-09T00:00:002016Systemic-pulmonary artery shunt: A rare cause of false-positive filling defect in the pulmonary arteries.17492592Blackard JT, Hiasa Y, Smeaton L, Jamieson DJ, Rodriguez I, Mayer KH, Chung RTThe Journal of infectious diseasesCompartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. J Infect Dis. 2007 Jun 15; 195(12):1765-73.J Infect Dis2007-05-02T00:00:002007Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection.9890320Baid S, Pascual M, Williams WW, Tolkoff-Rubin N, Johnson SM, Collins B, Chung RT, Delmonico FL, Cosimi AB, Colvin RBJournal of the American Society of Nephrology : JASNRenal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol. 1999 Jan; 10(1):146-53.J Am Soc Nephrol1999-01-01T00:00:001999Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients.11493707Chung RT, He W, Saquib A, Contreras AM, Xavier RJ, Chawla A, Wang TC, Schmidt EVProceedings of the National Academy of Sciences of the United States of AmericaHepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system. Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9847-52.Proc Natl Acad Sci U S A2001-08-07T00:00:002001Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.12780680Leung JY, Abraczinskas DR, Bhan AK, Terella AM, Pascual M, Cosimi AB, Chung RTClinical transplantationRecurrent allograft HCV presenting as acute cellular rejection: successful management with interferon and ribavirin alone. Clin Transplant. 2003 Jun; 17(3):275-83.Clin Transplant2003-06-01T00:00:002003Recurrent allograft HCV presenting as acute cellular rejection: successful management with interferon and ribavirin alone.15017612Kuo A, Dienstag JL, Chung RTClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationTenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B. Clin Gastroenterol Hepatol. 2004 Mar; 2(3):266-72.Clin Gastroenterol Hepatol2004-03-01T00:00:002004Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B.10719018Abrahamian GA, Cosimi AB, Farrell ML, Schoenfeld DA, Chung RT, Pascual MLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyPrevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantation. Liver Transpl. 2000 Mar; 6(2):185-90.Liver Transpl2000-03-01T00:00:002000Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantation.22330232Corey KE, Lai M, Gelrud LG, Misdraji J, Barlow LL, Zheng H, Andersson KL, Thiim M, Pratt DS, Chung RTClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationNon-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2012 Jun; 10(6):651-6.Clin Gastroenterol Hepatol2012-02-10T00:00:002012Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis.1686725Chung R, Whaley J, Kley N, Anderson K, Louis D, Menon A, Hettlich C, Freiman R, Hedley-Whyte ET, Martuza RGenes, chromosomes & cancerTP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosomes Cancer. 1991 Sep; 3(5):323-31.Genes Chromosomes Cancer1991-09-01T00:00:001991TP53 gene mutations and 17p deletions in human astrocytomas.9524832Oldfield EC, Fessel WJ, Dunne MW, Dickinson G, Wallace MR, Byrne W, Chung R, Wagner KF, Paparello SF, Craig DB, Melcher G, Zajdowicz M, Williams RF, Kelly JW, Zelasky M, Heifets LB, Berman JDClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaOnce weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. Clin Infect Dis. 1998 Mar; 26(3):611-9.Clin Infect Dis1998-03-01T00:00:001998Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial.9825826Toth CM, Pascual M, Chung RT, Graeme-Cook F, Dienstag JL, Bhan AK, Cosimi ABTransplantationHepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation. 1998 Nov 15; 66(9):1254-8.Transplantation1998-11-15T00:00:001998Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy.15723444Kamegaya Y, Hiasa Y, Zukerberg L, Fowler N, Blackard JT, Lin W, Choe WH, Schmidt EV, Chung RTHepatology (Baltimore, Md.)Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology. 2005 Mar; 41(3):660-7.Hepatology2005-03-01T00:00:002005Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis.16187184Sekhon JS, Chung RT, Epstein M, Kaplan MMDigestive diseases and sciencesSteroid-responsive (autoimmune?) sclerosing cholangitis. Dig Dis Sci. 2005 Oct; 50(10):1839-43.Dig Dis Sci2005-10-01T00:00:002005Steroid-responsive (autoimmune?) sclerosing cholangitis.18325393Lin W, Weinberg EM, Tai AW, Peng LF, Brockman MA, Kim KA, Kim SS, Borges CB, Shao RX, Chung RTGastroenterologyHIV increases HCV replication in a TGF-beta1-dependent manner. Gastroenterology. 2008 Mar; 134(3):803-11.Gastroenterology2008-01-10T00:00:002008HIV increases HCV replication in a TGF-beta1-dependent manner.18825714Sabharwal S, Delgado-Borrego A, Chung RTLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyExtrahepatic hepatitis C virus after transplantation: diabetes and renal dysfunction. Liver Transpl. 2008 Oct; 14 Suppl 2:S51-7.Liver Transpl2008-10-01T00:00:002008Extrahepatic hepatitis C virus after transplantation: diabetes and renal dysfunction.19291787Lok AS, Everhart JE, Chung RT, Kim HY, Everson GT, Hoefs JC, Greenson JK, Sterling RK, Lindsay KL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Ghany MG, Morishima CHepatology (Baltimore, Md.)Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology. 2009 Jun; 49(6):1828-37.Hepatology2009-06-01T00:00:002009Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.19434718Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TRHepatology (Baltimore, Md.)Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology. 2009 Jun; 49(6):1847-58.Hepatology2009-06-01T00:00:002009Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.15016131Ross AS, Bhan AK, Pascual M, Thiim M, Benedict Cosimi A, Chung RTClinical transplantationPegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C. Clin Transplant. 2004 Apr; 18(2):166-73.Clin Transplant2004-04-01T00:00:002004Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C.12492714Baid S, Tolkoff-Rubin N, Saidman S, Chung R, Williams WW, Auchincloss H, Colvin RB, Delmonico FL, Cosimi AB, Pascual MAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsAcute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant. 2003 Jan; 3(1):74-8.Am J Transplant2003-01-01T00:00:002003Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy.16845623Schwarze-Zander C, Blackard JT, Zheng H, Addo MM, Lin W, Robbins GK, Sherman KE, Zdunek D, Hess G, Chung RTThe Journal of infectious diseasesGB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis. 2006 Aug 15; 194(4):410-9.J Infect Dis2006-07-12T00:00:002006GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.17418169Lauer GM, Chung RTGastroenterologyVaccine-induced T-cell responses against HCV: one step taken, more to follow. Gastroenterology. 2007 Apr; 132(4):1626-8.Gastroenterology2007-04-01T00:00:002007Vaccine-induced T-cell responses against HCV: one step taken, more to follow.17682098Peng LF, Kim SS, Matchacheep S, Lei X, Su S, Lin W, Runguphan W, Choe WH, Sakamoto N, Ikeda M, Kato N, Beeler AB, Porco JA, Schreiber SL, Chung RTAntimicrobial agents and chemotherapyIdentification of novel epoxide inhibitors of hepatitis C virus replication using a high-throughput screen. Antimicrob Agents Chemother. 2007 Oct; 51(10):3756-9.Antimicrob Agents Chemother2007-08-06T00:00:002007Identification of novel epoxide inhibitors of hepatitis C virus replication using a high-throughput screen.Authorship 9881244Authorship 986832328471314Holmes JA, Yu ML, Chung RTExpert opinion on drug safetyHepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals. Expert Opin Drug Saf. 2017 Jun; 16(6):651-672.Expert Opin Drug Saf2017-05-19T00:00:002017Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.28586089Chhatwal J, Samur S, Bethea E, Chung RTHepatology (Baltimore, Md.)Reply. Hepatology. 2017 09; 66(3):1005-1006.Hepatology2017-08-01T00:00:002017Reply.18755444Miller JC, Hahn PF, Chung RT, Thrall JH, Lee SIJournal of the American College of Radiology : JACRScreening for hepatocellular carcinoma in cirrhotic patients. J Am Coll Radiol. 2008 Sep; 5(9):1012-4.J Am Coll Radiol2008-09-01T00:00:002008Screening for hepatocellular carcinoma in cirrhotic patients.16752922Basavapathruni A, Vingerhoets J, de Béthune MP, Chung R, Bailey CM, Kim J, Anderson KSBiochemistryModulation of human immunodeficiency virus type 1 synergistic inhibition by reverse transcriptase mutations. Biochemistry. 2006 Jun 13; 45(23):7334-40.Biochemistry2006-06-13T00:00:002006Modulation of human immunodeficiency virus type 1 synergistic inhibition by reverse transcriptase mutations.17296523Yachimski P, Shah N, Chung RTClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationPorphyria cutanea tarda. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):e6.Clin Gastroenterol Hepatol2007-02-01T00:00:002007Porphyria cutanea tarda.18236394Delgado-Borrego A, Liu YS, Jordan SH, Agrawal S, Zhang H, Christofi M, Casson D, Cosimi AB, Chung RTLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyProspective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance. Liver Transpl. 2008 Feb; 14(2):193-201.Liver Transpl2008-02-01T00:00:002008Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance.18289678Romero V, Azocar J, Zúñiga J, Clavijo OP, Terreros D, Gu X, Husain Z, Chung RT, Amos C, Yunis EJMolecular immunologyInteraction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol. 2008 May; 45(9):2429-36.Mol Immunol2008-03-04T00:00:002008Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome.17854608Tai AW, Chung RTGastroenterologyThe hepatitis C virus plot thickens: enter claudin-1. Gastroenterology. 2007 Sep; 133(3):1041-2.Gastroenterology2007-09-01T00:00:002007The hepatitis C virus plot thickens: enter claudin-1.18452116Rutherford A, Chung RTSeminars in liver diseaseAcute liver failure: mechanisms of hepatocyte injury and regeneration. Semin Liver Dis. 2008 May; 28(2):167-74.Semin Liver Dis2008-05-01T00:00:002008Acute liver failure: mechanisms of hepatocyte injury and regeneration.Authorship 9917698Authorship 991935828634131Samur S, Kues B, Ayer T, Roberts MS, Kanwal F, Hur C, Donnell DMS, Chung RT, Chhatwal JClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationCost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):115-122.e10.Clin Gastroenterol Hepatol2017-06-17T00:00:002017Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals.28640287Goossens N, Singal AG, King LY, Andersson KL, Fuchs BC, Besa C, Taouli B, Chung RT, Hoshida YClinical and translational gastroenterologyCost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis. Clin Transl Gastroenterol. 2017 Jun 22; 8(6):e101.Clin Transl Gastroenterol2017-06-22T00:00:002017Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis.19957368Moriguchi H, Chung RT, Sato CHepatology (Baltimore, Md.)Tumorigenicity of human induced pluripotent stem cells depends on the balance of gene expression between p21 and p53. Hepatology. 2010 Mar; 51(3):1088-9.Hepatology2010-03-01T00:00:002010Tumorigenicity of human induced pluripotent stem cells depends on the balance of gene expression between p21 and p53.20375166Shao RX, Zhang L, Peng LF, Sun E, Chung WJ, Jang JY, Tsai WL, Hyppolite G, Chung RTJournal of virologySuppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner. J Virol. 2010 Jun; 84(12):6060-9.J Virol2010-04-07T00:00:002010Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.22674974Kumthip K, Chusri P, Jilg N, Zhao L, Fusco DN, Zhao H, Goto K, Cheng D, Schaefer EA, Zhang L, Pantip C, Thongsawat S, O'Brien A, Peng LF, Maneekarn N, Chung RT, Lin WJournal of virologyHepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling. J Virol. 2012 Aug; 86(16):8581-91.J Virol2012-06-06T00:00:002012Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.23031791Asmal M, Seaman M, Lin W, Chung RT, Letvin NL, Geiben-Lynn RVirology journalInhibition of HCV by the serpin antithrombin III. Virol J. 2012 Oct 02; 9:226.Virol J2012-10-02T00:00:002012Inhibition of HCV by the serpin antithrombin III.20738779Méndez-Navarro J, Corey KE, Zheng H, Barlow LL, Jang JY, Lin W, Zhao H, Shao RX, McAfee SL, Chung RTLiver international : official journal of the International Association for the Study of the LiverHepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy. Liver Int. 2011 Mar; 31(3):330-9.Liver Int2010-08-25T00:00:002010Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.12975468Day CL, Seth NP, Lucas M, Appel H, Gauthier L, Lauer GM, Robbins GK, Szczepiorkowski ZM, Casson DR, Chung RT, Bell S, Harcourt G, Walker BD, Klenerman P, Wucherpfennig KWThe Journal of clinical investigationEx vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest. 2003 Sep; 112(6):831-42.J Clin Invest2003-09-01T00:00:002003Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.16189000Lauer GM, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, Schulze Zur Wiesch J, Paranhos-Baccala G, Sheridan I, Casson DR, Reiser M, Gandhi RT, Li B, Allen TM, Chung RT, Klenerman P, Walker BDJournal of virologyFull-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. J Virol. 2005 Oct; 79(20):12979-88.J Virol2005-10-01T00:00:002005Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy.7794537Brown AE, Lane JR, Wagner KF, Zhou S, Chung R, Ray KL, Blatt SP, Burke DSAIDS (London, England)Rates of p24 antigenemia and viral isolation in comparable white and black HIV-infected subjects. Military Medical Consortium for Applied Retroviral Research. AIDS. 1995 Apr; 9(4):325-8.AIDS1995-04-01T00:00:001995Rates of p24 antigenemia and viral isolation in comparable white and black HIV-infected subjects. Military Medical Consortium for Applied Retroviral Research.15825084Lin W, Choe WH, Hiasa Y, Kamegaya Y, Blackard JT, Schmidt EV, Chung RTGastroenterologyHepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology. 2005 Apr; 128(4):1034-41.Gastroenterology2005-04-01T00:00:002005Hepatitis C virus expression suppresses interferon signaling by degrading STAT1.17115902Blackard JT, Kang M, Sherman KE, Koziel MJ, Peters MG, Chung RTJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine ResearchEffects of HCV treatment on cytokine expression during HCV/HIV coinfection. J Interferon Cytokine Res. 2006 Nov; 26(11):834-8.J Interferon Cytokine Res2006-11-01T00:00:002006Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.18167406Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BCJAMAEpidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA. 2008 Jan 02; 299(1):53-60.JAMA2008-01-02T00:00:002008Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.18221611Andersson KL, Chung RTCurrent treatment options in gastroenterologyHepatic schistosomiasis. Curr Treat Options Gastroenterol. 2007 Dec; 10(6):504-12.Curr Treat Options Gastroenterol2007-12-01T00:00:002007Hepatic schistosomiasis.18848905Andersson KL, Salomon JA, Goldie SJ, Chung RTClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationCost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2008 Dec; 6(12):1418-24.Clin Gastroenterol Hepatol2008-08-19T00:00:002008Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis.19674282Rodriguez-Torres M, Sulkowski MS, Chung RT, Hamzeh FM, Jensen DMJournal of viral hepatitisFactors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population. J Viral Hepat. 2010 Feb 01; 17(2):139-47.J Viral Hepat2009-08-05T00:00:002009Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population.8227367Schmaier AH, Dahl LD, Rozemuller AJ, Roos RA, Wagner SL, Chung R, Van Nostrand WEThe Journal of clinical investigationProtease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. J Clin Invest. 1993 Nov; 92(5):2540-5.J Clin Invest1993-11-01T00:00:001993Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.16372286Blackard JT, Komurian-Pradel F, Perret M, Sodoyer M, Smeaton L, St Clair JB, Chapman S, Taylor LE, Paranhos-Baccalà G, Chung RTJournal of medical virologyIntrahepatic cytokine expression is downregulated during HCV/HIV co-infection. J Med Virol. 2006 Feb; 78(2):202-7.J Med Virol2006-02-01T00:00:002006Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection.16721231Pekow J, Chung RTJournal of clinical gastroenterologyTreatment of type II cryoglobulinemia associated with hepatitis C with rituximab. J Clin Gastroenterol. 2006 May-Jun; 40(5):450.J Clin Gastroenterol2006-05-01T00:00:002006Treatment of type II cryoglobulinemia associated with hepatitis C with rituximab.17045111Andrade-Sierra J, Contreras AM, Monteon FJ, Celis A, Gutierrez R, Montañez JL, Ruelas S, Baid-Agrawal S, Chung RTArchives of medical researchRisk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients. Arch Med Res. 2006 Nov; 37(8):961-6.Arch Med Res2006-11-01T00:00:002006Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients.17241881Kim SS, Peng LF, Lin W, Choe WH, Sakamoto N, Kato N, Ikeda M, Schreiber SL, Chung RTGastroenterologyA cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication. Gastroenterology. 2007 Jan; 132(1):311-20.Gastroenterology2006-10-21T00:00:002006A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication.18322936Swan T, Chung RTHepatology (Baltimore, Md.)Development of novel agents for the treatment of hepatitis C virus. Hepatology. 2008 Apr; 47(4):1426.Hepatology2008-04-01T00:00:002008Development of novel agents for the treatment of hepatitis C virus.21354229Goldwasser J, Cohen PY, Lin W, Kitsberg D, Balaguer P, Polyak SJ, Chung RT, Yarmush ML, Nahmias YJournal of hepatologyNaringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. J Hepatol. 2011 Nov; 55(5):963-71.J Hepatol2011-02-24T00:00:002011Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism.23246482Ding Q, Lee YK, Schaefer EA, Peters DT, Veres A, Kim K, Kuperwasser N, Motola DL, Meissner TB, Hendriks WT, Trevisan M, Gupta RM, Moisan A, Banks E, Friesen M, Schinzel RT, Xia F, Tang A, Xia Y, Figueroa E, Wann A, Ahfeldt T, Daheron L, Zhang F, Rubin LL, Peng LF, Chung RT, Musunuru K, Cowan CACell stem cellA TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell. 2013 Feb 07; 12(2):238-51.Cell Stem Cell2012-12-13T00:00:002012A TALEN genome-editing system for generating human stem cell-based disease models.20230822Lin W, Tsai WL, Shao RX, Wu G, Peng LF, Barlow LL, Chung WJ, Zhang L, Zhao H, Jang JY, Chung RTGastroenterologyHepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology. 2010 Jun; 138(7):2509-18, 2518.e1.Gastroenterology2010-03-12T00:00:002010Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner.21147189Zhang L, Jilg N, Shao RX, Lin W, Fusco DN, Zhao H, Goto K, Peng LF, Chen WC, Chung RTJournal of hepatologyIL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. J Hepatol. 2011 Aug; 55(2):289-98.J Hepatol2010-12-13T00:00:002010IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.Authorship 10017112Authorship 10064119Authorship 10073832Authorship 10016873Authorship 1006576328473813Tsai WL, Cheng JS, Shu CW, Lai KH, Chan HH, Wu CC, Wu JM, Hsu PI, Chung RT, Chang THFrontiers in microbiologyAsunaprevir Evokes Hepatocytes Innate Immunity to Restrict the Replication of Hepatitis C and Dengue Virus. Front Microbiol. 2017; 8:668.Front Microbiol2017-04-20T00:00:002017Asunaprevir Evokes Hepatocytes Innate Immunity to Restrict the Replication of Hepatitis C and Dengue Virus.28745025Simon TG, Bamira DG, Chung RT, Weiner RB, Corey KEObesity (Silver Spring, Md.)Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction. Obesity (Silver Spring). 2017 08; 25(8):1313-1316.Obesity (Silver Spring)2017-08-01T00:00:002017Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction.28714142Lok AS, Chung RT, Vargas HE, Kim AY, Naggie S, Powderly WGHepatology (Baltimore, Md.)Comments on cochrane review on direct-acting antivirals for hepatitis C. Hepatology. 2017 10; 66(4):1016-1019.Hepatology2017-08-26T00:00:002017Comments on cochrane review on direct-acting antivirals for hepatitis C.28714210Rosen HR, Ghany MG, Chung RT, Lok ASFHepatology (Baltimore, Md.)NAM 2017 report: A national plan to eliminate hepatitis B and C in the United States by 2030 and the AASLD's response. Hepatology. 2017 10; 66(4):1020-1022.Hepatology2017-08-30T00:00:002017NAM 2017 report: A national plan to eliminate hepatitis B and C in the United States by 2030 and the AASLD's response.28812869Colpitts CC, Chung RT, Baumert TFACS infectious diseasesEntry Inhibitors: A Perspective for Prevention of Hepatitis C Virus Infection in Organ Transplantation. ACS Infect Dis. 2017 09 08; 3(9):620-623.ACS Infect Dis2017-08-16T00:00:002017Entry Inhibitors: A Perspective for Prevention of Hepatitis C Virus Infection in Organ Transplantation.19445938Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MGGastroenterologyWeight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology. 2009 Aug; 137(2):549-57.Gastroenterology2009-05-13T00:00:002009Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.21384507Rogal SS, Landsittel D, Surman O, Chung RT, Rutherford ALiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyPretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation. Liver Transpl. 2011 Mar; 17(3):251-60.Liver Transpl2011-03-01T00:00:002011Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation.Authorship 1009406328864272Samur S, Bethea ED, Chung RT, Chhatwal JClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationReply. Clin Gastroenterol Hepatol. 2017 12; 15(12):1981.Clin Gastroenterol Hepatol2017-08-31T00:00:002017Reply.16369399Yachimski P, Chung RTMedGenMed : Medscape general medicineHepatitis B virus infection in liver transplant candidates and recipients. MedGenMed. 2005 Apr 18; 7(2):20.MedGenMed2005-04-18T00:00:002005Hepatitis B virus infection in liver transplant candidates and recipients.9381532Pascual M, Thadhani R, Chung RT, Williams WW, Meehan S, Tolkoff-Rubin N, Colvin R, Cosimi ABTransplantationNephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis. Transplantation. 1997 Oct 15; 64(7):1073-6.Transplantation1997-10-15T00:00:001997Nephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis.Authorship 1011439928887750Chan J, Gogela N, Zheng H, Lammert S, Ajayi T, Fricker Z, Kim AY, Robbins GK, Chung RTDigestive diseases and sciencesDirect-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment. Dig Dis Sci. 2018 02; 63(2):486-492.Dig Dis Sci2017-09-08T00:00:002017Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment.15963332Yachimski P, Chung RTCurrent infectious disease reportsUpdate on Hepatitis B and C Coinfection in HIV. Curr Infect Dis Rep. 2005 Jul; 7(4):299-308.Curr Infect Dis Rep2005-07-01T00:00:002005Update on Hepatitis B and C Coinfection in HIV.16315313McGuire BM, Bonkovsky HL, Carithers RL, Chung RT, Goldstein LI, Lake JR, Lok AS, Potter CJ, Rand E, Voigt MD, Davis PR, Bloomer JRLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyLiver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl. 2005 Dec; 11(12):1590-6.Liver Transpl2005-12-01T00:00:002005Liver transplantation for erythropoietic protoporphyria liver disease.17487861Pekow JR, Bhan AK, Zheng H, Chung RTCancerHepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer. 2007 Jun 15; 109(12):2490-6.Cancer2007-06-15T00:00:002007Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.Authorship 1012662328925068Davis MI, Chute DF, Chung RT, Sise MESeminars in dialysisWhen and how can nephrologists treat hepatitis C virus infection in dialysis patients? Semin Dial. 2018 01; 31(1):26-36.Semin Dial2017-09-18T00:00:002017When and how can nephrologists treat hepatitis C virus infection in dialysis patients?18972443McGovern BH, Abu Dayyeh BK, Chung RTHepatology (Baltimore, Md.)Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology. 2008 Nov; 48(5):1700-12.Hepatology2008-11-01T00:00:002008Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection.19337691Zhao HT, Endo S, Ishikura S, Chung R, Hogg PJ, Hara A, El-Kabbani OCellular and molecular life sciences : CMLSStructure/function analysis of a critical disulfide bond in the active site of L-xylulose reductase. Cell Mol Life Sci. 2009 May; 66(9):1570-9.Cell Mol Life Sci2009-05-01T00:00:002009Structure/function analysis of a critical disulfide bond in the active site of L-xylulose reductase.22911469Jilg N, Chung RTHepatology (Baltimore, Md.)One more piece in the interleukin 28B gene puzzle? The case of hepatitis B. Hepatology. 2013 Mar; 57(3):870-2.Hepatology2013-03-01T00:00:002013One more piece in the interleukin 28B gene puzzle? The case of hepatitis B.Authorship 101588813Authorship 1015350628964324Simon TG, Trejo MEP, Zeb I, Frazier-Wood AC, McClelland RL, Chung RT, Budoff MJMetabolism: clinical and experimentalCoffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis. Metabolism. 2017 10; 75:1-5.Metabolism2017-06-24T00:00:002017Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis.28882857Sise ME, Backman E, Ortiz GA, Hundemer GL, Ufere NN, Chute DF, Brancale J, Xu D, Wisocky J, Lin MV, Kim AY, Thadhani R, Chung RTClinical journal of the American Society of Nephrology : CJASNEffect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD. Clin J Am Soc Nephrol. 2017 Oct 06; 12(10):1615-1623.Clin J Am Soc Nephrol2017-09-07T00:00:002017Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.12021343Lauer GM, Ouchi K, Chung RT, Nguyen TN, Day CL, Purkis DR, Reiser M, Kim AY, Lucas M, Klenerman P, Walker BDJournal of virologyComprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol. 2002 Jun; 76(12):6104-13.J Virol2002-06-01T00:00:002002Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.12404247Contreras AM, Chung RTGastroenterologyHepatitis C virus in solid organ transplantation: not always a bad thing? Gastroenterology. 2002 Nov; 123(5):1729-33.Gastroenterology2002-11-01T00:00:002002Hepatitis C virus in solid organ transplantation: not always a bad thing?29045899Wolski D, Foote PK, Chen DY, Lewis-Ximenez LL, Fauvelle C, Aneja J, Walker A, Tonnerre P, Torres-Cornejo A, Kvistad D, Imam S, Waring MT, Tully DC, Allen TM, Chung RT, Timm J, Haining WN, Kim AY, Baumert TF, Lauer GMImmunityEarly Transcriptional Divergence Marks Virus-Specific Primary Human CD8+ T Cells in Chronic versus Acute Infection. Immunity. 2017 10 17; 47(4):648-663.e8.Immunity2017-10-17T00:00:002017Early Transcriptional Divergence Marks Virus-Specific Primary Human CD8+ T Cells in Chronic versus Acute Infection.16049213Tanabe KK, Blaszkowsky LS, Chung RT, Blake MA, Lauwers GYThe New England journal of medicineCase records of the Massachusetts General Hospital. Case 23-2005. A 57-year-old man with a mass in the liver. N Engl J Med. 2005 Jul 28; 353(4):401-10.N Engl J Med2005-07-28T00:00:002005Case records of the Massachusetts General Hospital. Case 23-2005. A 57-year-old man with a mass in the liver.16171895Yeung E, Chung RTJournal of hepatologyRethinking hepatitis C viral kinetics: Insights into host-virus interactions in 'difficult-to-treat' groups and implications for novel treatment approaches. J Hepatol. 2005 Nov; 43(5):748-50.J Hepatol2005-08-24T00:00:002005Rethinking hepatitis C viral kinetics: Insights into host-virus interactions in 'difficult-to-treat' groups and implications for novel treatment approaches.11861849Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, McGowan K, Rosenberg ES, Lucas M, Klenerman P, Chung RT, Walker BDJournal of virologyHuman immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol. 2002 Mar; 76(6):2817-26.J Virol2002-03-01T00:00:002002Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.15482189O'Leary J, Chung RTExpert review of anti-infective therapyNew antiviral therapies for hepatitis C. Expert Rev Anti Infect Ther. 2004 Apr; 2(2):235-43.Expert Rev Anti Infect Ther2004-04-01T00:00:002004New antiviral therapies for hepatitis C.Authorship 10204602Authorship 10181776Authorship 10185325Authorship 10191135Authorship 10196011529049502Lok AS, Chung RT, Vargas HE, Kim AY, Naggie S, Powderly WGAnnals of internal medicineBenefits of Direct-Acting Antivirals for Hepatitis C. Ann Intern Med. 2017 Dec 05; 167(11):812-813.Ann Intern Med2017-10-17T00:00:002017Benefits of Direct-Acting Antivirals for Hepatitis C.28444148Butt AA, Yan P, Chew KW, Currier J, Corey K, Chung RT, Shuaib A, Abou-Samra AB, Butler J, Freiberg MSClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaRisk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES. Clin Infect Dis. 2017 Aug 15; 65(4):557-565.Clin Infect Dis2017-08-15T00:00:002017Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES.29025729Masia R, McCarty WJ, Lahmann C, Luther J, Chung RT, Yarmush ML, Yellen GAmerican journal of physiology. Gastrointestinal and liver physiologyLive cell imaging of cytosolic NADH/NAD+ ratio in hepatocytes and liver slices. Am J Physiol Gastrointest Liver Physiol. 2018 01 01; 314(1):G97-G108.Am J Physiol Gastrointest Liver Physiol2017-10-12T00:00:002017Live cell imaging of cytosolic NADH/NAD+ ratio in hepatocytes and liver slices.29020156Powderly WG, Naggie S, Kim AY, Vargas HE, Chung RT, Lok ASClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaIDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C. Clin Infect Dis. 2017 11 13; 65(11):1773-1775.Clin Infect Dis2017-11-13T00:00:002017IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C.15867490Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJAIDS (London, England)Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS. 2005 May 20; 19(8):767-73.AIDS2005-05-20T00:00:002005Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.16940534Lin W, Kim SS, Yeung E, Kamegaya Y, Blackard JT, Kim KA, Holtzman MJ, Chung RTJournal of virologyHepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol. 2006 Sep; 80(18):9226-35.J Virol2006-09-01T00:00:002006Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain.17296533Lok AS, Everhart JE, Chung RT, Padmanabhan L, Greenson JK, Shiffman ML, Everson GT, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Ghany MG, Morishima CClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationHepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):245-54.Clin Gastroenterol Hepatol2007-02-01T00:00:002007Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.18161743Chung RT, Gale M, Polyak SJ, Lemon SM, Liang TJ, Hoofnagle JHHepatology (Baltimore, Md.)Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop. Hepatology. 2008 Jan; 47(1):306-20.Hepatology2008-01-01T00:00:002008Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.19231005Kim KA, Lin W, Tai AW, Shao RX, Weinberg E, De Sa Borges CB, Bhan AK, Zheng H, Kamegaya Y, Chung RTJournal of hepatologyHepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection. J Hepatol. 2009 Apr; 50(4):705-11.J Hepatol2009-02-14T00:00:002009Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection.19399793Andersson KL, Chung RTHepatology (Baltimore, Md.)Monitoring during and after antiviral therapy for hepatitis B. Hepatology. 2009 May; 49(5 Suppl):S166-73.Hepatology2009-05-01T00:00:002009Monitoring during and after antiviral therapy for hepatitis B.19633647Deshpande V, Sainani NI, Chung RT, Pratt DS, Mentha G, Rubbia-Brandt L, Lauwers GYModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncIgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol. 2009 Oct; 22(10):1287-95.Mod Pathol2009-07-24T00:00:002009IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material.19725787McGovern BH, Birch CE, Bowen MJ, Reyor LL, Nagami EH, Chung RT, Kim AYClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaImproving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis. 2009 Oct 01; 49(7):1051-60.Clin Infect Dis2009-10-01T00:00:002009Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria.20041407Moriguchi H, Chung RT, Sato CHepatology (Baltimore, Md.)An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cells. Hepatology. 2010 Mar; 51(3):1090-1.Hepatology2010-03-01T00:00:002010An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cells.Authorship 1022199429059461Bethea ED, Chen Q, Hur C, Chung RT, Chhatwal JHepatology (Baltimore, Md.)Should we treat acute hepatitis C? A decision and cost-effectiveness analysis. Hepatology. 2018 03; 67(3):837-846.Hepatology2018-01-24T00:00:002018Should we treat acute hepatitis C? A decision and cost-effectiveness analysis.18680242Martin NM, Abu Dayyeh BK, Chung RTWorld journal of gastroenterologyAnabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage. World J Gastroenterol. 2008 Jul 28; 14(28):4573-5.World J Gastroenterol2008-07-28T00:00:002008Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage.22189977Schaefer EA, Chung RTSeminars in liver diseaseThe impact of human gene polymorphisms on HCV infection and disease outcome. Semin Liver Dis. 2011 Nov; 31(4):375-86.Semin Liver Dis2011-12-21T00:00:002011The impact of human gene polymorphisms on HCV infection and disease outcome.22885329Rutherford A, King LY, Hynan LS, Vedvyas C, Lin W, Lee WM, Chung RTGastroenterologyDevelopment of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology. 2012 Nov; 143(5):1237-1243.Gastroenterology2012-08-08T00:00:002012Development of an accurate index for predicting outcomes of patients with acute liver failure.22919034Sahani DV, Agarwal S, Chung RTRadiologyThe double-edged sword of functional liver imaging. Radiology. 2012 Sep; 264(3):621-3.Radiology2012-09-01T00:00:002012The double-edged sword of functional liver imaging.Authorship 10240035Authorship 1022799529085919Simon TG, Kartoun U, Zheng H, Chan AT, Chung RT, Shaw S, Corey KEHepatology communicationsMELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD). Hepatol Commun. 2017 Jul; 1(5):429-438.Hepatol Commun2017-05-22T00:00:002017MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD).29085229Seraj SM, Campbell EJ, Argyropoulos SK, Wegermann K, Chung RT, Richter JMWorld journal of gastroenterologyHospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy. World J Gastroenterol. 2017 Oct 07; 23(37):6868-6876.World J Gastroenterol2017-10-07T00:00:002017Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy.2023-10-31CHUNG, RAYMOND T2017-11-03HIV, HCV, Hippo, and Liver Disease ProgressionR01AI136715Principal Investigator29122911Allegretti AS, Parada XV, Eneanya ND, Gilligan H, Xu D, Zhao S, Dienstag JL, Chung RT, Thadhani RIClinical journal of the American Society of Nephrology : CJASNPrognosis of Patients with Cirrhosis and AKI Who Initiate RRT. Clin J Am Soc Nephrol. 2018 01 06; 13(1):16-25.Clin J Am Soc Nephrol2017-11-09T00:00:002017Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.15656540Torriani FJ, Chung RTACP journal clubPeginterferon alpha-2a improved the hepatitis C virologic response in concurrent HIV and chronic hepatitis C virus infections. ACP J Club. 2005 Jan-Feb; 142(1):A12; author reply A13.ACP J Club2005-01-01T00:00:002005Peginterferon alpha-2a improved the hepatitis C virologic response in concurrent HIV and chronic hepatitis C virus infections.Authorship 1025592816148104Schulze zur Wiesch J, Lauer GM, Day CL, Kim AY, Ouchi K, Duncan JE, Wurcel AG, Timm J, Jones AM, Mothe B, Allen TM, McGovern B, Lewis-Ximenez L, Sidney J, Sette A, Chung RT, Walker BDJournal of immunology (Baltimore, Md. : 1950)Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol. 2005 Sep 15; 175(6):3603-13.J Immunol2005-09-15T00:00:002005Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes.16439867Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJAIDS (London, England)Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS. 2006 Feb 14; 20(3):345-51.AIDS2006-02-14T00:00:002006Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.17101320Bonkovsky HL, Naishadham D, Lambrecht RW, Chung RT, Hoefs JC, Nash SR, Rogers TE, Banner BF, Sterling RK, Donovan JA, Fontana RJ, Di Bisceglie AM, Ghany MG, Morishima CGastroenterologyRoles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. Gastroenterology. 2006 Nov; 131(5):1440-51.Gastroenterology2006-08-18T00:00:002006Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.17596833Tokumoto Y, Hiasa Y, Horiike N, Michitaka K, Matsuura B, Chung RT, Onji MJournal of medical virologyHepatitis C virus expression and interferon antiviral action is dependent on PKR expression. J Med Virol. 2007 Aug; 79(8):1120-7.J Med Virol2007-08-01T00:00:002007Hepatitis C virus expression and interferon antiviral action is dependent on PKR expression.11152496Wong DK, Dudley DD, Dohrenwend PB, Lauer GM, Chung RT, Thomas DL, Walker BDJournal of virologyDetection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J Virol. 2001 Feb; 75(3):1229-35.J Virol2001-02-01T00:00:002001Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV.29152763Simon TG, King LY, Chong DQ, Nguyen LH, Ma Y, VoPham T, Giovannucci EL, Fuchs CS, Meyerhardt JA, Corey KE, Khalili H, Chung RT, Zhang X, Chan ATHepatology (Baltimore, Md.)Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology. 2018 05; 67(5):1797-1806.Hepatology2018-03-26T00:00:002018Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.20034040Moriguchi H, Chung RT, Sato CHepatology (Baltimore, Md.)An identification of the novel combination therapy for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells. Hepatology. 2010 Jan; 51(1):351-2.Hepatology2010-01-01T00:00:002010An identification of the novel combination therapy for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells.15021833Delgado-Borrego A, Casson D, Schoenfeld D, Somsouk M, Terella A, Jordan SH, Bhan A, Baid S, Cosimi AB, Pascual M, Chung RTTransplantationHepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation. 2004 Mar 15; 77(5):703-10.Transplantation2004-03-15T00:00:002004Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation.Authorship 102786912Authorship 10287092429158528Huang H, Duggal P, Thio CL, Latanich R, Goedert JJ, Mangia A, Cox AL, Kirk GD, Mehta S, Aneja J, Alric L, Donfield SM, Cramp ME, Khakoo SI, Tobler LH, Busch M, Alexander GJ, Rosen HR, Edlin BR, Segal FP, Lauer GM, Thomas DL, Daly MJ, Chung RT, Kim AYScientific reportsFine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection. Sci Rep. 2017 Nov 20; 7(1):15843.Sci Rep2017-11-20T00:00:002017Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection.15660829Eichbaum QG, Dzik WH, Chung RT, Szczepiorkowski ZMTransfusionRed blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria. Transfusion. 2005 Feb; 45(2):208-13.Transfusion2005-02-01T00:00:002005Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria.Authorship 1029305729193564Carlton-Smith C, Holmes JA, Naggie S, Lidofsky A, Lauer GM, Kim AY, Chung RTJournal of viral hepatitisIFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR. J Viral Hepat. 2018 05; 25(5):465-472.J Viral Hepat2017-12-27T00:00:002017IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR.16361043Yeung E, Chung RTClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationMicroarrays and prediction of interferon response in chronic hepatitis C: not yet ready for prime time. Clin Gastroenterol Hepatol. 2005 Dec; 3(12):1192-4.Clin Gastroenterol Hepatol2005-12-01T00:00:002005Microarrays and prediction of interferon response in chronic hepatitis C: not yet ready for prime time.16707754Chung RT, Iafrate AJ, Amrein PC, Sahani DV, Misdraji JThe New England journal of medicineCase records of the Massachusetts General Hospital. Case 15-2006. A 46-year-old woman with sudden onset of abdominal distention. N Engl J Med. 2006 May 18; 354(20):2166-75.N Engl J Med2006-05-18T00:00:002006Case records of the Massachusetts General Hospital. Case 15-2006. A 46-year-old woman with sudden onset of abdominal distention.17559151Timm J, Li B, Daniels MG, Bhattacharya T, Reyor LL, Allgaier R, Kuntzen T, Fischer W, Nolan BE, Duncan J, Schulze zur Wiesch J, Kim AY, Frahm N, Brander C, Chung RT, Lauer GM, Korber BT, Allen TMHepatology (Baltimore, Md.)Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology. 2007 Aug; 46(2):339-49.Hepatology2007-08-01T00:00:002007Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.18326817Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HYBloodHemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood. 2008 May 15; 111(10):5195-204.Blood2008-03-07T00:00:002008Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.19070928Tai AW, Chung RTJournal of hepatologyTreatment failure in hepatitis C: mechanisms of non-response. J Hepatol. 2009 Feb; 50(2):412-20.J Hepatol2008-12-03T00:00:002008Treatment failure in hepatitis C: mechanisms of non-response.22296090John S, Chung RTThe New England journal of medicineEarly liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2012 02 02; 366(5):478; author reply 479.N Engl J Med2012-02-02T00:00:002012Early liver transplantation for severe alcoholic hepatitis.18482587Abu Dayyeh BK, Chung RTGastroenterologyBroadly neutralizing antibodies against hepatitis C virus: new hope for immunization? Gastroenterology. 2008 Jun; 134(7):2184-6.Gastroenterology2008-05-13T00:00:002008Broadly neutralizing antibodies against hepatitis C virus: new hope for immunization?Authorship 10307069Authorship 1033899929222916Chhatwal J, Samur S, Bethea ED, Ayer T, Kanwal F, Hur C, Roberts MS, Terrault N, Chung RTHepatology (Baltimore, Md.)Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study. Hepatology. 2018 06; 67(6):2085-2095.Hepatology2018-04-19T00:00:002018Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.29205416Li DK, Ren Y, Fierer DS, Rutledge S, Shaikh OS, Lo Re V, Simon T, Abou-Samra AB, Chung RT, Butt AAHepatology (Baltimore, Md.)The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study. Hepatology. 2018 06; 67(6):2244-2253.Hepatology2018-04-19T00:00:002018The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study.20105080Sherman KE, Rouster SD, Stanford S, Blackard JT, Shire N, Koziel M, Peters M, Chung RTThe Journal of infectious diseasesHepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. J Infect Dis. 2010 Mar; 201(5):712-9.J Infect Dis2010-03-01T00:00:002010Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.21791663Peng LF, Schaefer EA, Maloof N, Skaff A, Berical A, Belon CA, Heck JA, Lin W, Frick DN, Allen TM, Miziorko HM, Schreiber SL, Chung RTThe Journal of infectious diseasesCeestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J Infect Dis. 2011 Aug 15; 204(4):609-16.J Infect Dis2011-08-15T00:00:002011Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase.17983821Kim AY, Chung RTGastroenterologySex, drugs, and hepatitis C virus in men who have sex with men: evidence for permucosal transmission. Gastroenterology. 2007 Nov; 133(5):1734-6; discussion 1736-7.Gastroenterology2007-11-01T00:00:002007Sex, drugs, and hepatitis C virus in men who have sex with men: evidence for permucosal transmission.18619701Morgan TR, Lambrecht RW, Bonkovsky HL, Chung RT, Naishadham D, Sterling RK, Fontana RJ, Lee WM, Ghany MG, Wright EC, O'Brien TRJournal of hepatologyDNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. J Hepatol. 2008 Oct; 49(4):548-56.J Hepatol2008-06-05T00:00:002008DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.23420232Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao X, Abdel-Hamid M, Apps R, Carrington M, Thomas DLAnnals of internal medicineGenome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med. 2013 Feb 19; 158(4):235-45.Ann Intern Med2013-02-19T00:00:002013Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.Authorship 10377882Authorship 10379824Authorship 10369801629315738Bethea ED, Chen Q, Hur C, Chung RT, Chhatwal JHepatology (Baltimore, Md.)Reply. Hepatology. 2018 04; 67(4):1641-1642.Hepatology2018-02-27T00:00:002018Reply.29321333Duan X, Li S, Holmes JA, Tu Z, Li Y, Cai D, Liu X, Li W, Yang C, Jiao B, Schaefer EA, Fusco DN, Salloum S, Chen L, Lin W, Chung RTJournal of virologyMicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway. J Virol. 2018 04 01; 92(7).J Virol2018-03-14T00:00:002018MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.29325996Chute DF, Chung RT, Sise MEKidney internationalDirect-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient. Kidney Int. 2018 03; 93(3):560-567.Kidney Int2018-01-09T00:00:002018Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.20875418Kim AY, Kuntzen T, Timm J, Nolan BE, Baca MA, Reyor LL, Berical AC, Feller AJ, Johnson KL, Schulze zur Wiesch J, Robbins GK, Chung RT, Walker BD, Carrington M, Allen TM, Lauer GMGastroenterologySpontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology. 2011 Feb; 140(2):686-696.e1.Gastroenterology2010-09-24T00:00:002010Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.21136163Abu Dayyeh BK, Yang M, Dienstag JL, Chung RTDigestive diseases and sciencesThe effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort. Dig Dis Sci. 2011 Feb; 56(2):564-8.Dig Dis Sci2010-12-07T00:00:002010The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort.21942423Fusco DN, Chung RTAnnual review of medicineNovel therapies for hepatitis C: insights from the structure of the virus. Annu Rev Med. 2012; 63:373-87.Annu Rev Med2011-09-14T00:00:002011Novel therapies for hepatitis C: insights from the structure of the virus.22537441Schaefer EA, Chung RTGastroenterologyAnti-hepatitis C virus drugs in development. Gastroenterology. 2012 May; 142(6):1340-1350.e1.Gastroenterology2012-05-01T00:00:002012Anti-hepatitis C virus drugs in development.17477814Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RTJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine ResearchViral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res. 2007 Apr; 27(4):263-9.J Interferon Cytokine Res2007-04-01T00:00:002007Viral factors associated with cytokine expression during HCV/HIV co-infection.18090301Kang M, Chung RTJournal of acquired immune deficiency syndromes (1999)The role of early viral decline in the treatment of hepatitis C in HIV-1-coinfected persons. J Acquir Immune Defic Syndr. 2007 Nov 01; 46(3):371-3.J Acquir Immune Defic Syndr2007-11-01T00:00:002007The role of early viral decline in the treatment of hepatitis C in HIV-1-coinfected persons.19787818Corey KE, Kane E, Munroe C, Barlow LL, Zheng H, Chung RTHepatology (Baltimore, Md.)Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology. 2009 Oct; 50(4):1030-7.Hepatology2009-10-01T00:00:002009Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up.22480142Rodgers MA, Villareal VA, Schaefer EA, Peng LF, Corey KE, Chung RT, Yang PLJournal of the American Chemical SocietyLipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus. J Am Chem Soc. 2012 Apr 25; 134(16):6896-9.J Am Chem Soc2012-04-11T00:00:002012Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.Authorship 104404311Authorship 1044253729377504Long MT, Pedley A, Massaro JM, Hoffmann U, Ma J, Loomba R, Chung RT, Benjamin EJLiver international : official journal of the International Association for the Study of the LiverA simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study. Liver Int. 2018 08; 38(8):1495-1503.Liver Int2018-03-12T00:00:002018A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.29404462Schaefer E, Wu W, Mark C, Yang A, DiGiacomo E, Carlton-Smith C, Salloum S, Brisac C, Lin W, Corey KE, Chung RTHepatology communicationsIntermittent hypoxia is a proinflammatory stimulus resulting in IL-6 expression and M1 macrophage polarization. Hepatol Commun. 2017 06; 1(4):326-337.Hepatol Commun2017-05-18T00:00:002017Intermittent hypoxia is a proinflammatory stimulus resulting in IL-6 expression and M1 macrophage polarization.11594692Chung RT, Kim AY, Polsky BAntiviral chemistry & chemotherapyHIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy. Antivir Chem Chemother. 2001; 12 Suppl 1:73-91.Antivir Chem Chemother2001-01-01T00:00:002001HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.14552320Moriguchi H, Chung RT, Contreras AM, Izumi N, Uemura T, Kobayashi M, Sato CGastroenterologyThe interferon sensitivity determining region in the era of combination therapies and the rational use of such therapies for patients with HCV genotype 1b infection. Gastroenterology. 2003 Oct; 125(4):1284-6.Gastroenterology2003-10-01T00:00:002003The interferon sensitivity determining region in the era of combination therapies and the rational use of such therapies for patients with HCV genotype 1b infection.15459014Kim AY, Lauer GM, Ouchi K, Addo MM, Lucas M, Schulze Zur Wiesch J, Timm J, Boczanowski M, Duncan JE, Wurcel AG, Casson D, Chung RT, Draenert R, Klenerman P, Walker BDBloodThe magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood. 2005 Feb 01; 105(3):1170-8.Blood2004-09-30T00:00:002004The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1.15611288Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, Lucas M, Pillay T, Ouchi K, Reyor LL, Schulze zur Wiesch J, Gandhi RT, Chung RT, Bhardwaj N, Klenerman P, Walker BD, Allen TMThe Journal of experimental medicineCD8 epitope escape and reversion in acute HCV infection. J Exp Med. 2004 Dec 20; 200(12):1593-604.J Exp Med2004-12-20T00:00:002004CD8 epitope escape and reversion in acute HCV infection.10421401Chung RT, Monto A, Dienstag JL, Kaplan LMJournal of medical virologyMutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus. J Med Virol. 1999 Aug; 58(4):353-8.J Med Virol1999-08-01T00:00:001999Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus.16573786Fontana RJ, Sanyal AJ, Mehta S, Doherty MC, Neuschwander-Tetri BA, Everson GT, Kahn JA, Malet PF, Sheikh MY, Chung RT, Ghany MG, Gretch DRThe American journal of gastroenterologyPortal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am J Gastroenterol. 2006 May; 101(5):983-92.Am J Gastroenterol2006-05-01T00:00:002006Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial.12499895Sikaneta T, Williams WW, Chung RT, Cosimi AB, Pascual AMTransplantationRemission of hepatitis C virus-associated cryoglobulinemic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation. Transplantation. 2002 Dec 27; 74(12):1767-8.Transplantation2002-12-27T00:00:002002Remission of hepatitis C virus-associated cryoglobulinemic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation.7505215Chung RT, Kaplan LMComprehensive therapyParenterally transmitted hepatitis: viruses, vaccines, and antiviral therapy. Compr Ther. 1993; 19(4):163-73.Compr Ther1993-01-01T00:00:001993Parenterally transmitted hepatitis: viruses, vaccines, and antiviral therapy.